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The structure, known but not yet accessible by synthesis, 
is to the chemist what the unclimbed mountain, 
 the unchartered sea, the untilled field, 
the unreached planet, are to other men. 
R.B. Woodward 
 
 
Wonder is the beginning of all science. 
Aristotele, Metaphysics, I,2,982b 
 
 
Nothing great in the world has been accomplished without passion. 
F. Hegel 
 

Contents 
List of Abbreviations and Acronyms..................................................................... 12 
General Introduction .............................................................................................. 14 
Chapter 1 : Ellagitannins Structural Description and Total Synthesis ....... 17 
1.1 Ellagitannins : a class of bioactive plant polyphenols.................................... 18 
1.2 C-Glucosidic ellagitannins : A special subclass of ellagitannins ................... 24 
1.3 Biological activity of C-glucosidic ellagitannins ............................................. 30 
1.4 Ellagitannins Total Synthesis ........................................................................... 32 
1.5 HHDP-formation via oxidative biaryl coupling (Method A) ........................ 37 
1.5.1 Total synthesis of tellimagrandin I and II (4,6-HHDP) ....................................... 37 
1.5.2 Total synthesis of sanguiine H-5 (2,3-HHDP)...................................................... 39 
1.5.3 Total synthesis of pedunculagin (2,3,4,6-HHDP)................................................. 40 
1.5.4 Ullmann Coupling.................................................................................................. 41 
1.5.5 Total synthesis of corilagin (3,6-HHDP)............................................................... 44 
1.5.6 The strategy of Spring for the synthesis of sanguiin-H5...................................... 46 
1.5.7 PIFA mediated oxidative coupling attempts.......................................................... 47 
1.6 Enantiomerically pure Ellagitannins via double esterification of 
hexahydroxydiphenic acid       (Method B) ........................................................... 48 
1.6.A Enantioselective synthesis of a group (S)-HHDP ................................................ 49 
1.6.B Kinetic resolution................................................................................................... 51 
1.6.1 Total synthesis of strictinin (4,6-HHDP)............................................................... 52 
1.6.2 Total synthesis of gemine D, hippomanin A and 1,3-di-O-galloyl-4,6-O-(S)-
hydroxydiphenoyl--D-glucopyranoside (4,6-HHDP)................................................... 54 
1.6.3 Total synthesis of praecoxin B, pterocarinin C, pariin M and mahtabin A (2,3-
HHDP)............................................................................................................................. 55 
1.6.4 Khanbabee’s pedunculagin (2,3,4,6-HHDP) total synthesis................................ 58 
1.7 Hemisynthesis of a C-arylglucosidic ellagitannin .......................................... 59 
Chapter 2 : Retrosynthetic Analysis and Precursors Synthesis ................... 60 
2.1 Retrosynthetic analysis ..................................................................................... 62 
2.2 Synthesis of intermediate D.............................................................................. 65 
2.2.1 Synthesis of polyhydroxylated intermediate D3..................................................... 65 
2.2.2. Synthesis of sugar E.............................................................................................. 66 
2.2.3. “Biomimetic” approach to the D3 synthesis: esterification of the sugar E with 
gallic acid......................................................................................................................... 68 
2.2.4 Synthesis of completely protected galloyl units F0 ................................................ 70 
2.2.5 Preparation of intermediates D0 ............................................................................ 71 
2.2.6 Preparation of the itermediates D3 via orthogonal deprotection of precursors D0
.......................................................................................................................................... 72 
Contents 
 9
2.2.7 Synthesis of para-protected galloyl units F2.......................................................... 74 
2.2.8 Preparation of intermediates D2 ............................................................................ 75 
2.2.9 Protection of F2 units ............................................................................................. 76 
2.2.10 Preparation of intermediates D2’ ......................................................................... 77 
2.2.11 Preparation of the intermediates D2 via orthogonal deprotection of D2’ ........... 78 
2.3 Synthesis of inetrmediates B ............................................................................ 79 
2.4 Intermediates B via Biarylic oxidative coupling ............................................ 80 
2.4.1. o-chloranil mediated intramolecular biarylic oxidative coupling ....................... 80 
2.4.2 o-chloranil mediated oxidative coupling of 135b.................................................. 85 
2.4.3 o-chloranil mediated oxidative coupling of 135d.................................................. 87 
2.4.4 Cu(II)-amine complex promoted intramolecular biarylic oxidative coupling..... 88 
2.4.5 Cu(II)-amine complex mediate oxidative coupling of 149b ................................. 91 
2.5 Intermediates B via acetylation of a racemic unit (±)-HHDP....................... 93 
2.5.1 Synthesis of the racemic (±)-HHDP...................................................................... 94 
2.5.2 Installation of the HHDP unit on the sugar E...................................................... 95 
Chapter 3 : C-arylglucosidation Step............................................................ 100 
3.1 The key step of C-arylglucosidation .............................................................. 101 
3.2 Our approach to C-arylglucosidation............................................................ 103 
3.3 First C-arylglucosidation attempts:     Tanaka’s conditions .................... 106 
3.3.1 C-arylglucosidation on the architecture B (HHDP-bearing) ............................. 106 
3.3.2 C-arylglucosidation on the architecture D (two galloyl not coupled) ................ 107 
3.4 C-arylglucosidation attempts in organic solvents ........................................ 108 
3.5 C-arylglucosidation attempts in acid conditions on the architecture B ..... 109 
3.6 The C-arylglucosidation step.......................................................................... 112 
3.6.1 Reaction on (S)-158        work-up and products purification.......................... 112 
3.6.2 Products 175 and  characterization ................................................................ 114 
3.6.3 C-1 configuration determination ......................................................................... 119 
3.7 C-arylglucosidation on the architecture D.................................................... 121 
3.8 C-arylglucosidation attempts in acid conditions on a completely deprotected 
intermediate ........................................................................................................... 123 
3.9 Towards the NHTP-unit constuction:           C-arylglucosidation on the 
para-protected compound (S)-159 124 
3.9.1 C-arylglucosidation products of (S)-159 ............................................................. 127 
3.9.2 C-arylglucosidation on the architecture D.......................................................... 131 
Chapter 4 : Conclusion and perspectives...................................................... 132 
4.1 Conclusion and perspectives .......................................................................... 133 
4.2 Benzylidene cleavage and synthesis of O-5-degalloyl epipunicacortein A. 138 
Chapter 5 : Experimental Section ................................................................. 142 
Contents 
 10
5.1 General Methods ............................................................................................. 143 
5.2 Synthesis and characterization of products.................................................. 145 
Sugar precursors (E) ..................................................................................................... 145 
Galloyl units (F) ............................................................................................................ 153 
HHDP units (G)............................................................................................................. 161 
Sugar derivatives (D)..................................................................................................... 165 
General procedure a1 (Steglich esterification) : ..................................................... 165 
General procedure a2 (modified Steglich esterification) : ...................................... 165 
General procedure a3 : ............................................................................................ 165 
General procedure b1 (« two steps » acylation) : ................................................... 166 
Sugar derivatives HHDP bearing (B)........................................................................... 173 
Bis-esterification of glucose derivative 129 with HHDP unit................................ 173 
Bis-esterification of glucose derivative 30 with HHBP unit.................................. 178 
Synthons A..................................................................................................................... 186 
Annex 1................................................................................................................... 194 
Steglich Esterification ................................................................................................... 194 
Annex 2................................................................................................................... 197 
Palladium catalyzed hydrogenolysis ............................................................................. 197 
Annex 3................................................................................................................... 199 
NMR spectra of most significant intermediates of the synthesis................................. 199 
Table of Contents .................................................................................................. 219 
Résumé ................................................................................................................... 222 
References ........................................................................................................ 226 

List of Abbreviations and Acronyms 
 12
List of Abbreviations and Acronyms 
The bibliografic references are indicated as superscript and reported in the end of the 
manuscript.  
 
  Reflux 
Ac  Acetate 
anal.  Elemental Analysis 
aq.  Aqueous 
Ar  Aromatic 
Bn  Benzyl 
Bu  Butyl 
CC50  cytotoxic concentration 50%  
TLC  Thin Layer Chromatography 
CIMS  Chemical ionization mass spectrometry 
COSY  Correlation spectroscopy 
cat.  Catalytic 
Cq  Quaternary carbon 
DCC  N,N’-dicyclohexylcarbodiimide 
DDQ  2,3-dichloro-5,6-dicyano-p-benzoquinon 
DEAD  Diethylazodicarboxylate 
DHHDP  Dehydrohexahydroxydiphenoyl 
DIAD  Diisopropylazodicarboxylate 
DMAP  4-dimethylaminopyridine 
DMF  N,N-dimethylformamide 
DMSO  Dimethylsulfoxide 
DTBS  Di-tert-butylsilylene 
EC50  Effective concentation 50% 
EDCI  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EIMS  Electronic impact mass spectrometry 
eq  Equivalent 
ESIMS  Electrospray ionization mass spectrometry 
Et  Ethyl 
G  Galloyl unit 
Hex  Hexyl 
HHDP  Hexahydroxydiphenoyl 
HMBC  Heteronuclear multiple bond correlation 
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HMQC  Heteronuclear quantum correlation 
HPLC  High performance liquid chromatography 
HRMS  High resolution mass spectrometry 
Hz  Hertz 
IR  Infrared 
lit.  Literature 
Me  Methyl 
Mol. Wt.  Molar weight 
MOM  Methoxymethyl 
m.p.  Melting point 
NHTP  Nonahydroxyterphenoyl 
Nu  Nucleophile 
MOM  Methoxymethyl 
Ph  Phenyl 
PIFA  Bis(trifluoroacetoxyiodo)benzene 
ppm  Parts per million 
Pr  Propyl 
quant.  Quantitative 
Rf  Retention factor 
NMR  Nuclear Magnetic Resonance 
ROESY  Rotating frame Overhause effect spectroscopy 
RT  Room temperature 
TBAF  Tetrabutylammonium fluoride 
TBS  tert-butyl-dimethylsilyl 
TBDPS  tert-butyl-diphenylsilyl 
Tf  Triflate 
THF  Tetrahydrofuran 
UV  Ultraviolet 
 
General Introduction 
 14
General Introduction 
“No matter how many three-dimensional models of a compound are built, the number of time its 
connectivities are drawn on paper, or the length of time spent mentally contemplating its structural 
intricacies, these actions alone can never reveal all the secrets of a molecule. It is the physical act of 
creation, the process of synthesis, that holds the key unlocking some of these closely guarded and often 
highly valuable pieces of information. After all, every molecule, just like a person, is unique sum of its 
individual parts. Its physical characteristics, its personality, if you will, emerge from the specific 
combination of its atom bonds, and stereocenters; to remove or alter just one of these items would be 
essentially the same as close friend transforming in a complete stranger”1 
K.C. Nicolau 
 
Organic chemistry is a discipline that involves study of structure, properties, composition, 
reaction and preparation of hydrocarbons and their derivatives. 
Organic compounds are structurally diverse and their applications are numerous. They are 
constituents of many products (i.e. paints, plastics, food, explosive, drugs, petrochemicals, to 
name but a few) and, with very few exceptions, they form the basis of all earthly life 
processes. 
Organic synthesis of a novel compound is a problem solving task, where a synthesis is 
designed for a target molecule by selecting optimal reactions from optimal starting materials. 
A chemist that I had the opportunity to met during my Ph.D. compared once the organic 
chemist to an architect, a molecular architect, who builds molecular complex architectures, 
starting from simple molecular entities (the bricks) and exploiting their intrinsecal reactivity 
(the cement). 
Complex compounds can have tens of reaction steps that sequentially build the desired 
molecule.The scientific practice of creating novel synthetic routes for complex molecules is 
called total synthesis. 
There are several strategies to design a synthesis. The modern method of retrosynthesis, 
developed by E. J. Corey,2 starts with the target molecule and splices it into pieces according 
to known reactions. The pieces, or proposed precursors, receive the same treatment, until 
available and ideally inexpensive starting materials are reached. Then, the retrosynthesis is 
written in the opposite direction to give the synthesis. A “synthetic tree” can be constructed, 
because each compound and also each precursor has multiple syntheses.  
General Introduction 
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Accomplishing a total synthesis is far to be an easy task. The défaillances of the 
retrosynthetic plain due to an unexpected reactivity are generally – unfortunatly! - not 
discussed.  
 
 
 
But the defeats and difficulties are the main driving forces of this branch of chemistry. The 
defeats train and stimulate the discovery of new reactions, allow to evaluate the real potential 
of the available synthetic methodologies, contribute to the evaluation of theoretical 
hypothesis.  
Moreover, since a total synthesis project will often span a variety of reactions, it serves to 
prepare chemists for pursuit in process chemistry, where knowledge of chemical reactions 
and a strong and accurate sense of chemical intuition are necessary. 
 
The birth of this multifacet science that is organic synthesis is marked by Wöhler’s synthesis 
of urea in 1828.3 This milestone even as trivial as it may seem by today contributed to a 
demystification of Nature. Organic synthesis is considered, to a large extent, to be 
responsible for some of the most exciting and important discoveries of the twentieth century 
in chemistry, biology, and medicine, and it continues to fuel the drug discovery and 
General Introduction 
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development process with myriad processes and compounds for new biomedical 
breakthroughs and applications. 
 
It is in this context that the present thesis work is inserted with the aim to develop an efficient 
methodology to the synthesis of C-arylglucosidic ellagitannins, natural products 
characterized by interesting chemical and biological properties.  
The work herein exposed was carried out from february 2008 to december 2009 at the 
European Institute of Chemistry and Biology of Bordeaux, under the supervision of Dr. Denis 
Deffieux and Prof. Stéphane Quideau in the context of a collaboration between the 
Quideau’s research group at the University of Bordeaux I (France) and the research group 
directed by Prof. Stefano Manfredini at the University of Ferrara (Italy). 
In this thesis manuscript, a short historical perspective of ellagitannins isolation from natural 
sources and total synthesis is briefly discussed in the first chapter. The two following 
chapters have been focused on the synthetic strategy developed to the preparation of the 
advanced precursors of C-arylglucosidic ellagitannins. The conclusion and perspectives for 
future studies are discussed in the fourth chapter. Finally the fifth chapter contains the 
experimental section.  
 
The research project object of this study was winner of a fellowship (Bando Vinci 2008) from 
the French-Italian University, an institution that favors the scientific exchange between the 
two countries. Every year, hundreds of projects take part to the selection, and the research 
poject herein exposed was classified as 3rd.  
This PhD work has been object of several scientific communications to international 
congress: 
Oral Communications 
 VIII Giornata della Chimica dell’Emilia Romagna, 16 December 2008, Ferrara (Italy)  
Natangelo A., Malik G., Charris J., Deffieux D., Pouysegu L., Manfredini S., Quideau S. "Towards 
the total synthesis of C-aryl glycosidic ellagitannins for antitumoral evaluation" Prize for the best 
oral communication. 
 Journée scientifique de l’Institut des Sciences Moléculaires 12 December 2008, Bordeaux (France) 
Natangelo A., Malik G., Charris J., Deffieux D., Pouysegu L., Manfredini S., Quideau S., "Towards 
the total synthesis of C-arylglycosidic ellagitannins". 
Posters 
 IX Giornata della Chimica dell’Emilia Romagna, 4 December 2009, Bologna (Italy)  
Towards the total synthesis of C-glycosidic ellagitannins Vescalagin and Castalagin, A. 
Natangelo, G. Malik; J. Charris, D. Deffieux, L. Pouysegu, S. Manfredini and S.Quideau.  
 XXIVth International Conference on Polyphenols (ICP), 8-11 Juillet 2008, Salamanca (Espagne) 
Studies towards the total synthesis of nonahydroxyterphenoyl-containing C-glycosidic ellagitannin 
vestali, G. Malik, A. Natangelo, J. Charris, D. Deffieux, S. Quideau. 
.
 
 
 
 
 
 
 
 
 
 
 
Chapter 1  
 
Ellagitannins Structural Description  
and Total Synthesis 
 
In all things of nature there is something of the marvelous. 
Aristotele, Parts of Animals, I.645a16 
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1.1 Ellagitannins : a class of bioactive plant 
polyphenols 
Ellagitannins constitute one of the major classes of polyhydroxyphenyl-bearing polyphenols 
derived from the secondary metabolism of gallic acid in plant species of the Angiospermea.4 
This class of natural compounds has long been regarded as the active principles of many 
plant extracts used in traditional medicines.5,6  
Today, the regular intake of fruits and vegetables is highly recommended in the human diet, 
mainly because the polyphenols they contain are thought to play important roles in long-term 
health maintenance and reduction in the risk of chronic and degenerative diseases, such as 
atherosclerosis and cancer.7-13 
This increasing recognition of the benefits brought about by plant polyphenolics for human 
health has sparked a new appraisal of various plant-derived food and beverages, such as 
fruit juices, olive oil, chocolate, coffee, tea and even alcoholic beverages such as wine and 
cider. 
It has been suggested that France's high red wine consumption is a primary factor in the 
general trend of a low incidence of coronary heart disease in French people, despite having 
a diet relatively rich in saturated fats. This observation was defined “French Paradox” by Dr. 
Serge Rènaud, a scientist of Bordeaux University in France.12,14 
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1.1.1 Ellagitannins structural properties 
Ellagitannins belong to the hydrolyzable tannins family, a subclass of the group of tannin 
molecules. To date, after more than 50 years of investigations,6,15-27 more than 1000 
members of this subclass of hydrolyzable tannins have been isolated from various plant 
sources and fully characterized, thus constituting by far the largest group of known tannin 
molecules. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Tanninsclassification 4,28 
The ellagitannin chemical structures are basically composed of a central sugar core, typically 
D-glucopyranose, to which are esterified gallic acid units that are further connected together 
through C–C biaryl and C–O diaryl ether bonds as a result of intra- and intermolecular 
phenolic oxidative coupling processes.28-30 
The oxidative coupling of two galloyl units yields an axially chiral 6,6’-dicarbonyl-2,2’,3,3’,4,4’-
hexahydroxybiphenyl bisester group, commonly referred to as the hexahydroxydiphenoyl 
(HHDP) unit, which is the characteristic structural element of the monomeric ellagitannins 
(Figure 2). 
 
HO OH
OHOHHOHO
OO
HO OH
OHOHHOHO
OO
(S)-HHDP (R)-HHDP
S R
 
Figure 2. Axially chiral hexahydroxydiphenoyl biester (HHDP) 
TANNINS 
Condensed 
tannins 
Phlorotannins 
Gallotannins Ellagitannins 
Hydrolyzable 
tannins 
Complex 
tannins 
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The chirality is due to the atropisomerism caused by the inhibition of free rotation around the 
axis.  
In the majority of ellagitannins with an axially chiral glucose-bond HHDP unit, both the 
configuration of the biaryl unit and the conformation of the glucosyl unit are determined by 
their linkage positions. An HHDP unit bound to the 2,3- or 4,6- or 1,6-positions of D-
glucopyranose in the natural products always has the (S)-configuration, while most 2,4- or 
3,6-coupled HHDP units favor the (R)-configuration. 
Two chair conformations can be distinguished, designated 4C1 and 1C4, respectively. The first 
numeral indicates the number of the ring carbon atom above the “seat of the chair (C),” and 
the second numeral (subscript) indicates the number of the ring carbon atom below the plane 
of the seat (spanned by C-2, C-3, C-5, and the ring O). Chair conformations are designated 
from structures with the ring oxygen atom in the top right corner of the ring “seat,” resulting in 
the clockwise appearance of the ring numbering.  
 
O OOH
OH
HO
HO
HO
OH
OH
OH
OH
HO
1
4
4C1
1
4
1C4  
Figure 3. Chair conformations of D-glucose 
The resulting D-glucose conformation in ellagitannins is determined by the coupling positions 
of the HHDP unit to the glucopyranose ring. While the glucopyranosyl assumes a 4C1 
conformation in the case of 2,3- or 4,6-HHDP coupling, a 1,6- or 3,6- or 2,4-HHDP coupling 
always favors the thermodynamically less stable 1C4 conformation. 
1.1.2 Hydrolyzable tannins classification basisd on their 
structural properties 
A. Haslam’s classification 
Hydrolyzable tannins natural products are more than 1000 different molecular entities 
emanating from a single precursor [-penta-O-galloyl-D-glucopyranose (-PGG, 28)], 
characterized by the presence of five gallic acid units esterified on a central D-glucose 
core.31  
 The resulting structural variety is so large that subdividing it into distinct categories in 
a logically ordered manner was far from being a trivial task. 
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Haslam et coll. first proposed to subdivide the two known subclasses of hydrolyzable tannins 
(i.e., gallotannins and ellagitannins) into three groups A, B and C (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Hslam’s hydrolyzable tannins classification 
B. Okuda’s classification 
A second more exhaustive classification was proposed by Okuda 19,20,32 on the basis of the 
oxidation level of the galloyl ester groups.  
Gallotannins are so classified as type-I hydrolyzable tannins. Type II gathers the HHDP-
bearing ellagitannins at 2,3 and 4,6 positions with a D-glucopyranose in 4C1 stable 
conformation (atropoisomery of HHDP unit is exclusively S). The monomeric tellimagrandins 
I and II (1 and 2, Tellima grandiflora), casuarictin (6, Casuarina stricta),33 pedunculagin (8) 
and potentillin (7, Potentilla kleiniana)34,35 belong to this class. 
O
R1
O
OO
OO
O
O
O
HO
HO
HO
HO
HO
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HO
HO
HO
HO OH
HO
6: R1 = -OG, casuarictin  
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O
HO
HO
HO
HO OH
HO
3: R1 = -OG, R2 = G, pterocarinin C
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O
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Figure 5. Okuda’s classification of hydrolyzable tannins : monomeric ellagitannins of type II 
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Gallotannins 
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Type III ellagitannins are those featuring the DHHDP unit. In this case the most common 
conformation of D-glucopyranose is the 1C4 as exemplified in the structure of geraniin (9, 
Geranium thunbergii).36 The only exception is rapresented by the isoterchebin (22, Citynus 
hypocystis), characterized by the presence of a DHHDP unit at the 4,6- position of a D-
glucopyranose core in 4C1 conformation (Figure 6). 
 
O
O
O
OG
O
O
O O
O
HO
HO
OH
O
OH
OH
HOHO
HO
OH OH
OH
O
O
9: Geraniin
1C4
H
O
OG
O
OGO
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O
O
HO
HO
O
HO
OH O
OH
H
 10: Isoterchebin
4C1
DHHDP
unit
6
4
24
6
3
HHDP-unit
DHHDP
unit
R
Citynus hypocystis
 
Figure 6. Okuda’s classification of hydrolyzable tannins : monomeric ellagitannins of type III 
 
Ellagitannins in which the DHHDP unit has suffered additional transformations, such as the 
chebulagic acid (11) and ascorgeraniin (13), constitute the type-IV group. The chebuloyl and 
elaeocarpusoyl ester groups are only two examples of a large series of ester units derived 
from the parent DHHDP unit.  
Several other DHHDP-derived units have been identified as resulting from the condensation 
reaction of ascorbic acid and geraniin (9) DHHDP unit to give ascorgeranin (or 
elaeocarpusin, 12)37,38 (Figure 7). 
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Figure 7. Okuda’s classification of hydrolyzable tannins : monomeric ellagitannins of type IV  
 
This classification still left out many monomeric ellagitannins deriving from structural 
modifications as the opening of the D-glucopyranose core, the formation of C-arylglucosidic 
bonds and condensation reactions taking place at the glucose C-1. Since these ellagitannins 
mostly display the characteristic structural features of compounds belonging to primary types 
II-IV, Okuda et coll. classified these structures into types II+-IV+.19 
Type II+ principally gathers HHDP-bearing C-arylglucosidic ellagitannins, such as stachyurin 
(18, Figure 9). The dehydroellagitannins with moieties resulting from a diaryl ether linkage 
with another polyphenolic unit belong to the type-III+ group. For examples, we can notice 
rugosins A and B (15 and 16, Rosa rugosa)39 and coriariin B (14, Coriaria japonica),40 with a 
valoneoyl group linked to the 3,6-positions of a 2,4-DHHDP-bearing glucopyranose. 
Transformed dehydroellagitannins that feature moieties resulting from a C–C linkage with 
another polyphenolic unit belong to the type-IV+ group. The camelliatannin F (17, Camellia 
japonica)27 is an example (Figure 8). 
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Figure 8. Okuda’s classification of hydrolyzable tannins : monomeric ellagitannins of type III+ and IV+ 
This classification work becomes further complicated by the fact that ellagitannins of types II 
and II+ oligomerize via various modes basisd on oxidative coupling reactions between free 
and C–C-coupled galloyl groups, as well as on condensation reactions at the C-1 center of 
C-glucosidic ellagitannins.  
The description of these further classes goes over the purpose of these manuscript of thesis. 
The aim of this introduction was in fact to collocate the C-arylglucosidic ellagitannins in the 
context of the family of hydroyzable tannins.  
For more details, see the book recently edited by S. Quideau completely dedicated to 
ellagitannins chemistry.31 
1.2 C-Glucosidic ellagitannins :                                
 A special subclass of ellagitannins 
C-arylglucosidic ellagitannins constitute a tannin subclass in which a C–C bond links the C-1 
atom of an “open-chain” glucose core to the C-2’ atom of a galloyl-derived unit esterified to 
the 2-position of the glucose core. Their C-1-linked galloyl-derived unit is either part of a 
HHDP ester group bridging the 2- and 3-positions of the glucose core, as exemplified in the 
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punicacorteins 23 and 24 or part of a terarylic nonahydroxyterphenoyl (NHTP) variant (also 
known as the flavogalloyl group) that is attached via three ester bonds to the 2-, 3- and 5-
positions of the glucose core, as exemplified in the structures of vescalagin (21) and 
castalagin (22). In addition to these examples, one can also cite their 5-degalloylated 
analogues, as the casuariin (20), first isolated from Stachyurus (Stachyuraceae) and 
Casuarina (Casuarinaceae) species,33,41 together with stachyurin (18) and casuarinin 
(19).16,33,41 
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Figure 9. C-arylglucosidic ellagitannins 
Punicacortein A (23a) was isolated for the first time in 1986 by Nishioka et coll. from Punica 
granatum42 and was also found in Rosa taiwanensis43 and Osbeckia chinesis.44 
Punicacortein A (23) presumably results from hydrolytic cleavage of the 4,6-HHDP unit of 
casuarinin (19). Its degalloylated form 24 was isolated for the first time in 1988 by Osawa 
from Osbeckia Chinensis.44 
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Figure 10. Punicacortein A and its C-1 epimer 
Punica granatum 
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Epipunicacortein A (23b) was isolated for the first time in 1991 by Nishioka et coll. from 
Quercus aliena.45  
Vescalagin (21) and its C-1 epimer castalagin (22) were isolated from Castanea (chestnut) 
and Quercus (oak) woody species of the Fagaceae family for the first time by Mayer et coll.46-
48 Their structures were fully determined much later after revision of their respective 
configuration at C-1 by the Nishioka’s group.25 In addition to this C-arylglucosidic 
ellagitannins, oak heartwood contains two compounds, named vescalin (25) and castalin 
(26), that, as vescalagin and castalagin, are also extracted from oak by the wine during 
aging.49 Their occurrence in oak presumably results from hydrolytic cleavage of the 4,6-
HHDP unit of 21 and 22, and their presence in wine can additionally be due to the same 
hydrolysis taking place in the wine itself.  
They were hemisynthesized by Quideau et coll.50 by adaptation of the method previously 
described by Scalbert et coll.51,52 After 39h at 60°C in a 10% aqueous HCl solution, 
vescalagin (21) was converted into 25 (81% yield) with concomitant formation of ellagic acid 
(78), the bis-lactone formed from the release of the 4,6-HHDP unit. 
Hydrolysis of castalagin (22) took longer (65h) to go to completion under the same 
conditions, and surprisingly led to a 65:35 mixture of 26 and 25. Other minor product formed 
is the vescalene (27). It was hypotised that the formation of 25 was due, in this case, to an 
epimerization of 26. 
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Figure 11. NHTP-bearing C-arylglucosidic ellagitannins 
1.2.1 C- arylglucosidic ellagitannins biosynthesis 
The biosynthetic steps leading to glucopyranosic ellagitannins from their gallotannin 
precursor, β-pentagalloylglucopyranose (β-PGG, 28), are just today starting to get 
elucidated, thanks to the work initiated by Gross.53  
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Pentagalloylglucose (28) has been individuated as immediate precursor of two subsequent 
routes, one leading to gallotannins which are characterized by additional galloyl residues 
bound to the pentagalloylglucose core; the other leading to ellagitannins via oxidative 
processes that yield C–C linkages between adjacent galloyl groups of pentagalloylglucose.  
In 1950, Schmidt and Mayer15,54 were the first to postulate that the HHDP residues of 
ellagitannins should originate from the dehydrogenation of neighboring galloyl groups of 
pentagalloylglucose (28).  
This hypothesis was confirmed by Haslam in 1994.30 They suggested that the two galloyl 
groups at C-4 and C-6 can be interconnected to form one HHDP group, thus yielding 
tellimagrandin II (2) as a primary ellagitannin metabolite that can be subjected to further 
oxidation reactions to give casuarictin (6). 
Niemetz and Gross confirmed this hypotesis.55 They found that the oxidation of -PGG (28) 
catalyzed by an oxidase extracted from the leaves of Tellima grandiflora led to the formation 
of tellimagrandin II (2) in a regiospecific and stereospecific way. 
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Scheme 1. -PGG oxidation to tellimagrandin II 
 
The biochemical event that mediates the passage from the glucopyranosic ellagitannin to the 
open-chain C-glucosidic ellagitannin class remains a matter of speculation. Interesting 
observations have been made from the study of a plant species in which members of the two 
classes co-exist.16,56,57 It was proposed the following biogenetic filiation (Scheme 2): from 
tellimagrandin II (2) to casuarictin (6) via oxidative C–C coupling between the 2- and 3-galloyl 
groups followed by 1-O-degalloylation to pedunculagin (8).56 
Tellima grandiflora 
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Scheme 2. Proposed biosynthetic pathway from tellimagrandin II to C-arylglucosidic ellagitannins 
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Further investigations on Liquidambar formosana enabled the Okuda group to find one 
important piece of the puzzle missing. They isolated the open-chain aldehyde liquidambin 
(29)58 (Scheme 2). One can thus assume that an opening of the pedunculagin (8) 
glucopyranose ring is the first key event that opens up the door to the C-glucosidic 
ellagitannins. Then follows the intramolecular aldol-type nucleophilic addition of the phenolic 
2,3-HHDP unit to the aldehyde function of the resulting liquidambin (29), thus giving rise to a 
C-glucosidic bond such as in stachyurin (18) and its C-1 epimer casuarinin (19). Their HHDP 
hydrolysis leads to punicacortein A (23), while the oxidative coupling between the 5-galloyl 
and 2,3-HHDP groups would furnish vescalagin (21).13 
The proposed biosinthetic pathway (Scheme 2) is just an hypotesis. The order of the 
transformation and their mechanism is incertain. 
  30
1.3 Biological activity of C-glucosidic ellagitannins 
Many plant species containing ellagitannins have been used for the treatment of diseases, 
especially in Asia:59 it is notable that the comparison of the amounts and pharmacological 
properties of ellagitannins and other components in plants shows that some of these 
ellagitannins could be playing the main role in the medicinal application of these plants 
(Table 1). 
Ellagitannins share with other polyphenols two fundamental physico-chemical properties that 
are often cosidered responsible of their therapeutic action in traditional herbal remedies. The 
first one is their capability to scavenge reactive oxygen species in cellular prooxidant states 
and/or oxidatively generated free radicals such as those derived from lipid oxidation. This 
antioxidant activity is commonly thought to enable the prevention of age-related health 
deteriorations such as carcinogenesis, neurodegenerative and cardiovascular diseases, 
including atherosclerosis. 
The second property common to other polyphenols is the complexation of proteins through 
weak interactions between peptide side chains and polyphenol aromatic rings.12 
Besides these general activities basisd on chemical reactivity and structural features 
common to any polyphenolic substance (i.e., antioxidation and complexation), ellagitannins 
are capable of expressing remarkable biological activities such as antibacterial activity, 
antitumor and antiviral effects. 
The molecular mechanism at the basis of these effects is not yet fully elucidated.  
Recent studies have showed that the HHDP unit of ellagitannins confers them a globular 
structure very organized that renders them capable of interacting in a specific manner with 
biological target defined as some proteins involved in DNA replication.29,50  
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Geranium thunbergii  
(geraniin) 
 
Mallotus japonicus  
(mallotusinic acid) 
 
 
 
Agrimonia pilosa  
(agrimoniin) 
 
 
   
 
Cornus officinalis  
(cornusiin A) 
 
 
 
Punica granatum  
(granatin B) 
 
 
 
Geum japonicum  
(gemin A) 
 
 
  
 
Rosa rugosa  
(rugosin A) 
 
 
Trapa japonica  
(trapanin B) 
 
 
 
Liquidambar formosana 
(casuarictin) 
 
 
   
 
Camellia japonica  
(carmelliatannin A) 
 
 
Oenothera erythrosepala  
(oenithenin B) 
 
 
Terminalia chebula  
(chebulinic acid) 
 
Table 1. Selection of ellagitannin-rich medicinal plants31 
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A. Antiviral activity 
Several monomeric and dimeric ellagitannins, as tellimagrandin I (1) and geraniin (9)60,61 
inhibit replication of Herpes simplex virus in vitro by blocking viral adsorption to cultured cells 
with EC50 ranging from 20 to 100 nM and CC50 > 16 µM.62  
Many dimeric ellagitannins have been found able to inhibit the reverse transcriptase from 
RNA tumor virus.63 Other ellagitannins as gemin D64 (monomeric) and camelliin B65 (dimeric) 
have shown potent inhibitory effect on HIV reverse transcriptase activity.66 
B. Antitumoral activity 
Several reports have been reported in the last decades on the inibitory effect of polyphenols 
on the incidences and propagation of cancers.  
Several ellagitannins extracted from plants are inhibitors of human topoisomerase II (top2).67 
DNA top2 are ubiquitous nuclear enzyme that are essential for the removal of torsional 
constraints associated with DNA processes such as replication, transcription, chromosome 
condensation and segregation.68-70 They cleave the DNA backbone, leading to the formation 
of top2-DNA covalent cleavage complexes and to transient DNA double-strand breaks that 
allow the passage of intact DNA duplexes through the breaks. DNA continuity is then 
restored by the reverse reaction referred to as religation.  
Thus top 2 enzym represent attractive targets for the inhibition of cell proliferation.  
Various natural products were tested for their potential antiproliferative activity and their 
inhibitory status towards DNA top2. In particular some C-arylglucosidic ellagitannins tested 
resulted to be fully inhibitors of the top2 mediated decatenation of kinetoplastic DNA in 
vitro.50,71 Among the most active molecules there are the epimeric pair vescalin (25) and 
castalin (26), together with vescalen (27). 
1.4 Ellagitannins Total Synthesis 
The above mentioned biological properties, and the fact that ellagitannins are usually non 
toxic for humans, make them important and interesting compounds for pharmaceutical 
purposes. However, the full exploitation of their chemistry and mode of action is hindered by 
their limited accessibility in adeguate purity and amount from natural sources. Therefore the 
development of efficient synthetic routes towards the ellagitannins has received considerable 
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attention in the last years to improve the availability of lead compounds and to develop 
methodologies for the generation of analogues with enhanced pharmacological properties.  
 
The first total synthesis of an ellagitannin, the tellimagrandin I (1), was reported by Feldman 
in 1994.72 Since there, several total synthesis of natural ellagitannins72-92 and their 
permethylated derivatives93-96 were successively reported.  
The state of art on the ellagitannins total synthesis has been recently reviewed.29,31,85  
 
The challenge for total synthesis untill today reported, was centered on achieving 
chemoselectivity, regioselectivity and stereoselectivity in the formation of the HHDP unit.  
For these purposes, two general approaches have been developed (Scheme 3):  
Method A : In the first approach, developed by Feldman in 1994,72 the biaryl part of 
ellagitannins is constructed by the intramolecular diastereoselective oxidative coupling of two 
galloyl units (I), judiciously protected, attached to the D-glucose (II); 
Method B : The second methodology involves a double esterification approach, in which an 
appropriately protected diphenic acid V is esterified with the sugar derivative II, to give IV 
directly. This concept was introduced by Meyers in 1994.93 
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Scheme 3. Two approaches towards ellagitannins total synthesis 
In any case the evaluation and appropriate choice of protecting groups has a key role. The 
protecting groups must answer to two exigencies: (i) be orthogonal on the sugar and on the 
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galloyl unit; (ii) mainly in the case of the method A, allow the galloyl oxidative coupling with 
preservation of the ester linkages. 
 
The early recognition that galloylated glucose substrates were likely to be biosynthetic 
precursors of the HHDP-containing ellagitannin products spurred much effort at developing 
oxidative coupling protocols which effected this transformation in vitro. Numerous studies 
from 1916 detailed the consequences of exposing various galloyl esters to a set of oxidizing 
conditions. In those cases where products could be identified, biaryl bond formation was 
detected in low yields.  
This conspicuous failure to observe HHDP formation upon oxidative coupling of galloyl esters 
can be traced to the polyhydroxylic nature of the product (overoxidation, lactonization) it 
seemed plausible that prospecting among various partially etherified gallate derivatives as 
suitable candidates for controlling oxidation might prove rewarding. 
 
In order to simplify the representation, the different protected galloyl units will be described 
as represented in Figure 12. 
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Figure 12. Abbreviation for the differently protected galloyl units 
1.4.1 Stereochemistry of HHDP 
One of the critical issue raised by the conversion of glucose-bound galloyl esters to an HHDP 
unit is the stereochemistry of bond formation. The oxidative coupling of two galloyl units 
yields an axially chiral 6,6’-dicarbonyl-2,2’,3,3’,4,4’-hexahydroxybiphenyl bisester group, 
commonly referred to as the hexahydroxydiphenoyl (HHDP) unit. 
The chirality is due to the atropisomerism (from the Greek, a = not and tropos = turn)97,98 
resulting from hindered rotation around the single C-C bond where the steric strain barrier to 
rotation is high enough to allow for isolation of two conformers. Atropisomers differ from other 
chiral compounds in that they can be equilibrated thermally whereas in the other forms of 
chirality, isomerization is usually only possible chemically. 
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The most important class of atropisomers is constituted by biaryls with a complete set of 
ortho substituents. A minumum of three substituents is enough to have a barrier to rotation at 
room temperature.99 
In general, there are two necessary preconditions for axial chirality in biaryl molecules (I, 
Figure 12): a rotationally stable axis and the presence of different substituents on both sides 
of the axis A ≠ B and A’ ≠ B’.  
 
HO Me
Me OH
A'
A B
B'
I
*
OH
OH
Me Me
Me Me
Me
Me
H2N
NH2
N
N
HOOC COOH
HOOC COOH
Ph
Ph HO COO
HO COO
OH
OH
HO
HO
V
HHDP unit
II III
IV
* *
*
*
 
Figure 13. Selected substitution patterns that result in axial chirality98 
If A = A’ and B = B’, the molecule has C2 symmetry (but is still chiral) as in III and IV (Figure 
13). Axially chiral biaryl compounds that bear different ortho substituents (II), are the most 
frequent. Surprisingly, even biaryl compounds with four constitutionally identical substituents 
may be chiral if these are connected pair wise through two bridges (III-IV). Although less 
common, axial chirality may also result from an inequivalence of meta substituents (III). 
Furthermore, heteroaromatic systems provide the possibility to introduce chirality merely 
from the position of the heteroatom (IV). 
The absolute axial configuration99,100 can be denoted by analysis of a Newman projection 
along the biaryl axis (Figure 14). After assignment of priority to the ortho-ortho (or meta-meta 
if A = B and A’ = B’) substituents according to the Cahn-Ingold-Prelog (CIP) rules. The 
priority order for the substituents is assigned on the first aromatic cycle: (1) for the group with 
major priority and (2) for the other. In the same way, for the distal ring the highest priority 
substituent is (1’) and (2’) for the other. 
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Priority A>B and D>E according to CIP rules 
Figure 14. Assignment of absolute configuration in chiral biaryl species98 
The analysis is done by following the shortest 90° path from the substituent of highest priority 
at the proximal ring to the highest-ranking one at the distal ring (i.e. here from A to A’). If this 
90° turn is counterclockwise, the absolute configuration is M (for minus); if it is clockwise, 
then the descriptor is P.98 
The second avalaible nomenclature employs the (aR) and (aS) descriptors where « a » stays 
for axial. In this case the highest priority is assigned to the proximal ring. The rotation path is 
from (1) to (2) then (1’) to (2’). The configuration is (aR) if the path is clockwise, (aS) for the 
counterclockwise turn. 
There is always a correspondence P  (aS) and M  (aR). 
(In the following discussion the simplest notation S or R will be employed).  
The HHDP (V, Figure 13), key structural elements of ellagitannins family, is characterized by 
an axial chirality. 
In the majority of ellagitannins with an axially chiral glucose-bond HHDP unit, both the 
configuration of the biaryl unit and the conformation of the D-glucosyl unit are determined by 
their linkage positions.  
An HHDP unit bound to the 2,3- or 4,6- or 1,6-positions of D-glucopyranose in the natural 
products always has the (S)-configuration, while most 2,4- or 3,6-coupled HHDP units favor 
the (R)-configuration. 
These observations have led Schmidt15,54 and Haslam101-104 to postulate that the 
stereochemical outcome of biaryl formation in ellagitannin systems is dictated by the 
conformational preferences of the galloylated glucose core. The successful “biomimetic” 
diastereoselective bigalloyl coupling transformations briefly discussed in the following section 
are the first demonstrations of the validity of the Schmidt- Haslam hypothesis. 
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1.5 HHDP-formation via oxidative biaryl coupling 
(Method A) 
Feldman was the first to develop an efficient methodology for the diastereoselective 
formation of HHDP105,106 that was applied to the first total synthesis of tellimagrandin I (1) in 
1994. 
The diastereoselective formation of the crucial biphenyl C-C bond between monophenol 
galloyl moieties (G2OH) at O-2 and O-3 positions on an appropriately protected glucose-
derived precursor was realized by oxidation with Pb(OAc)4 (Wessely oxidation). 
This Pb(OAc)4  mediated oxidation was then extended to several ellagitannnins total 
synthesis realized by Feldman et coll.29,72-74,77,81,83,84,88 
1.5.1 Total synthesis of tellimagrandin I and II (4,6-
HHDP) 
Tellimagrandins I (1) and II (2) are characterized by the presence of a (S)-HHDP unit at 4,6- 
of a D-glucopyranose and two other galloyl moieties at the positions 2 and 3. Tellimagrandin 
II (2) has an additional galloyl unit at the anomeric position of the sugar. The synthetic 
strategies (Scheme 4) are identical for the two molecules, the difference being the protecting 
group strategy at the anomeric position of the starting sugar (30 or 31).29,72,81  
The starting sugar (30, for tellimagrandin I; with a photolabile ortho-nitrobenzyle and 31, for 
tellimagrandin II) was protected with a benzylidene group at 4,6 position. The alcohol 
functions were esterified in the Keck107 modified Steglich108 conditions with perbenzylated 
gallic acid (32 = G1OH). The benzylidene was then removed by hydrolysis and the alcoholic 
functions generated were esterified with an opportunely protected gallic acid moiety 35 (= 
G2OH) to give, after desilylation with tetrabutylammonium fluoride (TBAF) the compounds 36 
and 37. The key step of stereoselective coupling was then realized with Pb(OAc)4 to give 38 
and 39 (only S atropisomer was obtained!) as a mixture of regioisomeric diphenyl ketal 
isomers. Simple hydrogenation of this mixture liberated all the hydroxyl moieties and 
furnished natural tellimagrandin I (1) completely free of contaminants with an overall yield of 
51% on 6 steps. 
Tellimagrandin II (2) was obtained via a two steps deprotection/protection strategy on the 
mixture 39 leading to the perbenzylated compound 40. The selective removal of the 
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photolabile ortho-nitrobenzyl followed by -selective acylation at the anomeric position and 
hydrogenolysis lead tellimagrandin II (2) with an overall yield of 1% in 10 steps. 
(Feldman supposed that the presence of the electron poor ortho-nitrobenzyl group at the 
anomeric position is the cause of the lower yield obtained in the case of tellimagrandin II). 
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Scheme 4. Tellimagrandin I and II total synthesis 
 
A more concise alternative synthetic strategy was proposed by Feldman for the 
tellimagrandin I synthesis (Scheme 5).72,77  
In this case, the starting sugar derivative (43), bearing four galloyl moieties G2, was 
employed to explore the possibility of having a regioselective O-4,O-6 galloyl coupling. 
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Upon treatment with 1.1 equiv of Pb(OAc)4, they observed the formation of the expected 
compound as the only cyclised material! Hydrogenation of the crude reaction mixture 
afforded natural tellimagrandin (1) in 29% yield.  
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Scheme 5. Alternative approach to tellimagrandin I: regioselectivity of the coupling reaction 
1.5.2 Total synthesis of sanguiine H-5 (2,3-HHDP) 
The sanguiin H-5 (5), also known as isostrictinin,16 is a structurally simple member of 
ellagitannins. The successful synthesis of this molecule addressed the two critical 
challenges: (i) formation of only the (S)-atropisomer of the HHDP group via selective 
oxidation of the protected O-2 and O-3 galloyl moieties, and (ii) stereochemically controlled 
establishment of the -anomeric galloyl linkage. The strategy proposed by Feldman73 
(Scheme 6) started with the diol 31 with the photolabilee o-nitrobenzyl at the anomeric 
position. Galloylation at the 2- and 3-positions of the glucopyranose core, followed by 
desilylation of the diester so obtained, led to 45. Pb(OAc)4-mediated oxidation furnished the 
expected regioisomeric mixture 46. Benzylation of the free phenols in this mixture, followed 
by photolytic cleavage of the anomeric protecting group in the derived benzyl ether products, 
and -selective galloylation with G1Cl afforded the regioisomeric mixture 47 as a single 
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stereoisomer at C-1. Hydrolytic removal of the benzylidene acetal and the diphenyl ketals of 
the mixture 47 followed by hydrogenolysis to remove the benzyl protecting groups led to 
crude sanguiin H-5 (5) with an overall yield of 4% on 8 steps.  
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Scheme 6. Sanguiin H-5 total synthesis 
1.5.3 Total synthesis of pedunculagin (2,3,4,6-HHDP)  
Taking inspiration from the strategies developed for the synthesis of tellimagrandin I (1, 4,6-
HHDP) and sanguiin H-5 (5, 2,3-HHDP), Feldman et coll. carried out in 1996 the total 
synthesis of pedunculagin 874 wich bears two HHDP units at 2,3- and 4,6- positions of D-
glucopyranose (Scheme 7). The results obtained on the synthesis of tellimagrandin I showed 
that the 2,3- coupling is impossible in the presence of another HHDP in 4,6- positions in the 
classical conditions of oxidation with Pb(OAc)4.72,77 The alternative depicted in Scheme 7 
consists in: (i) construction of the HHDP unit at 2,3- positions of the intermediate 50 with a 
benzylidene group in 4,6-, then (ii) benzylidene cleavage and acylation with the two G2 units 
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(iii) followed by further Pb(OAc)4 coupling. A last hydrogenolysis step led to pedunculagin 8 
with an overall yield of 3% on 9 steps. 
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Scheme 7. Retrosynthetic analysis of pedunculagin 
1.5.4 Ullmann Coupling 
Reductive coupling of suitably activated galloyl synthons via Ullmann procedures has been 
successfully employed by Martin et coll. to deliver derivatives of the HHDP unit in protected 
form on several sugar derivatives (Scheme 8 and Scheme 9 report the results obtained from 
the application on the glucose).96 
Internal biaryl coupling reactions of carbohydrate derivatives carrying two 2-iodo-3,4,5-
trimethoxybenzoyl groups 52 under Ullmann conditions (Cu0 in dimethylformamide at reflux) 
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were investigated. With substituents at positions 2,3 or 4,6 of a D-glucopyranoside, 2,3 of a 
D-mannopyranoside, and 3,4 of a D-galactopyranoside, the coupling was found to  
 
proceed with a very high degree of stereoselectivity, leading exclusively to the (S)-epimer 53 
of the resulting hexamethoxydiphenoyl residue from the D-gluco and D-galacto substrates, 
and to the (R)-epimer from the D-manno substrate. With substituents at positions 2,4 of D-
glucopyranose derivatives in the 1C4 conformation and at positions 5,6 of a D-glucofuranose 
derivative, the coupling proceeded efficiently but with modest stereoselectivity. 
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Scheme 8. HHDP construction methodology developed by Martin 
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In all the conditions tested, a considerable amount of uncyclized starting compound without 
iodine was recovered in the end of reaction. 
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Scheme 9. Permethylated HHDP unit construction on D-glucose 
 
These results were relevant to ellagitannin chemistry in that they provide further 
understanding of the structural requirements for highly diastereoselective biaryl coupling 
within carbohydrate units. They present the only inconvenient to have employed as methyl 
protecting groups, requiring hard deprotection conditions, leading to permethylated 
derivatives of natural ellagitannins.  
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1.5.5 Total synthesis of corilagin (3,6-HHDP)  
Yamada was the first to achieve the total synthesis of corilagin (55, Caesalpinia coriaria109 
Figure 15),92 characterized by the presence of the HHDP group bridging the 3- and 6-
oxygens of the glucose, with an axial chirality R.  
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O
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Figure 15. Corilagin structure 
 
In 2004, he realized the synthesis of permethylated corilagin (55, Scheme 10), via the 
Martin’s conditions (Ullmann coupling). The main effort was the building of the 3,6-bridged 
bis-macrolactone structure, which is holding the glucose ring in the contra-thermodynamic 
conformation, and makes inapplicable the classical conditions (methods A or B) until now 
exposed.  
To overcome this difficulty the following strategy was employed: 
- ring-opening of the pyranose to give the compound 56 (obtained in 9 steps from D-
glucose);  
- esterification of two galloyl moieties mono-iodinated G3I; 
- preparation of the HHDP group by coupling of the two gallates on the 3- and 6-oxygens; 
- stereoselective intramolecular coupling in the Ullmann condition leading to 58; 
- reconstruction of the pyranose and esterification of a further G3 unit at the anomeric 
position.  
By this approach, the permethylated corilagine (60) was obtained with an overall yield of 23% 
on 6 steps. 
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a yield for the single step not given in the article 
Scheme 10. Total synthesis of corilagin and its permethylated derivative 
 
The unattainable complete demethylation of nonamethylcorilagin (60) prevented the total 
synthesis. Other protecting group were tried but difficulty of the iodination of corresponding 
tri-O-benzyl- or MOM-protected gallates forced to abandon the use of Ullmann coupling for 
the HHDP preparation. 
Taking inspiration from the Brussee’s110 work, Yamada realized in 2008 the first total 
synthesis of corilagin (55) through the key step of oxidative coupling realized between galloyl 
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moieties mono-benzylated (this symmetric protection allowed to avoid the regioisomers 
formation observed in the Feldman’s synthesis).92  
A CuCl2·-amine complex was employed as oxidant and allowed the obtention of the corilagin 
55 with an overall yield of 17% on 8 steps.  
1.5.6 The strategy of Spring for the synthesis of 
sanguiin-H5 
In 2008, Spring91 proposed a total synthesis of sanguiin-H5 (5) alternative to the one 
proposed by Feldman basisd on a different coupling methodology.  
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Scheme 11. Total synthesis of sanguiine H-5 by Spring 
 
The developed methodology consists of three steps : 
- metal-halogen exchange (iodine-magnesium111 or bromide-zinc112); 
- transmetallation with copper salts; 
- oxidation of the obtained organocuprate. 
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By this way. Spring managed to obtain – in despite of Yamada – the iodination (and 
bromination) of benzylated methyl gallate units.  
1.5.7 PIFA mediated oxidative coupling attempts 
The last methodology for the HHDP construction in a biomimetic way (method A) that it will 
be discussed concerns the strategy employed by Kita for the obtention of compounds 
bearing a permethylated HHDB group type 74a-b113 exploiting the chemistry of hypervalent 
iodine-type reagent.  
The reaction was carried out at –40°C with bis(trifluoroacetoxyiodo)benzene (PhI(OCOCF3)2, 
PIFA) and the Lewis acid BF3·Et2O. 1,2-diaroyl derivatives (73a-b) of protected -D-glucose 
underwent a smooth coupling reaction in the presence of PIFA–BF3•Et2O, unexpectedly in an 
intermolecular way, to afford the dimers (75a-b) in good yields and with high 
diastereoselectivity.  
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Scheme 12. PIFA mediated biaryl coupling attempts by Kita 
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1.6 Enantiomerically pure Ellagitannins via double 
esterification of hexahydroxydiphenic acid       
(Method B) 
An alternative to the biomimetic oxidative cyclization strategy for ellagitannin synthesis 
consists in the convergent union of glucose diols with a fully formed, chiral HHDP unit. The 
method B is not biomimetic because it does not follow the biosynthetic pathway described by 
Gross55 (Scheme 2). However it presents the advantage to reduce the steps number in 
respect to the above described method A (it does not need orthogonal and not-symmetrical 
phenols protection).  
 
Up to now, there are two approaches to produce enantiomerically pure ellagitannins 
according to the methodology B (Scheme 13) : 
- Incorporation of a presynthesized enantiomerically pure diacid (S)-I [or (R)-I] HHDP into an 
appropriately substituted glucose core II to give only one atropoisomer (S)-III [or (R)-III 
respectively] 
- Kinetic resolution of a racemic diacid mixture (±)-I obtained from ellagic acid (78) with a 
conveniently protected D-glucose II. The basic hydrolysis of the products (S)-III or (R)-III (in 
the Gassman conditions)114 allows to obtain the enantiomerically pure diacids HHDP (S)-I 
and (R)-I. 
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Scheme 13 Two ways towards the obtention of enantiomerically pure HHDP unit 
1.6.A Enantioselective synthesis of a group (S)-HHDP 
In 1994, Meyers93 described the oxazoline mediated asymmetric Ullmann coupling to 
produce (S)-hexamethoxydiphenic acid (S)-81, wich was used to synthesize the O-permethyl 
derivative of naturally occurring tellimagrandin I (84) (Scheme 14).  
The incompatibility of the removal condition of methyl protecting groups with the compounds 
did not allow to obtain the natural product. 
 
Lipshut94 also described an asymmetric synthesis of a biaryl system by an intramolecular 
oxidative coupling reaction of cyanocuprate intermediates. The bi-esterification of the diacid 
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in the Keck modified Steglich conditions107 on the glucose derivative 83 led to nonamethyled 
telimagrandin II (85) with a chemical yield of 77%. 
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Scheme 14. Enantioselective synthesis of permethylated tellimagrandin I and II 
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1.6.B Kinetic resolution 
The alternative strategy to the obtention of enantiopure HHDP diacid, proposed by Itoh in 
1995,95,115 consists in the realization of a kinetic resolution.  
The optical resolution of axially chiral biaryls (±)-81 acid (obtained in three steps from ellagic 
acid 78)95,116 or its chloride, can be realized through the esterification of a commercial sugar 
4,6-O-benzylidene--D-glucopyranoside 87 (Scheme 15). The compounds (S)-81 and (R)-81 
enantiomerically pure were so obtained after hydrolysis114 of compounds (S)-74b and (R)-
74b respectively. 
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Scheme 15. Kinetic resolution of HHDP racemic unit 
 
It was assumed that the diastereoselectivity did not depend on thermodynamic differences 
between the two atropisomers but on kinetic differences in the intramolecular cyclization. It 
can then be controlled by varying the basis and the solvent employed. The best 
diastereoselectivity was observed when sodium hydride was employed in toluene. In this 
condition, the formation of the (R)-HHDP was favored. While triethylamine in 
tetrahydrofurane favored the atropoisomer S. The major by-product obtained in this reaction 
conditions was the dimer 88. 
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Itoh et coll. employed this strategy in the total synthesis of permethylated pedunculagin (90). 
After benzylidene cleavage in acidic conditions on (S)-89 the esterification with the acyl 
chloride (S)-81 led to 90 with an overall yield of 31% on two steps.  
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Scheme 16. Total synthesis of per-methylated pedunculagine  
 
The same reaction sequence was applied to the compound (R)-74b in order to accomplish 
the total synthesis of permethylated platycaryanin D117 (same structure than 90 with an R 
configuration of the HHDP). The introduction of the second (R)-HHDP unit in 4,6- led to an 
intermolecular reaction giving the dimeric compound 91. 
1.6.1 Total synthesis of strictinin (4,6-HHDP) 
The strictinin (96, Scheme 17), isolated for the first time in 1982 by Okuda et coll. from 
Casuarina stricta33,41 and Pisidium guajava leaves,16 is constitued by an HHDP bonded to the 
oxygens 4 and 6 of a D-glucopyranose and a further galloyl group attached to the anomeric 
position of the sugar.  
Khanbabaee et coll. accomplished its total synthesis in 199776 through the diastereoselective 
esterification of a racemic perbenzylated diacid HHDP (±)-92 (obtained in three steps from  
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ellagic acid 78)118,119 on the conveniently protected sugar 92 in the Keck-modified Steglich 
conditions107 (Scheme 17).  
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Scheme 17. Total synthesis of strictinin 
 
 
The atropoisomeric S compound 96, was the only product obtained in these conditions with a 
yield of 32%.79 The photolysis of the ortho-nitrobenzyle protecting group followed by 
esterification of the perbenzylated galloyl unit G1 and hydrogenolysis (in the same conditions 
carried out by Feldman for the synthesis of tellimagrandin II, 2)81 of benzyl groups led to 
strictinin 96 with an overall yield on four steps of 20%. 
This total synthesis of Khanbabaee constitutes a first exmple of ellagitannin synthesis in a 
little steps number. It avoids in fact several protection-deprotection steps needed by the 
Feldman’s approach.  
Pisidium guajava
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1.6.2 Total synthesis of gemine D, hippomanin A and 
1,3-di-O-galloyl-4,6-O-(S)-hydroxydiphenoyl--D-
glucopyranoside (4,6-HHDP) 
The same approach employed for the strictinin synthesis was applied to the total synthesis of 
gemin D (109, Geum japonicum and Camellia japonica),64,120 hippomanin A (110, Hippomane 
mancinella)121,122 and the natural compound 111 (1,3-di-O-galloyl-4,6-O-(S)-
hydroxydiphenoyl--D-glucopyranoside, isolated from Reaumuria hirtella and Tamarix 
pakistanica).26,123 All these compounds are isomers because they are characterized by the 
presence of an HHDP-unit at 4,6- positions of a glucopyranose core and one or two galloyl 
groups linked to the remaining free oxygen of the D-glucopyranose (3-O-G for the gemin D 
109, 2-O-G for the hippomanin A 110 and 1,3-di-O-G for the compound 111) (Scheme 18). 
These compounds were synthesized80,86 through the same biesterification step of the 
racemic diacid HHDP (±)-93 as in the total synthesis of strictinin 96, possessing an (S)-
HHDP moiety located at 4,6 positions of the glucopyranose. For the synthesis of these 
ellagitannins it was necessary to develop a methodology for the selective esterification at 1, 2 
and/or 3 positions to give the intermediates 97, 98 and 99. Khanbabee et coll. demonstrated 
that this regioselectivity can be obtained through benzylation of the 2,3-glucopyranoside diols 
30-31 using tetrabutylammonium iodide (Bu4NI) as phase-transfer catalyst exploiting the 
intrinsecal distinct reactivity of the different hydroxyl on differently protected 
glucopyranosides. 
Both the regioisomers 97 and 98 were obtained from the reaction on 30 as not purifiable 
mixture. The mixture was then acylated with the benzyl-protected gallic acid G1OH to 
assemble the frameworks of 109 and 110. 
The biesterification on the compound 105 led to the formation of the diasteroisomer S with a 
chemical yield of 40%. A more polar fraction was also obtained but not characterized. It was 
supposed containing the (R)-HHDP diastereoisomer.86 
The syntheses of these naturally occuring ellagitannins was then completed by 
hydrogenolysis of the benzyl groups.  
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Scheme 18. Total synthesis of gemin D, hippomanin A and 111 
1.6.3 Total synthesis of praecoxin B, pterocarinin C, 
pariin M and mahtabin A (2,3-HHDP) 
As mentioned above, the chirality of the hexahydroxydiphenoyl (HHDP) moieties located at 
the 2,3- or 4,6-positions of the glucopyranoside core of the natural ellagitannins are 
invariably in the (S)-series as in praecoxin B (116) and pterocarinin C (or pterocaryanin C, 3), 
extracted from Stachyurus praecox124,125 and Tibouchina semidecandra.126 In contrast, 2,4- or 
3,6-HHDP-substituted ellagitannins exhibit the (R)-configuration as in the pariin M (117). 
The total synthesis (Scheme 19) of both atropisomers 3 and 116 was accomplished by 
Khanbabee. 
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The biesterification in the classical Steglich conditions108 of 31 with the racemic unit HHDP 
(±)-93 gave access to both the atropoisomers S and R (112), that were purified by column 
chromatography. The absolute configuration of the units HHDP was confirmed by 
comparison of the optical properties of the products obtained from hydrolysis in the Gassman 
conditions114 and the data reported in the literature.119  
It is interesting to observe that in these esterification conditions the two atropisomers are 
obtained in a ratio 1 :1, without any diastereoselectivity. 
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Scheme 19. Total synthesis of praecoxin B and pariin M 
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Benzylidene cleavage in the conditions of acid hydrolysis and the esterification of two further 
perbenzylated galloyl unit G1 led to compounds (S)-114 and (R)-114 completely protected. 
Two further steps of deprotection were needed to give praecoxin B 116 and pariin M 117 as 
/ anomers mixtures. 
 
Galloylation of the intermediates (S,R)-115 followed by hydrogenolysis led to pterocarinin 3 
and mahtabin 147 (Scheme 20). 
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Scheme 20. Total synthesis of pterocarinin C and mahtabin A 
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1.6.4 Khanbabee’s pedunculagin (2,3,4,6-HHDP) total 
synthesis  
The methodology developed by Khanbabee allowed the synthesis of pedunculagin (8) 87 in 
only two steps, against the 9 steps of the first total synthesis reported by Feldman in 199474) 
(Scheme 21). 
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Scheme 21. Total synthesis of pedunculagin by Kanbabee 
 
The compound (S,S)-120 was purified with a good yield of 60%. A complex mixture of not 
purifiable polar compounds was also obtained. The hydrogenolysis of 120 led to 
pedunculagin 9 with an overall yield of 39%. 
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1.7 Hemisynthesis of a C-arylglucosidic ellagitannin 
No member of this sub-class of ellagitannins has never been ssubmitted to a total synthesis. 
An only report is present in the literature concerning the C-arylglucosidic bond formation. 
Tanaka et coll.117 who managed to convert the glucopyranosyl pedunculagin (8) into the C-
arylglucosidic ellagitannin casuariin (19) and its C-1 epimer (18) (Scheme 22). 
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Scheme 22. Hemysynthesis of casuariin via C-arylglucosidation of pedunculagin 
 
According to the proposed mechanism, the reaction proceeds via the opening of the sugar 
with formation of the aldehydic form (as liquibambin 29 in the biosynthetic pathway) which 
undergoes nucleophilic attack to give casuariin (19) and its epimer (121) stachyirin 
degalloylated at the 5 position. 
The predominance of -OH was considered to be due to the nucleophilic attack of the 
pyrogallol ring on the glucose C-1 aldehyde from the lower side of the glucose. 
 
  
 
 
 
 
 
 
 
Chapter 2  
 
Retrosynthetic Analysis and Precursors Synthesis 
 
The practice of total synthesis demands the following  
virtues from, and cultivates the best in, those who practice it: 
ingenuity, artistic taste, experimental skill, persistence, and character. 
Nicolau K. C. 
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The research group directed by Prof. Stéphane Quideau at the European Institut of 
Chemistry and Biology in Bordeaux is at the moment one of the most active and experienced 
in the studies of chemistry and biological activities of C-arylglucosidic ellagitannins. Prof. 
Quideau has recently published a number of articles in highly reputed journals relating his 
group’s initial investigations of the chemical activities of these compounds, and he also 
edited the first book focusing on the chemistry and biology of ellagitannins. 
  
The present thesis work is part of a very ambitious project aimed to the development of C-
arylglucosidic ellagitannins as chemoterapeutic agents against cancer. The C-arylglucosidic 
ellagitannins present the structural particularity of having a highly characteristic C–C linkage 
between the C-1 atom of an open-chain glucose core and a galloyl-derived unit that is either 
part of an HHDP (hexahydroxydiphenoyl) ester group bridging the 2- and 3-positions of the 
glucose core, as exemplified in the structures of punicacortein A (23) or part of a terarilic 
nonahydroxyterphenoyl (NHTP) variant that is attached via three ester bonds to the 2-, 3- 
and 5-positions of the glucose core, as exemplified in the structures of vescalin (25) (Figure 
16). 
Preliminary studies conducted by Quideau et coll.50 have indicated that some of these 
ellagitannins are highly potent inhibitors of human DNA topoisomerase II, enzyme being a 
current target of anticancer chemotherapies. 
 
The specific objective of this PhD project was the development of general approaches to the 
compounds of this class. The punicacortein A (23a) and its C-1 epimer epipunicacortein A 
(23b) were the first objective of our synthetic efforts, as simplest structures of this class of 
natural compounds. 
Towards this aim it was necessary to develop novel methodologies related to sugar 
chemistry, to install the C-arylglucosidic bond on an open chain glucose core. 
A significant part of this objective, that it’s important to emphasize, was the development of 
an improved purification method for such polar and reactive compounds. 
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It is possible to identify three key issues that must be addressed in order to accomplish the 
synthesis of C-arylglucosidic ellagitannins: 
- Opening of the sugar 
- C-arylglucosidation reaction 
- Atroposelective intramolecular biaryl coupling for the HHDP construction (Figure 16) 
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Figure 16. Key structural elements of C-arylglucosidic ellagitannins 
2.1 Retrosynthetic analysis 
The retrosynthetic plan, depicted in Scheme 23, reflects our wish to develop a biomimetic 
route to Punicacortein A (23). 
The choice of the synthons has been made in order to allow: (i) to get information about the 
reactivity of these structures, (ii) to give access to lead-compounds for the synthesis of 
scaffolds of molecules for the structure-activity relationship studies, (iii) to furnish information 
about the biosynthetic pathway of C-arylglucosidic ellagitannins proposed in the literature 
(Scheme 23). 
In this vein, two possible synthetic strategies can be considered. For both, the access to 
punicacortein A 23 is done by a sequence of “selective galloylation/C-arylglucosidation” on 
the sugar derivatives B (substituted with an HHDP unit) or C (substituted with two galloyl 
units) that are the most important intermediates of the two retrosynthetic routes. The 
following step of C-arylglucosidation is carried out on the intermediate were the HHDP is 
already present on the sugar (route I) or alternatively on the architecture C with the two 
galloyl units not coupled (route II). 
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This transformation is the really most innovative and crucial step of the synthesis. It involves 
opening of the glucopyranosyl ring with concomitant formation of the C-arylglucosidic bond. 
Although both routes have been followed, our guess was from the beginning that the 
formation of the key C-arylglucosidic bond would be facilitated in the case of the 
conformationally-constrained HHDP-bearing intermediate B, in accordance with current 
biosynthetic hypothesis. 
In any event these synthesis permitted to evaluate both alternatives in the context of their 
relevance to the biogenesis of the target compounds. 
 
According to our strategy punicacortein A 23 is obtained via selective esterification of the 
secondary alcohol in position 5 of the sugar derivatives A with a galloyl unit F conveniently 
protected and at the same time activated on the carbonylic function. Several condition will be 
taken into account at this staid to ensure selective galloylation of the more nucleophilic 
secondary alcohol without affecting the phenolates. 
The intermediate B (route I), bearing the (S)-HHBP unit, can be prepared (i) via esterification 
of a glucopyranosic derivative 1,4,6-O-protected E with a racemic HHBP (±)-G unit or (ii) via 
an oxidative coupling, from the intermediate D, shared between the two retrosynthetic routes.  
 
Evidently, the choice of the protecting group is of paramount importance for the success of 
the synthesis. R1, R2 and R3 must be orthogonal and removable in mild conditions applicable 
to such complexes intermediates.  
The value of appropriate protecting groups becomes all the more obvious when manipulation 
of the end products are considered. The well documented difficulties associated with 
purification and isolation of the perhydroxylated natural products themselves highlights the 
absolute necessity of preparing a readily purifiable penultimate synthetic precursor which, 
upon simple deprotection, will deliver ellagitannin product free of impurities. Thus, the 
protecting groups not only must modulate the reactivity of the attached phenolic rings but 
also must provide “handles” compatible with delicate chromatographic purification at the end 
of the synthesis.29 
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Scheme 23. Retrosynthetic approach to punicacortein A 
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2.2 Synthesis of intermediate D 
The architecture D is shared by the two retrosynthetic routes, it was employed for the C-
arylglucosidation reaction (route II) and also for the construction of the intermediate B of 
route I.  
With this aim a family of eight related digalloyl substrates (135a-e, 148, 149a, 149b) with 
different oxidation potential was synthesized: 
- Intermediate D0, n=0  : completely protected intermediate 
-Intermediate D2, n=2 : para-protected galloyl units (reactivity phenols like, Yamada type) 
- Intermediate D3, n=3 : completely deprotected galloyl units (reactivity pyrogallol like, 
Feldman type) 
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Scheme 24. Compounds D for the intramolecular oxidative coupling 
 
2.2.1 Synthesis of polyhydroxylated intermediate D3 
The precursor D3 can be synthesized by two ways (Scheme 25): a) via esterification of gallic 
acid 77 on a glucopyranosic 1,4,6-O-triprotected derivative E ; b) via esterification of the 
same sugar derivative E with gallic units completely protected F. The desired compound D3 
is then obtained after an orthogonal deprotection R2 vs R1/R3 of D0. 
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Scheme 25. Two alternative ways for accessing to the intermediates polyhydroxylated D3 
2.2.2. Synthesis of sugar E 
Several sugars E were synthesized with different protecting groups at the anomeric position 
(R3 = methyle (Me), benzyl group (Bn) and o-nitrobenzyl group (oNO2Bn)) (Scheme 26). 
 
The compound 129 (R3 = -methyl) is commercially available. As the methyl group at the 
anomeric position is difficult to remove, this compound was employed for model studies.  
 
The protecting group benzyl (removable by hydrogenolysis) and o-nitrobenzyl (oNO2Bn, 
removable by photolysis) were chosen as they are cleaved under very mild conditions. 
The protecting groups cleavable by irradiation as ortho-nitrobenzyl moiety -the most 
employed-127 furnish a valid alternative to the conventional protecting group.128,129 It is stable 
under several condition and can be selectively removed for irradiation at 300 nm.73,130  
Moreover both Bn and oNO2Bn can be introduced easily and in quasi identical conditions. 
The starting compound acetobromo--D-glucose 125 is commercially available. The 
intermediates 126a-b are obtained easily via Koenigs-Knorr reaction131 with the alcohol 
R3OH in presence of silver carbonate and iodine in dichloromethane. A classical 
deacetylation reaction131 gives the sugars 33 and 34 in quantitative yields. 
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The sugar derivatives obtained can be regioselectively protected in 4,6-positions by a 
benzilydene group (removable in acid conditions) or a 1,1,3,3-tetraisopropyldisiloxan-1,3-diyl 
(TIPS, selectively and softly removable by reaction with fluoride ion), both orthogonal to the 
group R3 at the anomeric position, previously installed (Scheme 26). 
The benzylidene group is already present on the commercially available sugar 129. It can be 
easily installed on the sugars 33 and 34 by reaction with zinc chloride and benzaldehyde to 
give the sugars 30 and 31, both largely employed in the total synthesis of ellagitannins. 
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Scheme 26. Synthesis of sugars E (4,6-O-protected D-glucopyranoside derivative)
 
The group R1 = TIPDS was introduced on the sugar 33 by treating with 1,3-dichloro-1,1,3,3-
tetraisopropyldisiloxan (TIPDSCl2) in dimethylformamide (DMF) in the presence of imidazole 
to give 127 with a chemical yield of 61%.132 
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This protection step was characterized by not reproducible yields so it was tried as 
alternative protecting group R1 = di-t-butylsilyl (DTBD). In this case, the resulting 6-
membered cycle is thermodynamically more stable than the 8 membered cycle obtained with 
TIPDS. Moreover, it is simple to install as diols protecting group, and it results to be very 
stable to both acid and basic conditions. The reaction conditions introduced by Seeberger133 
were applied on the compound 33 and the sugar 128 was obtained with a reproducible 
chemical yield of 84%. 
 
The sugar precursors E synthesized were so employed in the following reaction of 
esterification with the opportunely protected galloyl unit F (Scheme 25). 
2.2.3. “Biomimetic” approach to the D3 synthesis: 
esterification of the sugar E with gallic acid 
At first, we considered the possibility to perform the esterification in a direct way, without 
protecting the gallic acid 77. 
 
Even if the galloylation of a sugar derivative is a classical reaction in the ellagitannins 
chemistry, the only conditions at today optimized are the Steglich conditions107,108 employable 
to completely protected galloyl units F. 
 
The difficulty consists in the fact that the free phenols on the gallic acid 77 can compete with 
the secondary alcohols of E in the esterification. According to the classical Steglich 
conditions, the esterification is performed in presence of carbodiimide in basic conditions. 
These are not the best conditions to favor the reactivity of the alcohol against the phenol. 
The use of an nitrogenated basis (DMAP, pyridine…) causes the deprotonation of the 
phenols that become more nucleophilic than the aliphatic alcohol.  
The most employed methodology to favor the nucleophilicity of an alcohol on a phenol is the 
one proposed by Mitsunobu and applied by Appendino to the synthesis of gallic acid 
esters.134 The Mitsunobu esterification is exploitable on a wide variety of substrates with 
several functional group. The major inconvenient is due to the inversion of configuration at 
the substitution center.  
The alternative is to promote the reaction with DCC without the basis in order to obtain an 
activation of the alcohol in neutral conditions. In these conditions, the aliphatic alcohols, more 
nucleophile that the phenols, can react preferentially.135,136 
Chapter 2 – Retrosynthetic Analysis and Precursors Synthesis 
 69
 
Preliminary promising results were obtained on a model compound, the para-
hydroxybenzylic acid 130 (Scheme 27). 
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 a Not optimized conditions. Not complete consumption of the starting material. Esterification on the phenolic function not 
observed. 
Scheme 27. Direct esterification of gallic acid 
 
These results encouraged us to apply the same conditions on the commercially available 
sugar 129 as model system, prior to venturing toward the actual synthesis. In this case, even 
after prolonged reaction time, and variing the reaction conditions (stochiometry of DCC, 
temperature, concentrations) any consumption of the starting compounds was observed. The 
secondary alcohols on 129 are maybe less accessible than in 130, this could be an 
explication of the experimental finding. 
 
Even if other strategy could be tried (i.e. utilization of a chloride of the acid or an anhydride), 
or other catalyst, we preferred to continue the synthesis by employing a fully protected 
derivative of the gallic acid, under the classical Steglich conditions. 
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2.2.4 Synthesis of completely protected galloyl units F0  
A protecting benzyl group (R2 = OBn), easy to introduce on the phenols of gallic acid, has 
been chosen.  
The perbenzylated F0 unit was synthesized under Chen conditions137 from the methyl gallate 
132 (Scheme 28). The benzylation was carried out in acetone with benzyl chloride in 
presence of potassium iodide and potassium carbonate. The perbenzylated compound 
obtained was then hydrolyzed in presence of sodium hydroxide in ethanol to give the 
compound 32 with a global yield of 82%. 
 
HO
OH
COOH
OH
77: gallic acid132: Methyl gallate
HO
OH
COOMe
OH
NaOH, EtOH, 
reflux, 2h
then HCl (1M), RT, 
10min BnO
OBn
COOH
OBn
32 = G1OH
 (82%)  (43%)
BnO
OBn
COOMe
OBn
BnCl, KI, 
K2CO3
acetone, 
reflux, 20h
BnO
OBn
COOBn
OBn
BnBr, KI, 
K2CO3
acetone, 
reflux, 18h
KOH, MeOH, 
reflux, 9h
66 (100%) 133 (38%)
 
Scheme 28. Syntesis of F0 –unit 
 
An alternative way leading to the compound 32 is a perbenzylation of gallic acid 77 promoted 
by benzyl bromide in acetone followed by hydrolysis in methanol with sodium hydroxide.138 
The overall yield in this case was lower than 20%, so the first way was preferred. 
 
The next step of esterification can demand the preparation of the acyl chloride in order to 
improve the chemical yields. 
The preparation of F0 chloride of was performed by using oxalyl chloride in toluene in the 
presence of a catalytic amount of DMF.137 
The chloride obtained has been employed directly in the following esterification reaction.  
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BnO
OBn
COOH
OBn
32 = G1OH
BnO
OBn
COCl
OBn
32b = G1Cl (100%)
(COCl)2
toluene, DMFcat.
 
Scheme 29. Synthesis of F1-Cl unit 
2.2.5 Preparation of intermediates D0  
The previously synthesized F0 unit was introduced on the sugar E in the classical Steglich 
conditions,107,108 that are also the most employed in ellagitannins synthesis.  
The reaction was carried out in dichloromethane in presence of dicyclohexylcarbodiimide 
(DCC) and 4-dimethylaminopyridine (DMAP) to give the esterified sugars D0 (Scheme 30).  
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OR3
O O
R2OR1
R2O
OR2
COOH
OR2
F0E
R1
R2O
R2O
R2O OR2
OR2
+ 2
"One-pot" 
Steglich conditions
a1 or a2
a1: E (1 eq.), F1 (2.2 eq.), DCC (4.4 eq.), DMAP (2.2 eq.), CH2Cl2 (0.025 M), ta ou , 16-48h
a2: E (1 eq.), F1 (2.2 eq.), DCC (2.2 eq.), DMAP (0.5 eq.), DMAP.HCl (0.5 eq.), CH2Cl2 (0.025 M), , 5 -24h
D0
 
Scheme 30. « one-pot » esterification conditions 
 
The conditions a2 are the Keck107 modified Steglich conditions. The addition of an 
hydrochloride amine, DMAP·HCl, permits to favor the proton transfer needed for the 
esterification, and reduce the formation of N-acylurea, secondary and undesired product of 
the esterification DCC-promoted (see annex 1).  
 
As the a1 and a2 conditions, that can be defined « one-pot », gave not reproducible chemical 
yields, a two steps strategy was developed as alternative. It consists in the formation of the 
acyl chloride F1-Cl of the gallic acid derivative, then bi-esterification of E with an excess of 
chloride (Scheme 31).  
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Scheme 31. « Two-steps » esterification conditions 
 
This “two-steps” strategy is rarely utilized in the ellagitannins synthesis; even if it adds 
another step to the synthesis, it is easy to realize as the acyl chloride intermediate is directly 
involved in the esterification without any purification. 
The results are synthesized in the Table 2. 
 
Entry Galloyl unit  Sugar  Products Conditionsa Yieldsb 
 F0 F0-Cl R2 E R1 R3 D0   
1 129 PhCH -Me 134a a2 
b1 
97% 
80% 
2 30 PhCH -Bn 134b a2 56%c 
3 31 PhCH -oNO2Bn 134cd a2 100% 
4 
32 32b Bn 
128 DTBS -Bn 134ed a1 
b1 
20%c,d 
30%c 
a a = conditions « one-pot » ; b = conditions « two-steps ». b Chemical yield after silica gel column chromatography purification. c 
Not optimized yields. d product monogalloylated obtained. dProduct synthesized by G. Malik. Characterization not detailed in the 
experimental section. 
Table 2. Results of the esterification of F0 units 
2.2.6 Preparation of the itermediates D3 via orthogonal 
deprotection of precursors D0 
The orthogonal deprotection of D0 intermediates was carried out via two ways: 
- hydrogenolysis of benzyl groups;  
- photolysis of the ortho-nitrobenzyl group at the anomeric position. 
It is important to highlight that the polyhydroxylated products of deprotection are very polar 
compounds and very sensitive to oxidation. For these reasons, the deprotection steps must 
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be easy and fast in the work-up and in the purification. Sometimes a reverse phase column 
chromatography was employed for the purification and in all cases important lost of mass 
were observed.  
The hydrogenation gave the best conditions: a simple filtration on celite in the end of the 
reaction allowed the obtention of pure final compound. 
The purity of the starting material and the following of the reaction appeared extremely 
important factors to get compounds 135a-e as pure as possible. 
In certain cases, we got a partially deprotected product. As the benzyl group on the phenols 
in 134b is easier to remove than the benzyl group at the anomeric position, compound 135c 
was obtained. It needed to make addition of new catalyst in order to complete the reaction.  
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BnO OBn
OBn
Ph
134a: R3 = -Me
134b: R3 = -Bn
134c: R3 = -oNO2Bne
134d: R3 = -He (56%)
(i)
H2, Pd/C, THF
RT, 24h
(ii) : h, EtOH-THF-H2O 
(3:1:0.05)
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HO
HO OH
OH
Si
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O O
BnO
BnO
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BnO OBn
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Si
(i)
135ee (40%)d
(ii)
135a
R3 = -Me
135bea
R3 = -oNO2Bn
135ca
R3 = -Bn
135d
R3 = H
D3
134ee: R3 = -Bn
D3
 
a Yield basisd on 1H-NMR of the crude ; b not-purificable complexe mixture of products was formed; any observation of expected 
product formation ; c Reaction not complete; chemical yields after column chromatography purification ; products obtained 135d 
(40%) and partially deprotected product 135c (15%). d Chemical yields after C18 – reverse phase column chromatography; e 
Product synthesized by G. Malik. Characterization not detailed in the experimental section. 
Scheme 32. D3  orthogonal deprotection 
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The hydrogenolysis conditions on the perbenzylated compounds 134c and 135b, with an 
ortho-nitrobenzyl group at the anomeric position, led to the formation of a complex mixture of 
products difficult to purify and characterize. To go over this problem the deprotection of the 
ortho-nitrobenzyl group of 134c was carried out at first via photolytic reaction at 365 nm (too 
much slow at 312 nm), to give the compound 134d with a chemical yield of 56%, the 
following hydrogenolysis gave the compound 135d (48% of chemical yield on two steps, 
lower than the quantitative yield obtained for the hydrolysis of 134b). 
 
The intermediates D so synthesized with the pyrogallol functions were directly employed in (i) 
the synthesis of the intermediates B via oxidative coupling and (ii) for the studies towards the 
development of a methodology for the C-arylglucosidic bond formation (route II of the 
retrosynthesis; Scheme 23). 
2.2.7 Synthesis of para-protected galloyl units F2 
For accessing to such galloyl units F2 it was chosen a protecting group R2 = Bn (cleavable 
via hydrogenolysis).139  
AcO
OAc
COOMe
OAc
Ac2O, pyridine,
RT, 16h
AcO
OBn
COOMe
OAc
136a (75%)
137a (86%)
HO
OH
COOMe
OH
132: Methyl gallate
AcO
O
OAc
O OMe
K
I
K2CO3, BnCl, KI, 
acetone, , 18h
HO
OBn
COOMe
OH
138a (91%)
HO
OBn
COOH
OH
139a (100% via b.; 99% via a.)
BnCl, K2CO3
MeOH-H2O (2:1)
RT, 15min-3h
b. KOH, THF-H2O (1:1), D, 16h
a. NaOH (5M)
MeOH
, 2h30
 
aProducts characterization not detailed in the experimental section. 
Scheme 33. Synthesis of para-protected galloyl units F2 
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The peracetylated intermediate 137 was synthesized in two steps according to the 
procedures described by Pearson140 and Zhu141 with a global yield of 65%. The selective 
introduction of an alkyl group on the para-position is maybe due to the presence of the ester 
that led to the intermediate I.141 Finally, the selective hydrolysis of the acetate groups in 
weakly basic conditions led to methyl ester. 
The acid function was then deprotected via basic hydrolysis of the intermediate 138 or 
through the pathway b (Scheme 33) consisting in a one step esters hydrolysis.  
2.2.8 Preparation of intermediates D2 
Drawing from biomimetic esterification of gallic acid 77 with sugar E to get polyhydroxylated 
precursors D3, direct esterifications were attempted on galloyl unit F2 featuring a 3-5 hydroxyl 
pattern. 
Preliminary results were obtained on the model compound para-hydroxybenzylic alcohol 130. 
The same conditions working on the gallic acid conducted in this case to the non-reactive N-
acylurea,deriving from the rearrangement of the O-acylurea (see annex 1). 
In spite of the number of different reaction conditions carried out (different solvents and 
carbodiimide concentration), only the formation of the secondary undesired product was 
observed.  
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Scheme 34. Direct esterification of F2  
 
It was decided to protect again the phenolic functions for the following esterification. 
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2.2.9 Protection of F2 units 
R2’ = MOM (methoxymethyl group, removable in acidic conditions) or TBS (removable via 
reaction with fluoro) were chosen as protecting group of the meta phenolic functions on F2.  
Three different F2’ galloyl units were so synthesized (Scheme 35). 
The methoxymethylation step was not realized in the classical conditions (MOMCl, NaH, 
DMF).92  
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OBn
COOMe
OMOM
142 (42%)
MOMO
OBn
COOH
OMOM
143 (100%)
TBSO
OBn
COOH
OTBS
144 (74%)
CH2Cl2
RT, 3h
Ghosez Chloroenammine
DMM,a P2O5
CH2Cl2
RT, 18h
LiOH·H2O
MeOH-THF (2:1)
, 2h
1. TBSCl, imidazole, 
DMF, ta, 24h
2. AcOH-THF-H2O
(6:3:2),RT, 18h
Cl
NMe2
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OBn
COOCl
OTBS
145 (100%)
138
F2'
F2'
F2'-Cl
 
Products synthesized by G. Malik, their characterization is not detailed in the experimental section. 
Scheme 35. F2 units protection 
Milder conditions were carried out on the methyl ester 138. Compound 142 was obtained 
with a not-optimized yield of 42%.142,143 The basic hydrolysis of this compounds gave the 
galloyl unit F2’-(143) with a global yield of 25% on 5 steps. 
 
The acid 138 was also protected via trisylilation in classical conditions. Selective deprotection 
of TBS groups on the acid72,144 gave the galloyl units F2’ (144) (Scheme 35). 
 
The acyl chloride 145 was synthesized via reaction with the Ghosez’s chloroenamine on the 
compound 144 with a quantitative yield. It was employed in the following step of esterification 
without further purification. 
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2.2.10 Preparation of intermediates D2’ 
Our first attempts of esterifications were performed in THF with dicyclohexylurea (DCC). Also 
in this case, this essay led to the only formation of the N-acylurea.  
The classical conditions “one pot” (a) and “two-steps” (b) were so exploited with the following 
results: 
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. 
Entry Galloyl unit Sugar Products Conditionsa Yieldsb
 F2  F2’-Cl R2 R2’ E R1 R3    
1 143 - Bn MOM 129 PhCH -Me 146 a3c 90% 
24% 
80% 2 144 145 Bn TBS 31 PhCH oNO2Bn 147 
a1 
a3c 
b1 25%d 
Products synthesized by G. Malik. Their characterization is not detailed in the experimental section  
 a a = conditions « one-pot » ; b = conditions « two-steps ». b Chemical yield after silica gel column chromatography purification. 
c Conditions a3 = E (1 eq.), F2’ (2.5  eq.), EDCI (5 eq.), DMAP (7 eq.), CH2Cl2 (0.025M), RT, 8-18h ; d Partial consumption of 
starting compound, monogalloylated product isolated. 
Table 3. bi-esterification of galloyl units F2’  
 
The classical conditions a1 and b1 applied on the combination sugar 31 and galloyl 144 led to 
low yields (24 and 25% respectively). 
As an alternative the 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDCI, conditions a3) 
allowed to reach a good yields for the compound 147. The by-products obtained in the 
reaction EDCI promoted, are easily removed by an acid work up. 
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2.2.11 Preparation of the intermediates D2 via 
orthogonal deprotection of D2’ 
The methoxymethyl groups (MOM) of 146 can be cleaved in acid conditions. These 
conditions are not orthogonal to the benzylidene protecting group. The compounds 148 was 
so obtained with a yield of 78% for reaction with HCl in isopropanol (Scheme 36). 
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Products synthesized by G. Malik. Their characterization is not detailed in the experimental section. 
Scheme 36. D2  synthesis via orthogonal cleavage of R2’  
The silyl groups were so preferred as removable in an orthogonal manner. Compounds 149a 
was so obtained from 147  in a 72% chemical yield.  
 
The cleavage of the photolabile ortho-nitrobenzyl group was successfully achieved on the 
compound 149a leading to the compound 149b. 
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2.3 Synthesis of inetrmediates B 
As showed in the retrosynthetic plan (Scheme 23) the synthons B can be obtained by two 
ways: (i) via an oxidative intramolecular coupling starting from D-type intermediates or (ii) via 
acetylation of the sugar E with a racemic mixture (±)-G.  
Beyond featuring a biomimetic inspiration way, (i) also allows a straightforward rout from 
punicacortein A (23) to NHTP bearing ellagitannins. 
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Scheme 37. Retrosynthetic approaches to synthons B 
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2.4 Intermediates B via Biarylic oxidative coupling 
This section will focus on the results obtained form the oxidative-coupling studies aimed to 
develop an efficient methodology to generate the teraryl- (NHTP) type unit in an 
atropoisomerically controlled manner. Beyond possessing an intrinsic synthetic value, this 
approach, basisd on the coupling between suitably protected galloyl units attached to a 
glucose core, will give information about the biosynthetic construction of these 
characteristical structural elements of ellagitannin molecules.  
In particular, the results here exposed were obtained by Gaelle Malik, a PhD student in the 
Quideau’s group, who addressed the development of a synthetic strategy towards the NHTP-
unit construction. 
The presentation of some of her results may help to outline the framework in wich the C-
arylglucosidation of the architecture B was addressed.  
 
A family of eight related digalloyl substrates (135a-e, 148, 149a, 149b) of varying oxidation 
potential was crossed with several common oxidants to forge the biaryl HHDP core.  
Two of the oxidant systems exploited are herein discussed: 
- (i) o-chloranil mediated oxidative coupling on substrates with pyrogallol-like reactivity (n=3) 
(on polyhydroxylated compounds 135a-d); 
- (ii) CuCl2-amine complexes mediate oxidative coupling requiring a phenol-like reactivity 
(n=1) (on compounds 148 and 149a-b). 
2.4.1. o-chloranil mediated intramolecular biarylic 
oxidative coupling 
The first reported HHDP construction towards ellagitannins synthesis was achieved by 
Feldman et coll. and was centered around the use of a Pb(OAc)4 mediated intramolecular 
oxidative coupling of diphenylmethylene-protected gallates attached on a glucopyranose 
core.72 This coupling step generated the desired (S)-atropoisomer of the HHDP group. Free 
hydroxyl groups in the gallic acid moieties were required to facilitate the cyclization; this 
necessitated the introduction of additional protection/deprotection steps in the synthesis. 
Overall the complete reaction pathway suffered from somewhat moderate yields, reflecting 
the complexity of targeted molecules. Moreover, this method provides a mixture of 
regioisomers due to the asymmetry of the protecting groups.  
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Our aim was to develop a new methodology of oxidative coupling on completely deprotected 
galloyl units that allows a reduction of protection/deprotection steps number. 
o-chloranil was already employed by Feldman for the intermolecular coupling between two 
methyl gallate units 122 to give a poly-hydroxylated HHDP unit (±)-124 (Scheme 38).145 
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Scheme 38. Intermolecular o-chloranil-mediated oxidative coupling of methyl gallate units  
A model system study was deemed appropriate prior to venturing toward the actual 
synthesis. So the coupling was carried out on the compound 135a (obtained easily in three 
steps from the commercially available sugar 129) under Feldman’s conditions. 
The reaction was monitored by analytic RP-C18 HPLC Varian Pursuit C18 (250 x 4,6 mm) 
(Eluents H2O:MeOH gradient from 1:0 to 0:1 in 20 min, flow 1 mL/min) because the starting 
compounds and the products reactions are poorly resolved by thin layer chromatography.  
The reaction (Scheme 39) was carried out in acetonitrile and the starting compound 135a 
was added at 0°C to the o-chloranil solution. The temperature was let to go to 25°C and after 
2h, 8 equivalents of sodium dithionite were added with a catalytic amount of water.  
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Scheme 39. Intramolecular o-chloranil-mediated oxidative coupling of 135a  
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The reaction mixture was then stirred at RT for 18h. The HPLC profile (Figure 17) showed 
the consumption of the starting compound and the formation of two new products. The less 
polar between them (Rt = 21.7 min) was identified as the tetrachlorocathecol (the reduced 
form of o-chloranil) on the basis of the comparison with a standard obtained from o-chloranil 
reduction. An LC/MS analysis showed that the other compound at 17.3 min was the coupling 
product, as confirmed by comparison with the compound (S)-162, obtained from 
hydrogenolysis of (S)-153 (Scheme 53). Accordingly with the Schmidt and Haslam postulate, 
the only S atropoisomer was obtained.  
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Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 20 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 17. HPLC profile of the oxidative coupling of 135a 
 
The HPLC monitoring of the reaction showed that the oxidation was a very fast process that 
resulted completed after 1h and gave rise to a mixture of products. The following reduction 
step demanded longer reaction time. It needed 24h to be completed. During the reduction 
several partially reduced compounds are formed. 
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Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 20 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 18. HPLC profile of the oxidative coupling of 135a 
 
The reaction crude was tritured with diethyl eter. This work-up allowed the removal of the 
reduced form of o-chloranil. The HPLC profile in Figure 19 shows that the totality of tetra 
chlorocatechol was removed by trituration.  
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Figure 19. HPLC profile of the work-up of the oxidative coupling of 135a 
 
The 1H-NMR of the product obtained after purification allowed the confirmation of its 
structure. In Figure 20, the comparison between the proton NMR spectra of compounds S-
164 and the starting material 135a is shown.  
The most important differences are : 
- H-3 of the sugar is shielded of 0.4 ppm in the coupling product with respect to the starting 
compound; 
- The aromatic protons on the galloyl moieties (2’I, 6’I, 2’II, 6’II) are upfield (0.4 ppm of 
difference) and their integration is halved (corresponding to the lost of two protons). 
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The spectra A and B are exactly the same. The only difference is the lower resolution 
obtained for the coupled product. A further purification step resulted necessary. The only 
envisageable method was the inversed phased preparative HPLC.  
 
 
A : 1H-NMR (acetone-d6) compound (S)-164 obtained from o-chloranil coupling 
B : 1H-NMR (acetone-d6) compound (S)-162 obtained from hydrogenolysis of (S)-135a 
C: 1H-NMR (acetone-d6) compound 135a starting compound of the oxidative coupling 
Figure 20. Comparison of 1H-NMR spectra of compounds (S)-164, (S)-162 and 135a 
 
It was tried to remove the methoxy-protecting group at the anomeric position by reaction with 
trityl-tetrafluoroborate (Ph3CBF4), as described by Vankar.146 The strategy appeared not 
compatible with the complex structure of (S)-164. 
2.4.2 o-chloranil mediated oxidative coupling of 135b  
The same conditions were so applied on 135b, with an ortho-nitrobenzyl protecting group 
removable under milder conditions (Scheme 40).  
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Scheme 40. o-chloranil mediated oxidative coupling of 135b  
In these conditions, a product (Rt = 23.2 min, Figure 21) less polar than the tetra-
chlorocatechol was formed. It was impossible to characterize this new compound, but we 
could affirm with certitude that it was not the coupling product. As already reported, the C-1 
protecting group affect the efficiency of the oxidative coupling, possibly through an inductive 
effect. An electron-deficient moiety (e.g., o-nitrobenzyl) at this position appeared to reduce 
the yield of the coupled product compared to its more electron-rich counterparts.29 
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Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 20 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 21. HPLC profile of the oxidative coupling of 135b o-chloranil mediated 
 
The LC/MS analysis of the reaction crude showed the presence of three products with an 
isotopic pattern characteristic of the presence of chloro atoms.  
After RP-C18 column chromatography a too little amount of product was obtained so it 
resulted impossible to purse the complete characterization. 
Starting compound 135b 
Reduced form of o-chloranil 
Reaction mixture after 2h 
18h of reduction 
Reaction crude
New product 
(tr = 23.2 min) 
tr = 21.5 min
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2.4.3 o-chloranil mediated oxidative coupling of 135d  
The Feldman’s conditions were so carried out directly on the reducing sugar 135d.  
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Scheme 41. o-chloranil mediated oxidative coupling of 135d  
 
Even after 3h of oxidation the starting compound was only partially consumed. It was 
necessary to add three further equivalents of o-chloranil. The formation of several new 
products was observed by HPLC as in the case of the oxidation on 135a.  
The reaction products were so purified by preparative HPLC, but it resulted impossible to 
complete the characterization because of the too little amount obtained. As in the case of 
135b the coupling product was not obtained. 
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2.4.4 Cu(II)-amine complex promoted intramolecular 
biarylic oxidative coupling 
An alternative synthetic method for the HHDP group construction was applied by Yamada to 
the corilagin total synthesis.92 Symmetrically designed methyl 4-O-benzylgallate were applied 
in the phenol coupling methods employing CuCl2-amine complex.  
The feasibility of this synthetic approach towards the HHDP construction was investigated by 
Yamada92 at first on methyl 4-O-benzyl gallate unit 138 (Scheme 42). 
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HO
OBn
OH
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169a: n = 0 (35 to 49%)
169b: n = 1 (5 to 8%)
169c-d: n = 2 and 3 (traces)
138
 
Scheme 42. Coupling of 4-O-Benzylgallates by CuCl2 amine complex 
 
The coupling of 138 was successful when using not only ethylamine (EtNH2), but also n-
butyl- (n-BuNH2) and n-hexylamines (n-HexNH2) to give the corresponding dimer. It is worth 
of note the fact that also the trimer is obtained in this conditions. That means that this method 
could be employed to the construction of the (S,S)-NHTP unit of vescalin.   
The same reaction conditions were then applied by Yamada et coll. to the intramolecular 
cases with a digallate 170 in which the four-carbon-linker corresponded to the 3- to 6- 
positions of glucose. The yields in the intramolecular coupling were even better than those 
on the intermolecular cases providing 171 in 77-85% yield.  
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OH
OHHO
HO
171 (77 to 85%)170  
Scheme 43. Intramolecular oxidative coupling of 4-O-Benzylgallates by CuCl2 amine complex 
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These results afforded to the total synthesis of corilagin accomplished by Yamada et coll. in 
2008.92  
The same conditions were applied on our D architectures with para-protected galloyl units. 
As already mentioned above the para-protection - as in the case of the polyhydroxylated 
employed in the biomimetic o-chloranil coupling - presents the advantage to avoid the 
formation of several regioisomers.  
 
The Yamada conditions were at first experimented on the model compound 148 
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Products synthesized by G. Malik. Their characterization is not detailed in the experimental section. 
Scheme 44. CuCl2 amine complex mediated oxidative coupling of 4-O-Benzylgallates functionalized 
compound 148  
The coupled product (S)-172 was obtained from the para-benzylated product after 30 
minutes of reaction. 
 
The 1H-NMR of the crude reaction showed the presence of the coupling product and the 
starting compound in a ratio of 1:1. 
Diagnostic feature in the 1H-NMR spectra of the formation of the coupling product is the 
shielding of the H-3 protons (5.76 ppm for 148 ; 5.31 ppm for (S)-172). 
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A : 1H-NMR (acetone-d6) of (S)-172 
B: 1H-NMR (acetone-d6) of compound 148  starting compound of the oxidative coupling 
Figure 22. Comparison of 1H-NMR of reaction product (S)-172 and starting compound 148 
 
The compound (S)-172 was purified by preparative HPLC and obtained with a yield of 56%. 
The atropoisomery was established on the basis of the comparison with the NMR proton 
spectra of compounds previously synthesized (Figure 23). 
 
It is worthing to note that the aromatic protons characteristic of the coupled product (S)-172 
integrate for two protons and possess a chemical shift comparable to the compound (S)-162. 
The other atropoisomer (R)-162 presents two broad singlets for the aromatic protons. 
From this observation, it was possible to be sure that the atropoisomer obtained was the S 
accordingly with the Schmidt and Haslam postulate. 
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Figure 23. 1H-NMR spectra comparison among not coupled compounds (148 and 134a) and coupled ones 
(162 and (S)-172) 
2.4.5 Cu(II)-amine complex mediate oxidative coupling 
of 149b 
The same conditions were so carried out on the compound 149b (Scheme 45). 
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Scheme 45. CuCl2 amine complex mediated oxidative coupling of 4-O-Benzylgallates functionalized 
compound 149b  
 
OO
O
S
Ph
O
O
O
O
OH
HO
HO
HO
HO
HO
OMe
I
II
2'
6'
2'
6' 1
3
7
5
O
O
OO
O
O
HO OH
OH
O
HO
HO
HO
Ph
OMe
I
II
2'
6'
2'
6'
1
3
7
5
OHO
HO
S
O
O
O
O
OH
BnO
HO
HO
BnO
HO
OMe
I
II
2'
6'
2'
6' 1
3
5
O
O
OHO
HO
O
HO OBn
OH
O
HO
BnO
HO
OMe
I
II
2'
6'
2'
6'
1
3
5
OO
O
R
O
OO
O
OH
HO
HO
HO
HO
HO
OMe
Ph
I
II
2'6'
2'
6' 1
3
7
5
134a
(S)-162
(R)-162
(S)-172
148
S
R 
Not coupled 
Chapter 2 – Retrosynthetic Analysis and Precursors Synthesis 
 92
I
II
2'
6'
2'
6'
1
3
5 OO
O
S
O
O
O
O
OH
BnO
HO
HO
BnO
HO
(S)-173
OH
Ph
O
O
O
O
O
OO
HO
BnO
HO
HO OBn
OH149b
OH
Ph
I
II
2'
6'
2'
6'
1
3
5
 
 
 
A : 1H-NMR (acetone-d6) of compound (S)-173 obtained after purification by column chromatography 
B : 1H-NMR (acetone-d6) of reaction crude after 45 min 
C : 1H-NMR (acetone-d6) of starting compound 149b 
Figure 24. 1H-NMR comparison between the reaction crude and the starting compound 
The crude 1H-NMR spectra showed that after 45 min, the starting compound was completely 
consumed.  
The reaction time resulted strictly dependent on the reaction scale, i.e. for n = 0.265 mmol 
(200 mg) of starting compound it needs 45 min, for n = 0.771 mmol (580 mg) of starting 
compound 2h are needed. 
The product (S)-173 was obtained with a yield of 54% even if the spectra of the crude 
reaction let expect better yields. Important lost of material were caused by the purification 
step. 
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2.5 Intermediates B via acetylation of a racemic unit 
(±)-HHDP 
This strategy was inspired by the work already reported by Khanbabee on the kinetic 
resolution of a racemic mixture of (±)-HHDP unit.75 
As showed in Scheme 46, the esterification of (±)-HHDP on the sugar E gives rise to two 
atropoisomers (R)-B’ and (S)-B’. The atropoisomer of interest (S) can be involved in an 
orthogonal deprotection step to give the most important synthon of our synthetic strategy. 
This product is in fact the direct precursor of the C-arylglucosidation step. 
The starting point of this alternative synthesis is the preparation of the racemic unit (±)-G. 
Then its introduction on the sugar E will be detailed. 
A benzyl group was chosen as R2’ as cleavable at the same time than the anomeric 
protecting group.  
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Scheme 46. Kinetic resolution of a racemic HHDP mixture 
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2.5.1 Synthesis of the racemic (±)-HHDP 
The racemic mixture (±)-G was synthsized according to the procedure reported by 
Schmidt116,118,119 and successively optimized by Kashiwada,147 that was already applied to 
the ellagitannins synthesis by Khanbabee and Itoh. 
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Scheme 47. Synthesis of perbenzylated (±)-HHDP  
 
At first, the ellagic acid 78 was perbenzylated by reaction with benzyl chloride in 
acetophenone in the presence of potassium carbonate and potassium iodide. The yield of 
53% resulted difficult to reproduce because of insolubility of ellagic acid. Rigorous anhydrous 
conditions resulted extremely important to the obtention of this yield even modest for a 
protection step. The presence of water lead to the introduction of benzyl moiety in ortho of 
the esters bond as collateral reaction.148  
The product 220 was then involved in a « one-pot » sequence of basic hydrolysis/benzylation 
of the esters and phenols leading to 221. The following of the reaction by TLC was of 
paramount importance because several regioisomers of partial hydrolysis were obtained. 
The least esters hydrolysis was carried out in a mixture acetone/methanol/water to give the 
racemic mixture of perbenylated (±)-93 with a global yield of 44% in three steps.  
Another method for the synthesis of the racemic HHDP unit was reported by Feldman.145  
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This methodology is easier to get under way and also the chemical yields are higher, but at 
least two more steps (protection of the phenolic functions; methyl esters hydrolysis) are 
needed to address our target compound. 
2.5.2 Installation of the HHDP unit on the sugar E 
As reported in the literature for the ellagitannins synthesis, the installation of the racemic unit 
(±)-G is mainly carried out under classical esterification conditions (Steglich or via acyl 
chloride). 
In our studies, we first attempted the reaction in the conditions described by Itoh95,115 on the 
commercial sugar 129.  
After activation of the acid (±)-93 as acyl chloride (±)-152, the bi-esterification was carried out 
in the presence of DMAP (b1 conditions) to give the desired atropoisomer (S)-153 with a 
satisfactory yield of 24%. In agreement with what reported by Itoh, the atropoisomer (R)-153 
(4% yield) and the dimer 154a were also obtained.  
 
The desired S atropoisomer was obtained as main product. Several reaction conditions were 
tested changing solvent and concentration of reactants without any improvements in the 
yields. In any case it was obtained an improvement in the yield of the atropoisomer R and the 
diastereoselectivity resulted to be worse. 
 
HHDP units (S)-93 and (R)-93 were obtained in pure form after hydrolysis114 of (S)-153 and 
(R)-153 respectively. It was so possible to make a full characterization. The optical activities 
of the so obtained compounds were in agreement with the values reported by Schmidt.119 
 
                                                 
a The product was obtained as a complex mixture with other products so it was impossible to make a full characterization. It was 
characterized on the basis of the comparison of the NMR data with what reported in the literature.113. Arisawa, M. et al. 
An unexpected intermolecular chiral biaryl coupling reaction induced by hypervalent iodine (III) reagent : synthesis of potential 
precursor for ellagitannin. Chem. Commun., 469-470 (1999), 115. Itoh, T. & Chika, J. New method for kinetic resolution of 
axially chiral biaryl compounds using a sugar template. J. Org. Chem. 60, 4968-4969 (1995). 
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Scheme 48. Kinetic resolution of (±)-93 
 
 
We applied then the same conditions on the sugar E with a cleavable protecting group at the 
anomeric position. 
 
The esterification was carried out on the sugar 128 in the classical Steglich conditions 
(conditions a1) and via the chloride (±)-152.  
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Products characterization is not detailed in the experimental section. 
Scheme 49. Bi-esterification HHDP unit on the sylilated sugar 
The atropoisomers of interest (S)-155 was obtained with a 30% yield on two steps in the b1 
conditions, and 47% yield in the a1 conditions.  
The last conditions (a1) were the most satisfying even better than with the commercial sugar.  
 
These conditions were also applied on the sugar 30 (Scheme 50) with still good results, even 
if the stereo-control of the reaction resulted less efficacious (the atropoisomers S and R were 
obtained with comparable yields). We were not interested to isolate the dimer in these 
conditions. 
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Scheme 50. Bi-esterification of the HHDP unit on the sugar 30 
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The compounds 155-156 so synthesized were subject to hydrogenolysis reaction to give the 
key intermediates of our synthetic plain (Scheme 51). 
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Scheme 51. Hydrogenolysis of compounds (S)-155 and (S)-156  
 
The hydrogenolysis reaction revealed to be more difficult than expected. The products (S)-
159-(S)-160 of partial deprotection were also obtained together with the completely 
deprotected product (S)-161.  
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Scheme 52. By-products of hydrogenolysis 
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This deprotection reaction was also performed on the compounds 153 in order to have 
references for the studies of oxidative coupling.  
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Products synthesized by G.Malik. Their characterization is not detailed in the experimental section. 
Scheme 53. Hydrogenolysis of compounds S- and R-153  
 
With all these compound in hands, we focused our synthetic effort towards the development 
of a procedure for the C-arylglucosydation reaction. 
 
  
 
 
 
 
 
 
 
Chapter 3  
C-arylglucosidation Step 
 
Nature does nothing uselessly. 
Aristotele, Politics, I.1253a8 
 
3.1 The key step of C-arylglucosidation 
First described by Mayer in the late 1960s, C-arylglucosidic ellagitannins are natural 
compounds characterized by the particularity, unique among the natural products, of 
featuring an open-chain glucose core and a carbon–carbon (C–C) linkage between an 
aromatic aglycon and the C-1 of the attached carbohydrate.  
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This unique C-arylglucosidic structure is embodied in a variety of biologically important 
natural products and confers remarkable stability to both enzymatic and/or chemical 
hydrolysis. Moreover – maybe as a consequence of the rigidity of their bicyclic structure - 
these unusual natural products exhibit a diverse range of biological activities as antibacterial, 
antiviral and antitumor activity.149,150  
3.1.1. Synthetic approaches to C-arylglucosidation 
Due to their significant biological activities and the inherent novel architectures, the C-
arylglucosidic natural products present unique challenges for contemporary total synthesis. 
Before starting a discussion on the developed strategies towards the C-arylglucosidic bond 
formation, it is important to make a precisation. 
Formally a glucoside (more generally a glycoside, if we want extend the discussion to any 
sugar different from glucose) is any molecule in which a glucose group is bounded through 
its anomeric carbon to another group via a glucosidic bond. 
Glycosides can be linked by an O (O-glycosides), N (N-glycosides), S (thioglycosides) or C 
(C-glycosides) glycosidic bond (Figure 25). (The given definition is the one used by IUPAC). 
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The glycone part of a glycoside consists of a single sugar group (monosaccharide) or several 
sugar groups (oligosaccharide). 
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NHR
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O
SR
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Figure 25. Glucosidic structures 
 
In this light, the definition of C-arylglucosidic ellagitannins could not be completely 
appropriate. However, the scientific community continues to name these molecule as C-
glucosides. 
 
Numerous specifically methods for C-arylglucosidation reaction have been developed in the 
last years151 but any of these resulted relevant to our purposes, because in any case the 
sugar of the final compound is in open chain. 
Only one report for convertion of reducing monosaccharides into C-glucosidic derivatives 
exploiting the reactivity of the aldehydic form of the sugar was reported in 1986 by Gonzalez 
et coll.152 They developed a general methodology for the synthesis of pyrimidine C-
nucleosides involving a one step reaction of aldohexose and aldopentose with barbituric 
acids in a water solution of sodium carbonate at 50°C (Scheme 54). 
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Scheme 54. C-glucosylbarbiturates synthesis under physiological conditions and proposed reaction 
mechanism
In Scheme 54 it is showed the guest mechanism for this transformation. From the pKa values 
of the barbituric acid 175 (about 4) it is reasonable to suppose that this compound can react 
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as nucleophile even in absence of a strong basis. One can guest that the initial adduct I 
undergoes a -elimination of water to give the unsaturated intermediate II, which, as in 
similar reactions from noncarbohydrate aldehydes153 can be attacked by another nucleophile. 
The most probable is the intermolecular reaction with the oxygen six position. 
This work was of inspiration for Tanaka et coll.117 who managed to convert the 
glucopyranosyl pedunculagin (8) into the C-arylglucosidic ellagitannin casuariin (19) and its 
C-1 epimer (121) (Scheme 55) under biomimetic conditions. 
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Scheme 55. Hemisynthesis of casuariin via C-arylglucosidation of pedunculagin and proposed 
mechanism for the C-arylglucosidic bond formation 
 
Accordingly to the Gonzalez’s proposition, the reaction mechanism is though to be an aldol-
type condensation on the aldehydic form of the sugar. The predominance of -OH was 
considered by Tanaka et coll. to be due to the nucleophilic attack of the pyrogallol ring on the 
glucose C-1 aldehyde from the lower side of the glucose.  
3.2 Our approach to C-arylglucosidation 
According to the mechanism proposed by Tanaka, one can assume that an opening of the 
sugar is the first key event that opens up the door to the C-glucosidic ellagitannins. Then 
follows the intramolecuar aldol-type nucleophilic addition to the aldehyde function giving rise 
to a C-glucosidic bond. This hypotesis was supported by the isolation of the open-chain 
aldehyde liquidambin (29)58 that can be considered as a molecular quoin for the passage 
from glucopyranosic to C-glucosidic ellagitannins.  
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3.2.A The mutarotation 
We know that aldehydes and ketones undergo a rapid and reversible nucleophilic addition 
reaction with alcohols to form hemiacetals. 
If the carbonyl and the hydroxyl group are in the same molecule, an intramolecular 
nucleophilic addition can take place leading to the formation of a cyclic hemiacetal.  
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Five- and six-membered cyclic hemiacetals are particularly stable, and many carbohydrates 
therefore exist in an equilibrium between open-chain and cyclic forms. When an open chain 
monosaccaride cyclizes to a pyranose or furanose form, a new chirality center is generated 
at the former carbonyl carbon. The two diastereoisomers produced are called ,-anomers, 
and the hemiacetal carbon is referred to as the anomeric center. When a sample of either 
pure anomer is dissolved in water its optical rotation slowly changes and ultimately reaches a 
constant value. This change in optical rotation is called mutarotation and it is due to the slow 
conversion of the pure anomer into an equilibrium mixture. Altought equilibration is possible 
at neutral pH, it is catalyzed by both acid and basis. 
3.2.B The aldolic condensation 
Aldol reactions like other carbonyl condensations occur by nucleophilic addition of an enolate 
ion of the donor molecule to the carbonyl group of the acceptor molecule, and give rise to the 
formation of a new C-C bond. The reaction is normally basis catalyzed, as in this condition 
the enol nucleophilicity is more accentuated. However an acidic catalysis is possible and 
consists in the activation of the carbonylic carbon after protonation of the oxygen. 
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Scheme 56. Aldolic condensation mechanisms 
The success of our approach stays in the choice of the reaction conditions, that must favor 
both (i) the mutarotation of the sugar derivatives B or D and (ii) the aldolic condensation 
between the C1 and C2’I (Scheme 57). 
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Scheme 57. C-arylglucosidation step 
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All reactions were followed by reverse phase analytic HPLC (column Pursuit C-18 15cm or 
25 cm; eluting system CH3CN-H2O-0.1% COOH), and by RP C-18 TLC (CH3CN-H2O =7:3) 
using FeCl3 to reveal the catecholic hydroxyl groups. In the general procedure, the starting 
material is dissolved in the solvent and stirred at the indicated temperature.  
3.3 First C-arylglucosidation attempts:    
 Tanaka’s conditions 
3.3.1 C-arylglucosidation on the architecture B (HHDP-
bearing) 
Our attemps of C-arylglucosidation were at first carried out on the coupled compound (S)-
158. We first attempted the C-arylglucosidation reaction in weakly basic condition117 were 
both the mutarotation and the aldolic condensation are well favored. 
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Scheme 58. C-arylglucosidation in the Tanaka’s conditions on compound (S)-158 
 
The starting compound was dissolved in water at RT and in two hours the formation of 
several products was observed by HPLC. To the consumption of the starting compound it 
corresponded the formation of a complex mixture of products deriving undoubtedly from the 
degradation of the starting material. It is known that the degradation due to oxidation of ortho 
catechol function is favored in basic conditions.154  
Any improvement was obtained when the reaction was performed in a strictly inert 
atmosphere. 
It is interesting to observe the different reactivity of our compounds and pedunculagin (8). 
Even if the yield reported by Tanaka are very low (40% total yield for C-arylglyucosidation 
products) the presence of a second HHDP unit at 4,6- position of the glucose seems to give 
major stability to the molecule, that resist to the weakly basic condition. 
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Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 30 to 100% of B in 25 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 26. HPLC profile C-arylglucosidation at pH = 7.7 on compound (S)-158 
The same HPLC profile was obtained in the successive experiment where the reaction was 
carried out in water using Na2CO3 as basis (pH = 7/8) at room temperature.152 A changing in 
the color of the reaction mixture, from yellow to dark violet through green accompanied from 
degradation of the starting material was observed, as for the previous essays. 
3.3.2 C-arylglucosidation on the architecture D (two 
galloyl not coupled) 
The same conditions were applied on compound 135d with two pending galloyl unit attached 
to the glucopyranose core (Scheme 59). 
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Scheme 59. C—arylglucosidation in the Tanaka’s conditions on compound 135d 
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(S)-225 ,) 
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The HPLC following of the reaction showed the rapid consumption of the starting compound 
and the formation of a complex mixture of products, as in the case of the HHDP-bearing 
intermediate. 
3.4 C-arylglucosidation attempts in organic solvents 
Having in mind the mechanism proposed by Tanaka for the C-arylglucosidic bond formation 
(Scheme 55), reaction conditions which were expected to drive the aldol-type reaction 
equilibrium toward the desired product were tested. It was tried to perform the reaction in 
organic solvents using nitrogen basiss of several strength and nature. The general procedure 
consisted in the addition of the basis to a solution of the starting compound in the organic 
solvent.  
The organic basiss were chosen on the basis of their pKa values.  
Nitrogen-containing basiss were employed both without and with the solvent (generally THF) 
and concerning the potassium tert-butyloxide (t-BuOK) it was employed in tert-butanol. 
 
Organic basiss pKa  (acidity in DMSO)a
Pyridine 5 
NEt3 9-10 
DBU 11-12 
t-BuOK 20 
a http://www.chem.wisc.edu/areas/reich/pkatable/ 
Table 4. pKa values of the basiss used for the C-arylglucosidic reaction in organic medium 
 
In another series of experiments the reaction was carried out in presence of carbonate (pKa 
about 10) of several cations (Li2CO3, K2CO3 and Cs2CO3) in polar solvent as acetone or 
trifluoroethanol, in which the opening of the sugar is favored. By this way it was tryied to 
activate the carbonyl group of the aldehydic form towards nucleophilic attack via oxygen 
coordination.  
In spite of the number of different reaction condition carried out we didn’t succeed in the 
realization of the C-arylglucosidic bond in this basic conditions: any consumption of the 
starting material was observed when weak basiss were utilized (even after prolonged 
reaction time 10 days), degradation of the starting material in presence of strong basiss was 
observed. 
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3.5 C-arylglucosidation attempts in acid conditions on 
the architecture B 
As the essays in organic solvents were not satisfactory we came back to the aqueous 
medium, that is the best solvent to favor the mutarotation. 
As the opening of the glucose necessary for the C-arylglucosidic reaction could be catalyzed 
in basic but also in acidic conditions, we decided to carry out the reaction in acidic condition. 
In these conditions the nucleofilicity of the enol -masked by the aromatic system- is less 
important than in basic conditions but the nucleophilic attack on the aldehydic form of the 
sugar is nevertheless favored by the carbonylic oxygen protonation. Moreover the oxidative 
processes responsible of the degradation of the starting material are less favored in acid 
conditions. 
The first attempt was carried out on the compound (S)-158 in phosphate buffer at pH = 4 
under argon atmosphere (Scheme 60). 
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Scheme 60 : C-arylglucosidation in phosphate buffer at pH = 4 on compound (S)-158 
 
After 1h stirring at 60°C, the HPLC profile showed a partial consumption of the starting 
compound and the formation of 4 new products. After three days the starting compound was 
almost completely consumed. The molecular masses of the reaction product (m/z) were 
obtained by an LC-MS analysis.  
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Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 20 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 27. HPLC profile C-arylglucosidation at pH = 4 on compound (S)-158 after three days 
 
An ESI(-) LC-MS analysis showed for two of the new products (Rt = 11.5 and 12.1 min) 
masse values m/z = 570 (ion [M-H]-), identical to the starting compound as expected for the 
C-arylglucosiditation epimeric products 175 and . The other pair of compounds (Rt = 6.1 et 
6.6 min, m/z [M-H]- = 481) derived from the benzylidene hydrolysis in acid condition (S)-161. 
It is interesting to highlight that the C-arylglucosidation products without the benzylidene 
group are not formed in these conditions. On the basis of this observation one can deduce 
that the compound (S)-161 is not involved in the C-arylglucosidation. Moreover another 
important information can be deduced: once the C-arylglucosidic bond is formed the 
benzylidene cleavage doesn’t take place (the two epimers 175 and 175 do not undergo 
the benzylidene cleavage).  
The epimer 175 is largely favored than the other. This is in agreement with the Tanaka 
results and it is likely due to a preferential attack of the nucleophil on the lower side of the 
aldehyde. 
As it is possible to see from the HPLC-UV trace (Figure 28) the major product at pH = 4 is 
the product of deprotection (S)-161. 
 
Products of benzylidene cleavage 
(S)-161 
m/z = 481 
(Rt = 6.1 and 6.6 min) 
175 and 175 
m/z = 570 
(Rt = 11.5 and 12.1 min) 
Starting compound 
(S)-158 () 
m/z = 570 
(Rt = 12.9 and 13.1 min) 
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Further experiments have been carried out at several pH in order to reduce the entity of the 
deprotection reaction in favor of the C-arylglucosylation reaction (Figure 28). 
A wide range of pH was exploited and it was found that the more basic is the pH, minor is the 
benzylidene cleavage, faster is the C-arylglucosidation reaction but degradation also occurs. 
In acid conditions the conversion of the starting compound is slower and to a lesser extent 
but cleaner.  
 
Minutes
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
m
AU
0
50
100
150
200
250
300
350
400
450
500
550
600
m
AU
0
50
100
150
200
250
300
350
400
450
500
550
600
Detector 1-280nm
ANA174-5.dat
Detector 1-280nm
ANA 176-7.dat
Detector 1-280nm
ANA 184-2.dat
Detector 1-280nm
ANA 178-5.dat
 
Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 20 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 28 : HPLC-UV C-aryl glucosydation in phosphate buffer at several pH after 48 h stirring at 60°C 
 
The best conditions were found to be between pH 5 and 6. The reaction was then carried out 
at pH 5.3 on larger scale. 
pH = 4 
pH = 5 
pH = 5.3 
pH = 6.4 
(S)-161
175 
(S)-158 () 
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3.6 The C-arylglucosidation step 
3.6.1 Reaction on (S)-158       
 work-up and products purification 
(S)-158 was dissolved in the phosphate buffer at pH = 5.3 and the resulting solution was 
stirred at 65°C for two days. Then the reaction mixture was concentrated in vacuum and 
purified by semipreparative reverse phase HPLC (Microsorb C18, 250 x 41.4 mm). 
An acid was added to the HPLC eluent in order to avoid ionization of the phenols, unless the 
peaks are considerably flattened and no reproducible retention times are obtained. 
After lyophilization of collected fractions the compounds 175, 175 and (S)-161 were 
obtained with a yield of 9%, 20% and 15%. The starting compound was also recovered 
(25%). 
These value were obtained on a scale of 20 mg of starting compound and are reproducible 
on analytical scale even if problems appeared when reaction was carried on a preparative 
scale. 
When the reaction was carried out on a scale of 300 mg of (S)-158 the purification became 
cumbersome (the maximum amount of 20 mg was injectable on semipreparative column to 
have a good separation) and the amount of solvent huge. 
Two preliminar work-up have been tested in order to semplify the reaction mixture by 
remotion of phosphate salts before the purification by HPLC:  
- reverse phase C-18 silica gel filtration  
- liquid-liquid extraction of the aqueous phase with an organic solvent 
The silica gel filtration on C-18 allowed to remove all the inorganic compounds that are not 
retained by the C-18 chain, fixed on the silica. The reaction product were after eluted with an 
organic solvent. The drawback of this method was that the total mass recovered in the end 
was never bigger than 75% and mostly constitued of degradation compounds. 
The liquid-liquid extraction with an organic solvent seemed to be the best solution. The ethyl 
acetate was chosen as organic solvent for its high polarity and because the reaction product 
were soluble in it. The acidification to pH = 2-3 of water by addition of a solution of 
hydrochloridric acid (2M) allowed the protonation all the species in the reaction mixture 
making the extraction more efficacious.  
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In the Figure 29 it is showed the monitoring of the acidification and extraction in the end of 
the reaction. 
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Analysis conditions : Column : Pursuit 3 C18 (150 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 10 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 29. HPLC profile of the work-up of the C-arylglucosidation of (S)-158 
 
As it is possible to see the acidification did not change the HPLC profile (any change in the 
product ratio is observed neither degradation). After three extractions with ethyl acetate the 
crude reaction mass after solvent evaporation corresponded almost to the 90% of the initial 
mass engaged in the reaction. 
After evaporation of all the organic phase the solid crude was very difficult to solubilize in 
water for the subsequent HPLC purification. A large amount of water was necessary to 
dissolve the solid and this lead to a big augmentation of injection numbers.  
Moreover a precipitate of ellagic acid was formed after evaporation, due to esters hydrolysis. 
In order to overcome this problem it was tried to not dry completely the crude by addition of 
some water to the ethyl acetate after extraction. Again a degradation of products was 
observed.  
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It was realized that the reaction products are very sensible to any treatment and we decided 
to purify directly the reaction mixture without any work-up by HPLC. In order to reduce the 
purification time the reaction was carried out at higher concentration.  
The chemical yield of the reaction is relatively small compared with what was expected on 
the basis of the crude proton NMR. That could be explained by the fact that the chemical 
yield depends not only on the initial concentration of the compounds in the raw material, but 
also on the degradation and dispersion compounds in several injections for the purification. 
3.6.2 Products 175 and  characterization 
The two epimeric compounds 175 and 175 (Figure 30) were obtained pure after HPLC 
purification. The minor compound was difficult to obtain in a pure form. 
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Figure 30. Epimeric products 175 and from C-arylglucosidation on (S)-158 
 
 
For the main compound 175 the considerations about the formation of the new C-C 
bond was done on the basis of the comparison with the specra of the starting material (S)-
158. 
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The chemical shift and the coupling patterns of the open-chain glucose core protons were 
assigned by 1H-1H COSY experiments: from H-2 to H-5 in the zone 3-5 ppm, with the H-6 
characteristic for the coupling 1J C-H HMQC with the only secondary carbon C-6.  
 
 
 H-1 H-2 H-3 H-4 H-5 H-6 
H-1       
H-2       
H-3       
H-4       
H-5       
H-6       
Table 5. 1H-1H COSY correlation of compound 175
 
Diagnostic features in the 1H-NMR spectra (Figure 31) was the presence of only one of the 
two isolated proton singlets at 6.5 attributable to the HHDP moiety (H6’II, red marked).  
The corresponding aromatic protons in the starting material (S)-158, integrate for 4H (2H for 
the  anomer and 2H for the ) and were 4 singlets in the region between 6.55 and 6.59 ppm 
(blue marked). 
The sugar protons H1, H2 and H3 of the reaction product resulted shielded in the region 
between 4.77 and 5.10 ppm and the coupling constants varying between 2.1 and 2.8 Hz. 
These little values for the coupling constants are different from the characteristic constants of 
glucopyranose (generally 3J = 8-9 Hz for H1, H2 and H3 and 3J ≈ 3.5 Hz for H1) and are 
typical of an open chain glucose.  
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 A : 1H-NMR (acetone-d6) compound 175  major product of C-arylglucosidation 
B : 1H-NMR (acetone-d6) compound (S)-158 (mixture of anomers  : = 1:1) starting material of C-arylglucosidation 
Figure 31. 1H-NMR spectra of the main product compared with the starting compound  
 
The carbon chemical shift were assigned on the basis of DEPT and HMQC experiments. 
In a DEPT-13C (distortionless enhancement of polarisation transfer) experiment, a sequence 
of pulses with various delay times are used to create the DEPT spectra where -CH3 and CH 
peaks appear as normal and -CH2- peaks appear inverted. Quaternary C are not usually 
seen. By this way the number of H attached to C can usually be deduced.  
The 2D-NMR experiment through the short distance C-H correlations (HMQC) allows to 
associate the proton signals to the signals on the DEPT of the carbon to whom they are 
linked.  
The appearance of six aliphatic carbon signals (region 62.4 and 83.3 ppm) indicated that 
compound 175 possessed a C-6 polyalchol core. The absence of an anomeric signal in the 
13C spectra (Figure 32) in the region 92-96 ppm (characteristic of  and  anomeric carbon of 
a glucopyranose) indicated that the glucose core was in an open-chain conformation. The 
upfield of C-1 signal as respect to the starting material (65,7 vs 92,4/95,6) was indicative of a 
C-C bond formed. 
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Two further information were deduced from the 13C-NMR spectra to support the guest 
structure.  
- the two carbons C2’I and C6’II belonging to the HHDP unit had a very different chemical shift 
(118.8 and 105.4 ppm respectively) as respect to the starting material and a DEPT 
experiment allowed the assignation of their multeplicity: C2’I resulted to be a quaternary 
carbon whereas C6’II tertiary; further sign of the C-arylglucosidic bond formation. 
- the carbonyl carbon on the cycle noted I (CI=O) involved in the new formed C-arylglucosidic 
bond was shielded at 164.6 ppm whereas the carbonylic carbon on the cycle II (CII=O) is 
deshielded at 171.0 ppm (the carbonylic carbons on the starting material occur between 
168.5 and 169.0 for the two anomers  and ) 
 
 
A : 13C-NMR (acetone-d6) compound 175 majoritaire product of C-arylglucosidation 
B : 13C-NMR (acetone-d6) compound (S)-158 (mixture of anomers  : = 1:1) starting material of C-arylglucosidation 
Figure 32. 13C-NMR spectra of the major epimer compared compared with the starting compound  
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A correlation HMBCb (Figure 33) with H-1 and H-2 and the quaternary carbon C2’I involved in 
the new C-C bond gave further confirmation of the structure. 
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Figure 33. HMBC experiment on compound 175
 
 
 
 
 
                                                 
b Heteronuclear Multiple Bond Correlation is an experiment that identifies proton nuclei with carbon 
nuclei that are separated by more than one bond 
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For the minor product 175 the 1H-NMR analysis allowed to confirm that this second 
compound was the second diastereoisomer at the C1 deriving from the C-arylglucosidation.  
 
The 1H-NMR spectra presented the same number of signals than the epimer. The chemical 
shift and the coupling patterns of the open-chain glucose core protons were assigned on the 
basis of 1H-1H COSY experiments  
 
 
A : 1H-NMR (acetone-d6) compound 175 minor product of C-arylglucosidation 
B : 1H-NMR (acetone-d6) compound 175 major product of C-arylglucosidation 
Figure 34. Comparison between the 1H-NMR spectra of the two epimers 175 
3.6.3 C-1 configuration determination 
The C-arylglucosylation reaction corresponds formally to an intramolecular aldol-type 
nucleophilic addition of the 2,3-HHBP unit to the aldehyde function generated during the 
mutarotation of the sugar. The two epimers at the C-1 position of the glucose are then 
obtained after the attack to the carbonylic carbon. 
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The C-1 configuration of the products obtained can be determined on the basis of two-
dimensional nuclear Overhauser effect (NOE) spectroscopy and NOE difference 
spectroscopy.  
An examination of the Dreiding models revealed in fact that there is no marked difference in 
the dihedral angles of the two C-1 epimers (the angle is, in all cases, ca. 60°), so their 
configuration cannot be assigned with certitude on the basis of the coupling constant values. 
In the course of their studies, Nonaka25 found that the NOESY of vescalagin ( configuration) 
showed a cross peak between the H-1 and the H-3, whereas in castalagin ( configuration), 
this cross peak was not observed. 
Likewise we carried ROESY experiments in order to assign the C-1 configurations of the two 
diasteroisomers obtained. Unfortunately, the expected correlation were not evident. However 
the C-1 configuration can be tentatively assigned on the basis of the value of the coupling 
constants of the H-1 signals. In 1990, on the basis of the accumulated data on several 
complex tannins as appropriate model compounds, Nonaka G. et coll.25 concluded that in the 
C-glucosidic hydrolyzable tannins, a small coupling constant (0-2 Hz) of the H-1 signal 
corresponds to the -linkage of the substituent, whereas a larger coupling constant (ca.5 Hz) 
indicates the linkage. 
The C-1 configuration of our products was so determined on the basis of the comparison 
between the coupling constant for the H1 proton between the two products obtained 175 
and 175 with that reported in literature for other epimeric pairs punicacortein 
A/epipunicacortein A (23a-b) and the castalin/vescalin (26/27) (Table 6).42,155,156 
 
 Castalin Vescalin Punicacortein A Epi-punicacortein A 
H-1 
d 
J=3.5 
d 
J=1.5 
d 
J=5 
d 
J=4.4 
H-2 brs 
d 
J=1.5 
dd 
J=2, 5 
m 
H-3 
d 
J=7.8 
d 
J=1.5 
brs brs 
C-1     
Table 6. H-1, H-2 and H-3 coupling constants reported in literature for C-arylglucosidic ellagitannins 
epimeric pairs 
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So it was assigned the  configuration to the C-1 of the main product. It presented a coupling 
constant 3J H1-H2 of 2.1 Hz, similar to vescalin 27 and epi-punicacortein A 23b. While to the 
minor product, with a 3J H1-H2 of 4.6 Hz, it was assigned an  C-1 configuration (Table 7). 
 
 major product 
175
minor product 
175
H-1 
d 
J = 2.1 
d 
J = 4.6 
H-2 
t 
J = 2.5 
dd 
J = 2.8, 4.5 
H-3 
t 
J = 2.8 
t 
J = 2.6 
 
 
C-1 configuration 
OH
1
2'I
2
H

 
H
1
2'I
2
OH

 
Table 7. C-1 configuration of the C-arylglucosidation products on the basis of their coupling constants 
3.7 C-arylglucosidation on the architecture D 
The same reaction conditions were carried out on the 2,3-digalloylated reducing glucose 
135d (Scheme 61). 
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Scheme 61. C-arylglucosidation in phosphate buffer at pH = 5.3 on compound 135d 
 
It is worth noting the different reactivity and solubility determined by the presence of the 
HHDP. The compound 135d resulted less soluble than the HHDP-bearing intermediate (S)-
158, so it was necessary to add some acetonitrile to obtain its complete solubilization. After 
1h stirring at 60°C the starting compound was almost completely consumed giving place to  
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the formation of a new major product (Figure 35). An LC/MS analysis allowed the attribution 
of this signal to gallic acid 77 generated from esters hydrolysis in 135d. 
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Analysis conditions : Column : Pursuit 5 C18 (250 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 0 to 100% of B in 20 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 35. HPLC profile C-arylglucosidation at pH = 5.3 on compound 135d  
 
Evidently the formation of the key C-arylglucosidic bond is made possible from the 
conformational constraint in the HHDP-bearing architecture B. This experimental observation 
invalidated our alternative retrosynthetic approach (route II) but furnished an important 
support to the current biosynthetic hypotheses:13 the HHDP formation is anterior to the C-
arylglucosidation. 
 
 
 
 
 
 
Gallic acid (77) 
Product of ester hydolysis 
m/z = 170 
(Rt = 6.8 min) 
Starting compound 
135d () 
m/z = 572 
(Rt = 12.8 and 13.3 min) 
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3.8 C-arylglucosidation attempts in acid conditions on 
a completely deprotected intermediate 
The reaction conditions optimized on compound (S)-158 leading to the C-arylglucosidic bond 
formation were also applied on the compound (S)-161 (Scheme 62). 
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Scheme 62. C-arylglucosidation in phosphate buffer at pH = 5.3 on compound (S)-161 
 
Even after prolonged reaction time (6 days), no conversion of the starting compound was 
observed by HPLC analysis of the reaction mixture. 
The starting compound was recovered with a 95% yield after filtration of the reaction mixture 
on LH-20 Sephadex (100% water to 100% MeOH). 
 
The presence of the benzylidene group at the O-4 and O-6 appears to be mandatory for the 
formation of the C-arylgucosidic bond. Pherhaps it may induce a structural strain on 
conformation favoring bond formation. 
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3.9 Towards the NHTP-unit constuction:          
C-arylglucosidation on the para-protected compound 
(S)-159 
In the section 2.4 reporting coupling studies, it has been showed the unfeasibility of a 
synthetic strategy involving C-C-biaryl bond formation on the perhydroxylated precursor. O-
chloranil did work on methyl glycosides but not on a reducing sugar and furthemore the 
coupling proved not easily reproducible.  
As an alternate route, the Yamada conditions - which required the preparation of a precursor 
featuring a para protected gallic units – were adapted to our substrates. By this way, it was 
possible to obtain the precursor (S)-159  for the C-arylglucosidic reaction which will be 
applied in the building of the NHTP unit. 
 
The para-benzylated compound (S)-159 resulted not soluble in water so several non-
nucleophilic co-solvents were tested to get the conditions most similar to previously adopted 
for the C-arylglucosidation reaction on the polyhydroxylated intermediate. The methanol 
resulted to be the best choice.  
 
The C-arylglucosidation reaction was at first carried out in methanol and phosphate buffer at 
pH = 5.3 under argon atmosphere (Figure 36). After 48 h stirring at 65°C, the starting 
compound (S)-159 was poorly consumed and the formation of little amounts of two more 
polar new compounds was observed. The two new products (Rt = 5.9 and 6.6 min) were 
identified by LC-MS analysis of the reaction mixture as the epimeric pairs of expected C-
arylglucosidation products (S)-159. 
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Scheme 63 : C-arylglucosidation in phosphate buffer at pH = 5.3 on compound (S)-159 
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Analysis conditions : Column : Pursuit 3 C18 (150 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 40 to 100% of B in 10 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 36. HPLC profile C-arylglucosidation at pH = 5.3 after 48h on compound (S)-159 
 
The benzyl group in para of the HHDP galloyl units allowed to mask the pseudo-catecholic 
function producing two meta phenol function. Then we guest that this structure changing (as 
respect to the polyhydroxylated compound (S)-158) conferred major stability to oxidation. On 
this hypothesis we tried to carry out the reaction in more basic conditions (pH = 7.5) in order 
to increment the kinetic of the reaction by the augmentation of the enol nucleophilicity. After 
only 2h in these conditions at 65°C, the starting material was almost completely consumed 
and four new products were formed, one major and three in little amount (Figure 37).  
 
Starting compound 
(S)-159 () 
m/z = 749 
(Rt = 7.2 and 7.3 min) 
176 and 176 
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(Rt = 5.9 and 6.6 min) 
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Scheme 64 : C-arylglucosidation in phosphate buffer at pH = 7.5 on compound (S)-159 
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Analysis conditions : Column : Pursuit 3 C18 (150 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 40 to 100% of B in 10 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 37. HPLC-UV C-arylglucosydation in phosphate buffer at several pH 
After 2h30 at 65°C at pH = 7.5 the reaction was almost complete, whereas at pH = 5.3 is just 
starting after 48h (Figure 37). But we had to observe that the increasing in the pH caused an 
augmentation of collateral processes leading to a more complex reaction mixture. 
 
The main product and one little (the one in the medium) presented the same molecular mass 
(m/z = 750) at an LC-MS analysis corresponding to the expected product 176. The remaining 
two little product were not ionizing in the analysis conditions. They were not attributed.  
Starting compound 
(S)-159 ( 
m/z = 749 
176 and 176 
m/z = 749 
pH = 7.5 (t = 2h30) 
pH = 5.3 (t = 48h) 
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3.9.1 C-arylglucosidation products of (S)-159 
Reaction work-up and products purification  
(S)-159 was dissolved in methanol/phosphate buffer at pH = 7.5 and the resulting solution 
was stirred at 65°C for 2h30. Then the reaction mixture was carefully (without warming) 
concentrated in vacuum (in order to remove the methanol) and purified by semipreparative 
reverse phase HPLC (Microsorb C18, 250 x 41.4 mm). 
After lyophilization of the fraction collected the major product of the reaction 176 was 
obtained with a 25% of yield. The minor compound was not yet obtained in pure forme 
because it resulted difficult so separate from the two other by-products. 
As in the case of the polyhydroxylated compound the yields obtained on little scale resulted 
difficult to reproduce it on larger scale 
The ethyl acetate extraction was carried out after methanol remotion when the reaction was 
performed with a buffer volum major than 10 ml. 
 
Prepurification steps were tried as RP C-18 silica gel filtration and or preparative TLC 
(eluent : CH2Cl2:EtOAc = 2:8) but big amount of mass went lost. So it was decided to avoid 
as much as possible pretreatment of the reaction mixture, to run the reaction on little scale in 
order to purify directly.  
Products 176 and  characterization 
The major product was easily characterized. While the characterization of the second 
compound, obtained in very little amount, resulted more difficult.  
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Figure 38. Epimeric products 176 and from C-arylglucosidation on (S)-159
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The NMR spectra obtained for the main product resulted superimposable to the spectra 
obtained for the polyhydroxylated 175, with the only differences due to the presence of the 
benzyl group on the HHDP unit.  
The formation of the new C-arylglucosidic bond was confirmed by full NMR analysis and 
comparison of the 1H and 13C spectra of the starting material (S)-159 and of the compound 
175 already described. The chemical schift and the coupling patterns of protons and 
carbons were assigned by mono and bi dimensional NMR experiments as 1H-1H COSY, 1H-13C  
HMQC and 1H-13C-HMBC. 
Diagnostic features in the 1H-NMR spectra (Figure 39) : 
- The presence of only one of the two isolated proton singlet at 6.5 attributable to the HHDP 
moiety (H6’II, red marked) vs. 4 singlets in the region between 6.56 and 6.58 ppm in the 
starting material (H2’I et H6’II /-anomers blue marked) 
- The sugar protons H1 and H3 were shielded to 4.79 and 5.07 ppm with coupling constants 
varying between 2.1 and 2.9 Hz.  
 
 
A : 1H-NMR (acetone-d6) compound 175 major product of C-arylglucosidation 
B : 1H-NMR (acetone-d6) compound (S)-159 (mixture of anomers  : = 1:1) starting material of C-arylglucosidation 
Figure 39. 1H-NMR spectra of the major epimer compared with the starting compound 
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The reaction product showed coupling constants 3J H1-H2 of 2.1 Hz identical to 175  and 
close to vescalin 27 (3J H1-H2 = 1.5 Hz). It was so possible to confirm the  configuration of the 
C1 carbon. 
 
The 13C-NMR spectra (Figure 40) presented the same features than the compound 175  :  
- C1 upfielded to 65.5 ppm (vs 92.4/95.6 ppm for the starting material); 
- two HHDP carbons one quaternary C2’I and tertiary the other C6’II at 118.8 and 105.8 ppm, 
clear sign of the C-arylglucosidic bond formation; 
- carbonylic carbons CI=O and CII=O at 164.4 and 170.4 ppm respectively. 
 
 
A : 1H-NMR (acetone-d6) compound 176 major product of C-arylglucosidation 
B : 1H-NMR (acetone-d6) compound (S)-159 (mixture of anomers  : = 1:1) starting material of C-arylglucosidation 
Figure 40. 13C-NMR spectra of the major epimer compared and the starting compound 
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A correlation HMBC (Figure 41) among H-1 and H-2 and the quaternary carbon C2’I involved 
in the new C-C bond gave further confirmation of the structure. 
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Figure 41. HMBC detail, experiment on compound 176 
 
The minor compound obtained resulted difficult to purify by HPLC and it was obtained in very 
little amounts.  
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3.9.2 C-arylglucosidation on the architecture D 
On the basis of the satisfactory results obtained on the compound B the same conditions 
were carried out on the intermediates with two galloyl units not coupled para-benzylated 
compound 149b (route II retrosynthesis).  
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Scheme 65. C-arylglucosidation in phosphate buffer at pH = 5.3 on compound 149b 
 
After only 2h30 the starting compound was completely consumed to give two major products 
(a and b Figure 43) corresponding to the galloyl units 77 (acid) and 132 (methyl ester). 
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A : HPLC-UV Profile (280 nm) reaction mixture after 1h 
B : HPLC-UV Profile (280 nm) reaction mixture after 2h30  
C : HPLC-UV Profile (280 nm) of the organic phase after acidification and extraction 
Analysis conditions : Column : Pursuit 3 C18 (150 x 4,6 mm), Eluent : A : H2O + 0.1% HCOOH, B : MeCN + 0.1% HCOOH, 
Method : gradient from 40 to 100% of B in 10 min, Flow : 1mL/min, Detector UV  (280nm). 
Figure 43. HPLC profile C-arylglucosidation at pH = 5.3 and work-up on compound 149b 
Again it was possible to confirm that the presence of the HHDP unit is essential for the C-
arylglucosidic bond formation in agreement with the proposed biosynthesic pathway. 
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4.1 Conclusion and perspectives 
C-arylglucosidic ellagitannins represent a unique sub-class of hydrolyzable tannins. 
Polyphenols such these have attracted considerable interest in the past fifteen years 
because of possible benefits in human health care and prevention of diseases such as 
carcinogenesis and arteriosclerosis.4,29,31 However, this class of natural product, with such 
unique structural architectures and potent biological activities, has not yet been fully explored 
for therapeutic potential. From here our interest in developing a synthetic strategy for 
generation of these compounds and their analogues with enhanced pharmacological 
properties. 
 
Our synthetic efforts were so focused on the synthesis of punicacortein A (23a) and its C-1 
epimer, epi-punicacortein A (23b) as simple structures of this class of natural compounds. 
The key step towards these molecular structures is the C-arylglucosidation reaction. In order 
to get this first objective several precursors sugar bearing HHDP unit (B) or two galloyl units 
(C) were synthesized as described in the second chapter of this manuscript. 
The compounds so obtained were employed in the following C-arylglucosidation step 
described in the third chapter. The opening of the sugar followed by the intramolecular aldol-
type nucleophilic addition to the aldehyde function are the two steps towards the C-glucosidic 
bond formation. After several attempts, the reaction was finally achieved in phosphate buffer. 
According to our guest and to the biosynthetic pathway the key C-arylglucosidic bond was 
achieved only in the case of the conformationally-constrained HHDP-bearing intermediate. 
Moreover it was showed that the presence of a cyclic protecting group at the O-4 and O-6 
positions of the sugar core is of paramount importance for the formation of the C-
arylglucosidic bond formation. It may induce a structural strain essential to the cyclization. 
Selective galloylation at the 5 position of the open-chain glucose on synthons A will give the 
punicacortein A (23a). 
 
In the end of this work we managed to obtain a route to access the C-arylglucosidic 
ellagitannins. This general strategy is showed in Scheme 66. 
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Scheme 66. Synthetic approach to punicacortein A 23 
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In the meantime an intramolecular atroposelective methodology for the construction of the 
hexahydroxyterphenolyl unit (HHDP) was developed in the laboratory by G. Malik, another 
PhD student in the Quideau’s research group.  
As discussed in the section 2.4, the developed methodology resulted not reproducible and 
neither applicable to our substrates. However an alternate route, inspired to the Yamada’s 
total synthesis of corilagin (55), was adapted to the synthesis of architectures B and we are 
confident it could be successfully applied to the NHTP construction. This strategy required 
the preparation of a precursor featuring a para-protected galloyl units.  
 
Our methodology for the C-arylglucosidic bond formation into biomimetic conditions resulted 
applicable even on differently protected substrates. So a biomimetic route to C-glucosidic 
ellagitannins have been developed as showed in Scheme 67.  
 
The introduction of a conveniently protected galloyl unit on the intermediates A gives access 
to the a product that could be further submitted to an oxidative coupling in the Yamada’s 
conditions to give, after deprotection, the NHTP-bearing C-arylglucosidic ellagitannin 
vescalin (25) (Scheme 67). 
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Scheme 67. Synthetic approach to vescalin 25 
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First galloylation attempts on compound 175 resulted unsatisfactory. Studies are still on 
going to address this point. 
 
At this point of the synthesis it was possible to obtain a first member of the C-arylglucosidic 
ellagitannin family.  
The benzylidene cleavage of compound 175 delivered the degalloyl epi-punicacortein A 179 
(Scheme 68). 
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Scheme 68. Degalloyl epi-punicacortein A 
 
This molecule has not yet isolated form a natural source, but it is reasonable to suppose that 
its structure corresponds to a natural compound. The hydrolysis of esters is the most 
frequent modification incurred by ellagitannins 42,44 so O-5-degalloyl epipunicacortein A could 
derive from epipunicacortein A (23b)44 as O-5-degalloyl punicacortein A (24) derives from 
hydrolysis of its precursor punicacortein A (23a). 
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4.2 Benzylidene cleavage and synthesis of O-5-
degalloyl epipunicacortein A 
A benzylidene acetal is a commonly used protective group for 1,2- and 1,3-diols. It presents 
the advantage that it can be removed under neutral conditions by hydrogenolysis or by acid 
hydrolysis.157 The well documented difficulties associated with purification of the 
perhydroxylated natural products37 oriented our choice towards cleavage conditions not 
demanding further purification. 
In this vein deprotection conditions as microwaves-promoted hydrolysis in pure water158 or 
Lewis acid catalyzed159-162 were tested on compound 174, as model compound. These 
methodologies resulted not applicable owing to the numerous collateral processes, specially 
hydrolysis of esters functions. 
In another series of experiments the same conditions reported by Feldman in his 
ellagitannins total synthesis were exploited. The I2-promoted methanolysis (Scheme 69) 
(employed by Feldman in the total synthesis of pedunculagin)74 led to the deprotected 
product 161 in 15% yields after preparative HPLC purification. 
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Scheme 69. I2-promoted benzylidene methanolysis 
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In order to reduce the purification steps it was tried to carry out the benzylidene cleavage 
“one-pot” after the C-arylglucosidation, through acidification of the reaction mixture (Scheme 
70). 
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Scheme 70. “One-pot” C-arylglucosidation and benzylidene cleavage 
 
Also in this conditions the product of deprotection was obtained in poor yields with significant 
impurities, requiring cumbersome chromatographic purification steps. 
 
In the light of these results the best deprotection method seemed to be the palladium-
catalyzed hydrogenolysis that could be carried out in neutral conditions, allowing to avoid 
hydrolysis collateral processes. 
 
Cleavage by catalytic hydrogenation can be performed with good selectivity under mild 
conditions using heterogeneous Palladium on Carbon (Pd/C) catalyst in the presence of 
hydrogen gas or a hydrogen transfer agent, e.g. ammonium formate or isopropanol. Efficient 
removal depends on selection of the most active and selective catalyst, and an optimized set 
of reaction conditions (see Annex 2). This method presents the advantage to deliver the 
product pure after simple filtration of the catalyst. 
At first the reaction was carried out in tetrahydrofuran with Pd/C as catalyst (Scheme 71), 
the same conditions that led to the formation of 161.  
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Scheme 71. Pd/C catalyzed hydrogenolysis of 175
 
The reaction was followed by HPLC and seven days were needed in order to get a complete 
consumption of the starting material. The formation of the deprotection product was 
accompanied by the formation of several products of degradation, and that it resulted 
impossible in the end to purify the reaction product. 
 
In a final set of experiments compound 175 was efficiently debenzylated by treatment with 
Pd(OH)2/C in tetrahydrofuran under an argon atmosphere (Scheme 72).  
The formation of a stable complex between the compound 175 and Pd catalyst implied that 
at least a stoichiometric amount of catalyst was required. 
Pure 179 was completely characterized by NMR (see annex 3). 
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Scheme 72. Degalloyl epi-punicacortein A synthesis 
 
In conclusion, the first total synthesis of a C-arylglucosidic ellagitannin, the 5-O degalloyl 
epipunicacortein A 179 was accomplished (Scheme 66).  
 
This allows access to diverse C-arylglucosidic ellagitannins scaffolds and derivatives. 
Chapter 4 – Conclusion and Perspectives 
 141
Attempts at synthesizing NHTP bearing C-arylglucosidic ellagitannins were retarded by 
difficulties encountered with the selective esterification on A precursors as the necessary 
intermediate. The search for alternate approaches was postponed to studies currently under 
development
 
 
 
 
 
 
 
 
 
 
 
Chapter 5  
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5.1 General Methods  
Reagents were purchased at the highest commercial quality and used without further 
purification unless otherwise stated.  
All moisture and oxygen sensitive reactions were carried out in flame-dried glassware under 
inert atmosphere with dry solvents. Tetrahydrofuran (THF) and dichloromethane (CH2Cl2) 
were purified immediately before use by filtration through activated alumina columns under 
nitrogen. Methanol (MeOH) was distilled from Mg under nitrogen prior to use. Benzaldehyde 
was purified by fractioned distillation with toluene in order to remove its oxidation products. 
Benzyl chloride was dinstilled under nitroger prior to use. Acetone, ethanol (EtOH), ethyl 
acetate (EtOAc), petroleum ether (PET), cyclohexane and diethyl ether (Et2O) were used as 
received.  
The molecular sieves were activated through in oven at 110°C. The zinc chloride (ZnCl2) was 
flammed under vacuum prior to use. The DMAP-HCl was prepared from DMAP and HCl in 
THF. o-chloranil was purified by christallization in benzene. Evaporations were conducted 
under reduced pressure at temperatures less than 45 °C.  
The phosphate buffers (0.2 M) were prepared prior to use (6 g of KH2PO4 in 240 mL of 
water). The pH (measured by a pHmeter) was adjusted by addition of aqueous solutions of 
HCl or NaOH.  
The photochemical reaction were realized with an UV Fischer Scientific Bioblock at 365 nm 
(6W) lamp on a maximum amount of starting compound of 300 mg.  
Room temperature is at around 20 and 25°C. The reaction at low temperatures were carried 
out in glaced (0°C) or ethanol/liquid nitrogen (0°C to -78°C) bath. A cryostat Julabo FT 901 
was employed for long reaction at temperature lower than 0°C.  
Reactions were monitored by thin layer chromatography (TLC) carried out on 0.25 mm E. 
Merck silica plates (60 F254), using UV light as the visualizing agent and a potassium 
permanganate solution and heat as the developing agent. A ferric chloride solution in HCl 
(0.5M) was used to reveal catechol functions. In the case of polar compounds, reactions 
were monitored by reverse phase (RP) thin layer chromatography (TLC) carried out on E. 
Merck aluminium sheets (RP-18 F254s), using UV light as the visualizing agent, or by HPLC 
on a reverse phase column (Pursuit C18, Varian), using MeCN/H2O/0.1% HCOOH as the 
mobile phase (UV detection at 280 nm). Column chromatography was carried out under 
positive pressure using 40-63 m silica gel (Merck) and the indicated solvents. Preparatory 
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HPLC was performed on a Varian semi-preparative LC system using a Varian Microsorb 
100-8 C18 (41.4 x 250 mm) column.  
Melting points were recorded in open capillary tubes on a Buchi B-540 apparatus and are 
uncorrected.  
Optical rotations were determined on a Krüss P3001 digital polarimeter at 589 nm, and are 
given as []t°CD (concentration in g/100 mL solvent).  
IR spectra were recorded on a Bruker IFS55 FT-IR spectrometer.  
NMR spectra of samples in the indicated solvent were recorded on Bruker Avance 300 or 
400 spectrometer and were calibrated using residual undeuterated solvent as an internal 
reference.  
 chloroform-d1 : 7.26 ppm for 1H-NMR, 77.0 ppm for 13C-NMR  
 acetone-d6 : 2.05 ppm for 1H-NMR, 29.84 ppm for 13C-NMR 
 DMSO-d6 : 2.50 ppm for 1H-NMR, 39.52 ppm for 13C-NMR 
 methanol-d4 : 3.31 ppm for 1H-NMR, 49.00 ppm for 13C-NMR 
The coupling constants (J) are expressed in Hz. The following abbreviations were used to 
explain multiplicities: s = singlet, d = doublet, t = triplet, m = multiplet, AB = AB quartet, br = 
broad singulet, HAr = aromatic proton, CHAr = tertiary aromatic carbon, Cq = quaternary 
carbon. Carbon multiplicities were determined by DEPT135 experiment. Diagnostic 
correlations were obtained by two-dimensional COSY, HSQC and HMBC experiments. 
Mass Spectromety Chemical ionization (CIMS) and electrospray (ESIMS) low and/or high 
resolution (HRMS) mass spectrometric analyses were obtained from the mass spectrometry 
laboratory at the Institut Européen de Chimie et Biologie (IECB), France.  
Elemental analyses were carried out at the Service Central d’Analyses du CNRS, 
Vernaison, France. 
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5.2 Synthesis and characterization of products 
Sugar precursors (E) 
126a 
Benzyl 2,3,4,6-tetra-O-acetyl--D-glucopyranoside 
 
C21H26O10 
MW = 438,43 Da 
CAS : [10343-13-2] 
 
According to the procedure described in the literature,131 Ag2CO3 (2.01 g, 7.29 mmol, 3 eq) 
and a crystal of iodine were added to a solution of commercially available benzyl alcohol 
(1.31 g, 12.15 mmol, 5 eq) in dry CH2Cl2 (15 mL) and the mixture was stirred over 4 Å 
molecular sieves for 15 minutes. A solution of commercially available 2,3,4,6-tetra-O-acetyl-
-D-glucopyranosyl bromide (125, 1 g, 2.43 mmol, 1 eq) in dry CH2Cl2 (5 mL) (also stirred 
over 4 Å molecular sieves for 15 minutes) was then added dropwise. The reaction flask was 
shielded from light and stirred at room temperature under nitrogen for 20 hours. The reaction 
mixture was diluted with EtOAc, filtered through Celite, and concentrated in vacuo. Crude 
was purified by column chromatography (4:1 cyclohexane:EtOAc) to give 126a as a white 
solid (976 mg, 92%). 
m.p. 93-94°C [lit.163 m.p. 93-93.3°C (EtOH)]; Rf = 0.05 (4:1 cyclohexane:EtOAc) 
21D = -52.0° (c = 1, CHCl3) [lit.163 25D = -51.0° (c = 1, CHCl3)] 
IR (NaCl) max 1752, 1369, 1221 cm-1 
1H NMR (300 MHz, chloroform-d1)  1.98-2.09 (m, 12H, H13/H15/H17/H19), 3.63-3.69 (m, 1H, 
H5), 4.15 (dd, J = 2.4, 12.2 Hz, 1H, H6), 4.26 (dd, J = 4.7, 12.3 Hz, 1H, H6), 4.54 (d, J = 7.8 
Hz, 1H, H1), 4.61 and 4.88 (AB, JAB = 12.3 Hz, 2H, H7), 5.02-5.19 (m, 3H, H2/H4/H3), 7.25-
7.36 (m, 5H, H9/H10/H11) 
13C NMR (75 MHz, chloroform-d1)  170.4/170.0/169.2/169.0 (C12/C14/C16/C18), 136.6 (C8), 
128.3/127.8/127.6 (C9/C10/C11), 99.2 (C1), 72.7 (C3), 71.7 (C5), 71.2 (C7), 70.6 (C2), 68.4 (C4), 
61.8 (C6), 20.5/20.4/20.4 (C13/C15/C17/C19) 
CIMS m/z (%) 457 [M+NH4]+ (100), 331 (54) 
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126b 
2-Nitrobenzyl-2,3,4,6-tetra-O-acetyl--D-glucopyranoside 
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C21H25NO12 
MW = 483,42 Da 
CAS : [34546-55-9] 
 
According to the procedure described in the literature,131 to a solution of commercially 
available 2-nitrobenzyl alcohol (3.72 g, 24.32 mmol, 5 eq) in dry CH2Cl2 (20 mL) were added 
Ag2CO3 (4.02 g, 14.58 mmol, 3 eq), and one crystal of iodine. The reaction was stirred over 4 
Å molecular sieves for 15 minutes. A solution of commercially available 2,3,4,6-tetra-O-
acetyl--D-glucopyranosyl bromide (166, 2 g, 4.86 mmol, 1 eq) in dry CH2Cl2 (10 mL) (also 
stirred over 4 Å molecular sieves for 15 minutes) was then added dropwise. The reaction 
flask was shielded from light and stirred at room temperature under nitrogen for 6 hours. The 
reaction mixture was diluted with EtOAc, filtered through Celite, and concentrated in vacuo. 
Crude material was purified by column chromatography (8:2 cyclohexane:EtOAc) to afford 
126b as white crystals (2.27 g, 100 %). 
m.p. 67-68°C 
Rf = 0.20 (7:3 cyclohexane:EtOAc) 
24D = -1.96° (c = 0.51, acetone) 
IR (NaCl) max 2962, 1740, 1530, 1369, 1227, 1042 cm-1 
1H NMR (300 MHz, chloroform-d1)  2.02 (s, 3H, CH3 from Ac groups), 2.03 (s, 3H, CH3 from 
Ac groups), 2.06 (s, 3H, CH3 from Ac groups), 2.08 (s, 3H, CH3 from Ac groups), 3.73-3.78 
(m, 1H, H5), 4.15 (dd, J = 2.2, 12.3 Hz, 1H, H6), 4.30 (dd, J = 4.8, 12.4 Hz, 1H, H6), 4.68 (d, J 
= 7.9 Hz, 1H, H1), 5.06 and 5.26 (AB, JAB = 14.5 Hz, 2H, H7), 5.10-5.25 (m, 3H, H2/H3/H4), 
7.46 (t, J = 7.6 Hz, 1H, H11), 7.63 (d, J = 7.6 Hz, 1H, H9), 7.70 (t, J = 7.7 Hz, 1H, H10), 8.08 (d, 
J = 8.1 Hz, 1H, H12) 
13C NMR (75 MHz, chloroform-d1)  170.6/170.1/169.4 (C14/C16/C18/C20), 147.1 (C13), 133.8 
(C9), 133.4 (C8), 128.9 (C10), 128.4 (C11), 124.7 (C12), 100.5 (C1), 72.0 (C5), 72.7/71.3/68.4 
(C2/C3/C4), 68.1 (C7), 61.8 (C6), 20.6/20.6/20.5 (C15/C17/C19/C21) 
CIMS m/z (%) 501 [M+NH4]+ (100), 455 (61), 366 (34), 331 (33), 106 (76) 
Anal. calcd for C21H25NO12 : C, 52.18; H, 5.21; N, 2.90. Found : C, 52.22; H, 5.24; N, 2.80 
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33 
Benzyl--D-glucopyranoside 
 
 C13H18O6 
MW = 270,28 Da 
CAS : [4304-12-5] 
 
According to the procedure described in the literature,163 a catalytic amount of sodium 
methoxide was added to a solution of 126a (2.87 g, 6.55 mmol) in dry MeOH (40 mL). TLC 
analysis indicated after 3 hours complete conversion of starting material. The solution was 
then neutralized with Dowex® 50X8-400 ion-exchange resin (H+ form), filtered, and 
concentrated in vacuo to leave 33 in pure form as white crystals (1.77 g, 100%). 
m.p. 104°C [lit.163 m.p. 105-106°C (CHCl3-PET)] 
Rf = 0.34 (5% acetone in EtOAc) 
21D = -56.3° (c = 0.9, MeOH) [lit.163 25D = -49.9° (c = 1, MeOH)] 
IR (KBr) max 3502 (st), 3062, 2931, 2883, 1497, 1455, 1370, 1280, 1157, 1083, 1048, 990 
cm-1 
1H NMR (300 MHz, methanol-d4) 3.20-3.33 (m, 4H, H2/H3/H4/H5), 3.66 (dd, J = 5.2, 11.8 Hz, 
1H, H6), 3.86 (d, J = 11.7 Hz, 1H, H6), 4.32 (d, J = 7.5 Hz, 1H, H1), 4.63 and 4.89 (AB, JAB = 
11.8 Hz, 2H, H7), 7.20-7.39 (m, 5H, H9/H10/H11) 
13C NMR (75 MHz, methanol-d4)  139.0 (C8), 129.2/129.2/128.6 (C9/C10/C11), 103.2 (C1), 
78.0/77.9/75.1/71.7 (C2/C3/C4/C5), 71.6 (C7), 62.8 (C6) 
CIMS m/z (%) 288 [M+NH4]+ (100), 270 [M+H]+ (82), 180 (89), 108 (68), 91 (27) 
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34 
2-Nitrobenzyl--D-glucopyranoside 
 
 C13H17NO8 
MW = 315,28 Da 
CAS : [34546-53-7] 
 
According to the procedure described in the literature,163 a catalytic amount of sodium 
methoxide was added to a stirred solution of 126b (4.60 g, 3.36 mmol) in dry MeOH (20 mL). 
TLC analysis indicated after 30 minutes complete conversion of starting material. The 
solution was then neutralized with Dowex® 50X8-400 ion-exchange resin (H+ form), filtered, 
and concentrated in vacuo. Crude material was purified by column chromatography (5% 
acetone in EtOAc) to yield 34 as white crystals (3.10 g, 100%). 
m.p. 125°C [lit.130 m.p. 131°C (H2O)] 
Rf = 0.15 (5% acetone in EtOAc) 
21D = -36.4° (c = 0.55, pyridine) [lit.130 25D = -4.39° (c = 0.55, pyridine)] 
IR (KBr) max 3302 (st), 1522, 1336, 1077, 1037, 737 cm-1 
1H NMR (300 MHz, methanol-d4) 3.29-3.40 (m, 4H, H2/H3/H4/H5), 3.66 (dd, J = 4.9, 11.9 Hz, 
1H, H6), 3.85 (d, J = 11.1 Hz, 1H, H6), 4.41 (d, J = 7.6 Hz, 1H, H1), 5.05 and 5.25 (AB, JAB = 
15.3 Hz, 2H, H7), 7.47 (t, J = 7.7 Hz, 1H, H10), 7.68 (t, J = 7.2 Hz, 1H, H11), 7.99 (d, J = 7.7 
Hz, 1H, H12), 8.03 (d, J = 8.1 Hz, 1H, H9) 
13C NMR (75 MHz, methanol-d4)  148.7 (C13), 135.7 (C8), 134.7 (C11), 130.3 (C12), 129.2 
(C10), 125.5 (C9), 104.0 (C1), 78.0/75.1/71.5 (C2/C3/C4/C5), 68.4 (C7), 62.6 (C6) 
CIMS m/z (%) 333 [M+NH4]+ (100), 180 (49), 122 (47), 120 (73), 88 (41) 
Anal. calcd for C13H17NO8 : C, 49.53; H, 5.44; N, 4.44. Found : C, 49.32; H, 5.64; N, 4.00 
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127 
Benzyl-4,6-O-(tetraisopropyldisiloxane-1,3-diyl)--D-glucopyranoside 
 
 C25H44O7Si2 
MW = 512,78 Da 
CAS : [89291-61-2] 
 
According to the procedure described in the literature,132 dichlorotetraisopropyldisiloxane 
(2.84 mL, 8.88 mmol, 1.2 eq) was added dropwise to a solution of 33 (2 g, 7.40 mmol, 1 eq) 
and imidazole (2.51 g, 37.0 mmol, 5 eq) in dry DMF (150 mL). After 5 hours, excess of 
silylating agent was decomposed by the addition of 10 mL of MeOH, which was followed by 
the addition of 100 mL of EtOAc. The solution was poured into 150 mL of brine and extracted 
with EtOAc (3 x 100 mL). The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. Crude was purified by column chromatography (9:1  8:2 
cyclohexane:EtOAc) to give 127 as a yellow oil (2.33 g, 61%). 
Rf = 0.48 (7:3 cyclohexane:EtOAc) 
21D = -74.5° (c = 0.9, CHCl3) [lit.163 25D = -72.3° (c = 1, CHCl3)] 
IR (NaCl) max 3429, 1252, 1036 cm-1 
1H NMR (300 MHz, chloroform-d1)  1.02-1.11 (m, 28H, H12/H13), 3.19 (d, J = 9.3 Hz, 1H, H5), 
3.42 (t, J = 8.4 Hz, 1H, H2), 3.57 (t, J = 9.0 Hz, 1H, H3), 3.85 (t, J = 9.1 Hz, 1H, H4), 4.01 and 
4.12 (AB, JAB = 12.5  Hz, 2H, H6), 4.35 (d, J = 7.8 Hz, 1H, H1), 4.59 and 4.98 (AB, JAB = 11.7 
Hz, 2H, H7), 7.28-7.36 (m, 5H, H9/H10/H11) 
13C NMR (75 MHz, chloroform-d1)  137.1 (C8), 128.4/128.1/127.8 (C9/C10/C11), 101.8 (C1), 
76.7 (C5), 76.1 (C3), 73.9 (C2), 70.8 (C7), 69.2 (C4), 60.9 (C6), 17.3/17.3/17.2/17.2/17.2/17.0 
(C12), 13.6/13.2/12.5/12.5 (C13) 
CIMS m/z (%) 531 [M+NH4]+ (100), 423 (30), 405 (35), 108 (36), 91 (42) 
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128 
Benzyl-4,6-O-t-butylsilylanediyl--D-glucopyranoside 
 
 C21H34O6Si 
MW = 410,58 Da 
No CAS 
 
According to the procedure described in the literature,133 33 (1.35 g, 4.99 mmol, 1 eq) was 
azeotropically dried with benzene (3 x 5 mL) and taken up in DMF (8 mL). The mixture was 
cooled to –40°C and stirred for 30 minutes. Addition of di-tert-butylsilyl ditriflate (1.82 ml, 4.99 
mmol, 1 eq) over 5 minutes afforded a clear solution that was further stirred at –40°C for 1 
hour. Upon warming to room temperature, the reaction mixture was diluted with 100 mL of 
diethyl ether and washed with saturated aqueous solution of NaHCO3 (30 mL), H2O (30 mL) 
and brine (30 mL). The organic layer was then dried over Na2SO4, filtered and concentrated 
in vacuo to provide a very hygroscopic white solid. Crude was purified by column 
chromatography (75:25 cyclohexane:EtOAc) to give 128 as a very hygroscopic white foam 
(1,73 g, 84%). 
Rf = 0.44 (7:3 cyclohexane:EtOAc) 
[]D24 = +7.0° (c = 0.1, CH2Cl2) 
1H NMR (300 MHz, chloroform-d1)  1.00 (s, 9H, H12), 1.06 (s, 9H, H12), 2.46 (brs, 1H, OH), 
2.72 (brs, 1H, OH), 3.38-3.61 (m, 3H, H2/H3/H5), 3.74 (t, J= 8.9 Hz, 1H, H4), 3.95 (t, J= 10.2 
Hz, 1H, H6), 4.20 (dd, J= 5.1 Hz, J = 10.2 Hz, 1H, H6), 4.47 (d, J= 7.2 Hz, 1H, H1), 4.62 and 
4.91 (AB, JAB = 11.7 Hz, 1H, H7), 7.31-7.37 (m, 5H, H9/H10/H11) 
13C NMR (75 MHz, chloroform-d1)  136.8 (C8), 128.5/128.1/128.0 (C9/C10/C11), 102.0 (C1), 
76.7 (C4), 76.3 (C3), 73.6 (C2), 71.3 (C7), 70.5 (C5), 66.1 (C6), 27.4/27.0 (C12), 22.6/19.9 (C13) 
CIMS m/z (%) 411 [M+H]+ (100) 
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30 
Benzyl-4,6-O-benzylidene--D-glucopyranoside 
 
 C20H22O6 
MW = 358,39 Da 
CAS : [113973-86-7] 
 
According to the procedure described in the literature,73 zinc chloride (13.8 g, 0.10 mol, 5.3 
eq) was added under nitrogen to a suspension of 33 (5.13 g, 19 mmol, 1 eq) in 50 mL of 
benzaldehyde and the mixture was allowed to stir at room temperature for 16 hours. The 
reaction solution was then diluted with ice, and the crude product was extracted with EtOAc 
(3 x 50 mL). The organic layer was washed with brine (100 mL), dried over MgSO4 and 
concentrated in vacuo. The liquid residue (containing an excess of benzaldehyde) was 
purified by column chromatography (10:0  9:1 CH2Cl2:acetone) to give 30 as a white solid 
(6.1 g, 90%). 
m.p. 158.5°C  
Rf = 0.10 (3:2 cyclohexane:EtOAc) 
[]D24 = -61.0° (c = 1.2, CHCl3) 
IR (neat) max 3434, 3063, 3031, 2917, 2874, 1455, 1380, 1094, 1027, 1002 cm-1 
1H NMR (300 MHz, chloroform-d1)  2.65 (brs, OH), 3.46 (dt, J = 4.8 Hz, J = 9.5 Hz, 1H, H2), 
3.53-3.60 (m, 2H, H4/H5), 3.78-3.85 (m, 2H, H3/H6), 4.37 (dd, J = 4.8 Hz, J = 10.5 Hz, 1H, 
H6), 4.50 (d, J = 7.8 Hz, 1H, H1), 4.64 and 4.94 (AB, JAB = 11.5 Hz, 2H, H7), 5.54 (s, 1H, H12), 
7.32-7.51 (m, 10H, HAr) 
13C NMR (75 MHz, DMSO-d6)  128.8 (C11 or C16), 128.2/128.0/127.6/126.4 (C9/C10/C14/C15), 
127.5 (C11 or C16), 103.0 (C1), 100.7 (C12), 80.6 (C4), 74.4 (C2), 72.9 (C3), 70.2 (C7), 68.0 (C6), 
65.9 (C5) 
ESIMS m/z (%) 739 [2M+Na]+ (100) 
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31 
2-Nitrobenzyl-4,6-O-benzylidene--D-glucopyranoside 
 
 C20H21NO8 
MW = 403,38 Da 
CAS : [173204-63-2] 
 
According to the procedure described in the literature,73 zinc chloride (22.9 g, 168.1 mmol, 
5.3 eq) was added under nitrogen to a suspension of 34 (10 g, 31.7 mmol, 1.0 eq) in 100 mL 
of benzaldehyde and the mixture was stirred at room temperature for 24 hours. The reaction 
solution was then poured into ice, and the crude product was extracted with EtOAc (3 x 75 
mL). The combined extracts were washed with brine, dried over MgSO4 and concentrated in 
vacuo. Further concentration under high vacuum using Kugelrohr to remove excess of 
benzaldehyde furnished an orange solid which was purified by column chromatography (8:2 
 4:6 cyclohexane:EtOAc) to yield 31 as a slight yellow solid (10.20 g, 80%). 
m.p. 165°C 
Rf = 0.10 (3:2 cyclohexane:EtOAc) 
24D = -82.8° (c = 0.99, acetone) 
IR (neat) max 3430, 3050, 3025, 2921, 2871, 1749, 1443, 1379, 1087, 998 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.41-3.64 (m, 3H, H2/H4/H5), 3.72-3.85 (m, 2H, H3/H6), 
4.35 (dd, J = 4.8, 10.5 Hz, 1H, H6), 4.55 (d, J = 7.6 Hz, 1H, H1), 5.10 and 5.26 (AB, JAB = 14.7 
Hz, 2H, H7), 5.52 (s, 1H, H14), 7.35-7.50 (m, 6H, H16/H17/H18/H10), 7.65 (t, J = 7.6 Hz, 1H, H11), 
7.84 (d, J = 7.7 Hz, 1H, H12), 8.07 (d, J = 8.1 Hz, 1H, H9) 
13C NMR (75 MHz, DMSO-d6)  147.3 (C13), 136.9 (C15), 133.7 (C11), 133.6 (C8), 129.3 (C18), 
129.1 (C12), 128.3/128.3 (C16/C17), 126.3 (C10), 124.7 (C9), 102.8 (C1), 101.9 (C14), 80.4 (C4), 
74.6 (C2), 73.3 (C3), 68.5 (C6), 68.1 (C7), 66.4 (C5) 
CIMS m/z (%) 404 [M+H]+ (48), 122 (94), 108 (100) 
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Galloyl units (F) 
 
66 
Methyl 3,4,5-tribenzyloxybenzoate 
 
 
C29H26O5 
MW = 454,51 Da 
CAS : [70424-94-1] 
 
According to the procedure described in the literature,137 a mixture of methyl gallate (132, 2 
g, 10.86 mmol, 1.0 eq), KI (0.8 g, 4.78 mmol, 0.5 eq) and anhydrous powdered K2CO3 (8.8 g, 
63.64 mmol, 5.9 eq) in 120 mL of acetone was stirred at room temperature for 20 minutes. 
Benzyl chloride (4 mL, 34.75 mmol, 3.2 eq) was dissolved in 20 mL of acetone and added to 
the reaction mixture. The suspension was refluxed for 20 hours at which time TLC showed 
full conversion of the starting material. The mixture was filtered through Celite and the 
filtrate was evaporated in vacuo to give 66 as a pale yellow solid (4.94 g, 100%). 
m.p. 97°C [lit.91 m.p. 99-100°C (hexane)] 
Rf = 0.45 (4:1 cyclohexane:EtOAc) 
IR (NaCl) max 3064, 3033, 2950, 2892, 1715, 1126 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.89 (s, 3H, H16), 5.12 (s, 2H, H11), 5.14 (s, 4H, H6), 
7.25-7.45 (m, 17H, HAr) 
13C NMR (75 MHz, chloroform-d1)  166.5 (C1), 152.5 (C4), 142.4 (C5), 137.4 (C12), 136.6 
(C7), 128.4/128.4/128.1/127.9/127.8/127.5  (C8/C9/C10/C13/C14/C15), 125.2 (C2), 109.0 (C3), 
75.0 (C11), 71.1 (C6), 52.1 (C16) 
ESIMS m/z (%) 931 [2M+Na]+ (55), 477 [M+Na]+ (100), 445 [M+H]+ (67) 
HRMS calcd for C29H27O5 [M+H]+ 455.1858, found 455.1855 
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133 
Benzyl 3,4,5-tribenzyloxybenzoate 
 
 
C35H30O5 
MW = 530,61 Da 
CAS : [475161-97-8] 
 
According to the procedure described in the literature,138 gallic acid (77, 1 g, 5.88 mmol, 1 
eq) was dissolved in acetone (60 mL). K2CO3 (3.6 g, 25.87 mmol, 4.4 eq) and benzyl 
bromide (3.1 mL, 25.87 mmol, 4.4 eq) were added to the solution and the mixture was stirred 
under reflux for 18 hours. After adding H2O (200 mL), the mixture was extracted with EtOAc 
(3 x 100 mL). The solvent was removed in vacuo, and the residual oil was crystallized from 
ethanol to yield 133 (1.18 g, 38%) as white crystals. 
m.p. 92-93°C (EtOH) [lit.138 m.p. 93.5-94.5°C (EtOH)] 
Rf = 0.70 (4:1 PET:EtOAc) 
IR (NaCl) max 1714, 1428, 1335, 1205 cm-1 
1H NMR (300 MHz, DMSO-d6)  5.06 (s, 2H, H11), 5.19 (s, 4H, H6), 5.33 (s, 2H, H16), 7.27-
7.46 (m, 22H, HAr) 
13C NMR (75 MHz, DMSO-d6)  165.1 (C1), 152.1 (C4), 141.5 (C5), 137.3 (C12), 136.7 (C17), 
136.2 (C7), 128.5/128.2/128.1/128.0/127.9/127.8/127.6 (CHAr), 124.7 (C2), 108.2 (C3), 74.2 
(C11), 70.3 (C6), 66.1 (C16) 
CIMS m/z (%) 549 [M+NH4]+ (84), 532 [M+H]+ (45), 108 (100), 91 (92) 
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32 
3,4,5-tribenzyloxybenzoic acid 
 
 
C28H24O5 
MW = 440,49 Da 
CAS : [1486-48-2] 
 
Via hydrolysis of methyl ester 66 :137 
To a suspension of crude 66 (5.91 g) in 100 mL of ethanol was added NaOH (708 mg, 17.70 
mmol, 1.6 eq). The mixture was heated to reflux for 2 hours. The hot solution was poured 
into 100 mL of 1M aqueous solution of HCl and the resulting mixture was stirred for 10 
minutes before the solid was filtered off. The product was washed successively with a 1:1 
mixture of ethanol and water (20 mL), pure water (20 mL), ethanol (20 mL), methanol (20 
mL) and Et2O (20 mL). The solid was then crystallized from ethanol to afford 32 as a white 
solid (3.93 g, 82%). 
Via hydrolysis of benzyl ester 133 :138 
A suspension of 133 (945 mg) in 50 mL of a methanolic solution of KOH (3N) was heated to 
reflux for 9 hours. The hot solution was then acidified at room temperature with a solution of 
HCl (3N) until pH = 1. The resulting precipitate was filtered off and the product was dissolved 
in EtOAc (100 mL). The organic layer was washed with water (3 x 30 mL), dried over MgSO4 
and concentrated in vacuo. The solid was then crystallized from ethanol to afford 32 as a 
white solid (340 mg, 43%). 
m.p. 194-195°C (EtOH) [lit.164 m.p. 196-196.5°C (benzene-PET)] 
Rf = 0.40 (1:1 cyclohexane:EtOAc) 
IR (KBr) max 1688, 1428, 1124 cm-1 
1H NMR (300 MHz, DMSO-d6)  5.04 (s, 2H, H11), 5.18 (s, 4H, H6), 7.27-7.48 (m, 17H, HAr), 
12.95 (s large, 1H, H16) 
13C NMR (75 MHz, DMSO-d6)  166.9 (C1), 152.0 (C4), 141.0 (C5), 137.4 (C12), 136.9 (C7), 
128.4/128.2/128.1/127.9/127.6 (C8/C9/C10/C13/C14/C15), 126.1 (C2), 108.2 (C3), 74.2 (C11), 
70.2 (C6) 
CIMS m/z (%) 459 [M+NH4]+ (100), 368 (49), 108 (51), 91 (39) 
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136 
Methyl 3,4,5-triacetoxybenzoate 
 
 
C14H14O8 
MW = 310,26 Da 
CAS : [20189-90-6] 
 
According to the procedure described in the literature,140 a mixture of commercially available 
methyl gallate (132, 5 g, 0.027 mol) and acetic anhydride (10 mL, 0.106 mol, 4 eq) in pyridine 
(25 mL) was stirred 16 hours at room temperature. The reaction mixture was then poured 
into 10% solution of HCl in brine (100 mL) and extracted with EtOAc (3 x 75 mL). The 
combined organic layers were washed with 10% aqueous solution of NaHCO3 until pH 8 and 
brine (75 mL), dried over MgSO4 and evaporated in vacuo. After recrystallisation in EtOH, 
136 was obtained as white crystals (6.26 g, 75%). 
m.p. 127°C (EtOH) [lit.140 m.p. 126.5-128°C (EtOH)] 
Rf = 0.28 (3:2 cyclohexane:EtOAc) 
IR (neat) max 1783, 1720, 1430, 1370, 1325, 1166 cm-1 
1H NMR (300 MHz, chloroform-d1) 2.27 (s, 6H, H7), 2.28 (s, 3H, H9), 3.88 (s, 3H, H10), 7.78 
(s, 2H, H3) 
13C NMR (75 MHz, chloroform-d1)  167.5 (C6), 166.4/164.8 (C1/C8), 143.3 (C4), 138.5 (C5), 
128.1 (C2), 122.1 (C3), 52.5 (C10), 20.4 (C7), 20.0 (C9) 
ESIMS m/z (%) 638 [2M+NH4]+ (58), 328 [M+NH4]+ (100) 
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137 
Methyl-3,5-diacetoxy-4-(benzyloxy)benzoate 
 
 
C19H18O7 
MW = 358,34 Da 
CAS : [102019-30-7] 
 
According to the procedure described in the literature,140 a mixture of 136 (66.85 g, 0.215 
mol, 1 eq), K2CO3 (89.15 g, 0.645 mol, 3 eq), KI (5.37 g, 0.032 mol, 0.15 eq) and benzyl 
chloride (50 mL, 54.43 g, 0.430 mol, 2 eq) was heated in acetone (500 mL) under reflux for 
18 hours. The reaction mixture was then cooled, poured into water (500 mL) and extracted 
with Et2O (3 x 300 mL). The combined organic layers were washed with brine (3 x 200 mL), 
dried over MgSO4 and evaporated in vacuo. After recrystallization in EtOH, 137 was obtained 
as white crystals (66.2 g, 86%). 
m.p. 94°C (EtOH) [lit.140 m.p. 94-96°C (EtOH)] 
Rf = 0.61 (3:2 PET:EtOAc) 
IR (neat) max 1776, 1722, 1499, 1435, 1374, 1325, 1183, 1041 cm-1 
1H NMR (300 MHz, chloroform-d1)  2.18 (s, 6H, H7), 3.87 (s, 3H, H13), 5.05 (s, 2H, H8), 7.32-
7.37 (m, 5H, H10/H11/H12), 7.70 (s, 2H, H3) 
13C NMR (75 MHz, chloroform-d1)  168.3 (C6), 165.0 (C1), 147.3 (C9), 144.0 (C4), 136.5 (C5), 
128.2 (C12), 128.4/127.5 (C10/C11), 125.4 (C2), 122.5 (C3), 75.5 (C8), 52.2 (C13), 20.4 (C7) 
ESIMS m/z (%) 359 [M+H]+ (100) 
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138 
Methyl-4-(benzyloxy)-3,5-dihydroxybenzoate 
 
 
C15H14O5 
MW = 274,27 Da 
CAS : [91925-82-5] 
 
According to the procedure described in the literature,140 a solution of K2CO3 (45.82 g, 
331.53 mmol, 6.6 eq) in water (200 mL) was added to a solution of 137 (18 g, 50.23 mmol, 1 
eq) in MeOH (400 mL). After being stirred at room temperature for 3 hours, the reaction 
mixture was acidified with an excess of 3M HCl until pH 1. The acidified aqueous solution 
was extracted with EtOAc (3 x 300 mL). The combined organic layers were washed with 
brine (2 x 300 mL) and water (200 mL), dried over MgSO4 and concentrated in vacuo. After 
recrystallization in 1:4 CHCl3:pentane, 138 was obtained as orange crystals (12.54 g, 91%). 
m.p. 134°C (1:4 CHCl3:pentane) [lit.140 m.p. 133-134°C (CHCl3-pentane)] 
Rf = 0.23 (7:3 cyclohexane:EtOAc) 
IR (neat) max 3540, 1720, 1603, 1456, 1440, 1366, 1005 cm-1 
1H NMR (300 MHz, acetone-d6)  3.81 (s, 3H, H11), 5.19 (s, 2H, H6), 7.12 (s, 2H, H3), 7.29-
7.53 (m, 5H, H8/H9/H10), 8.38 (brs, 2H, OH) 
13C NMR (75 MHz, acetone-d6)  166.9 (C1), 151.3 (C4), 138.9/138.5 (C5/C7), 129.2/129.0 
(C8/C9), 128.8 (C10), 126.4 (C2), 109.9 (C3), 74.5 (C6), 52.2 (C11) 
CIMS m/z (%) 292 [M+NH4]+ (82), 275 [M+H]+ (100) 
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139 
4-(benzyloxy)-3,5-dihydroxybenzoic acid 
 
 
C14H12O5 
MW = 260,24 Da 
CAS : [100622-15-9] 
 
Via hydrolysis of 137 : 
To a stirred solution of 137 (563 mg, 1.57 mmol, 1 eq) in a 1:1 mixture of THF:H2O (40 mL) 
was added KOH (1.76 g, 31.40 mmol, 20 eq) and the resulting mixture was heated to 50°C 
for 16 hours. After cooling to room temperature, the reaction mixture was diluted with 40 mL 
of water. The mixture was then washed with EtOAc to remove excess of THF. 1M aqueous 
solution HCl was then added to the aqueous layer until pH 1. After extraction with EtOAc (3 x 
50 mL), the organic layer was washed with brine (50 mL), dried over MgSO4 and evaporated 
in vacuo to give 139 as an orange powder (408 mg, 100%). 
Via hydrolysis of 138 : 
A 5M aqueous solution of NaOH (28 mL, 0.14 mol, 3.3 eq) was added to a solution of 138 
(11.48 g, 0.042 mol, 1 eq) in MeOH (33 mL) and the mixture was stirred under reflux for 2 
hours and 30 minutes. After cooling to room temperature, excess of MeOH was evaporated 
and 5M aqueous solution of HCl (30 mL) was added to acidified the reaction mixture. The 
mixture was extracted with EtOAc (3 x 50 mL) and the organic layer was washed with brine 
(50 mL), dried over MgSO4 and evaporated in vacuo to give 139 as an orange powder (10.78 
g, 99%). 
m.p. 170°C [lit.165 m.p. 169.5-170.5°C (Et2O-PET) lit.166 m.p. 170°C (aqueous MeOH)] 
Rf = 0.05 (3:2 PET:EtOAc) 
IR (neat) max 3305, 1691, 1599, 1456, 1344, 1265, 1181, 1055 cm-1 
1H NMR (300 MHz, acetone-d6)  5.19 (s, 2H, H6), 7.13 (s, 2H, H3), 7.28-7.54 (m, 5H, 
H8/H9/H10), 8.35 (brs, 1H, OH) 
13C NMR (75 MHz, acetone-d6)  168.0 (C1), 151.2 (C4), 138.9/138.4 (C5/C7), 129.2/128.9 
(C8/C9), 128.7 (C10), 126.4 (C2), 110.2 (C3), 74.5 (C6) 
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32b 
3,4,5-tribenzyloxybenzoyl chloride 
 
 
C28H23ClO4 
MW = 458,93 Da 
CAS : [1486-47-1] 
 
According to the procedure described in the literature,137 a suspension of 32 (1 g, 2.27 mmol, 
1 eq) in 25 mL of dry toluene and 0.1 mL of dry DMF was stirred at room temperature. A 
solution of oxalyl chloride (292 µL, 3.41 mmol, 1.5 eq) in 3 mL of dry toluene was then added 
slowly via a dropping funnel. After being stirred at room temperature for an additional 15 
minutes, the mixture was heated to 50°C. The ceasing of gas evolution indicated the end of 
the reaction after 45 min. The solvent was evaporated in vacuo to give 32b as white crystals 
(1.05 g, 100%, basisd on TLC analysis and 1H NMR analysis on crude). 
m.p. 114°C [lit.137 m.p. 116-117°C (toluene-cyclohexane)] 
Rf = 0.91 (1:1 cyclohexane:EtOAc) 
1H NMR (300 MHz, DMSO-d6)  5.04 (s, 2H, H11), 5.18 (s, 4H, H6), 7.27-7.48 (m, 17H, 
H3/HAr) 
13C NMR (75 MHz, DMSO-d6)  166.8 (C1), 152.0 (C4), 141.0 (C5), 137.4 (C12), 136.9 (C7), 
128.4/128.2/128.1/128.1/127.9/127.6 (C8/C9/C10/C13/C14/C15), 126.0 (C2), 108.3 (C3), 74.3 
(C11), 70.2 (C6) 
ESIMS m/z (%) 481 [M+Na]+ (100) 
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HHDP units (G) 
 
220 
Tetrabenzylellagic acid 
 
 
C42H30O8 
MW = 662,68 Da 
CAS : [103442-14-4] 
 
Adapted from the method of Kashiwada et al.147 To a mixture of commercially available 
ellagic acid (20.0 g, 66 mmol, 1.0 eq), NaI (4.0 g, 27 mmol, 0.4 eq) and anhydrous powdered 
K2CO3 (76.8 g, 556 mmol, 8.4 eq) in 260 mL of acetophenone was added freshly distilled 
benzyl chloride (41 mL, 351 mmol, 5.3 eq). After 18 hours stirring at 140 °C, inorganic salts 
and unreacted ellagic acid were removed by filtration. Tetrabenzyl ellagic acid was 
crystallized from the filtrate by addition of cyclohexane. A large amount of cyclohexane was 
added until complete precipitation occurred. Compound 220 was obtained as a white solid 
(22.0 g, 50%). 
m.p. 265-266°C [lit.118 m.p. 267°C (1,4-dioxane)] 
Rf = 0.60 (4:1 cyclohexane:EtOAc) 
IR (KBr) max 2939, 2854, 1746, 1606, 1495, 1457, 1410, 1360, 1317, 1258, 1179, 1094 cm-1 
1H NMR (300 MHz, DMSO-d6)  5.37 (s, 8H, H8/H9), 7.34-7.66 (m, 22H, HAr), 11.08 (s, 2H, 
COOH formed by equilibrium between ester groups and their hydrolysed form) 
13C NMR (75 MHz, DMSO-d6)  The compound is not enough soluble in DMSO-d6 to obtain a 
good spectrum 
ESIMS m/z (%) The compound is insoluble in all the solvents generally used for MS 
spectroscopy 
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221 
Dibenzyl 2,2’,3,3’,4,4’-Hexakis(benzyloxy)-1,1’-diphenyl-6,6’-dicarboxylate 
 
 
C70H58O10 
MW = 1059,20 Da 
CAS : [154675-20-4] 
 
Adapted from the method of Schmidt et al.119 In a dry round-bottomed flask, a mixture of 220 
(5.3 g, 8 mmol, 1 eq), KOH (11.5 g, 205 mmol, 25 eq), NaI (0.6 g, 4 mmol, 0.5 eq) and 
benzyl chloride (40 mL) was heated at 145°C for 4 hours under argon atmosphere. The 
reaction mixture was then quenched with H2O (100 mL) and extracted with EtOAc (3 x 100 
mL). The organic layer was washed with brine (100 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The resulting mixture was distilled at 120°C under high vacuum using 
Kugelrohr to remove excess of benzyl alcohol. Crude material was purified by column 
chromatography (9:1  8:2 PET/EtOAc) to give 221 as a colorless syrup (7.4 g, 87%). 
Rf = 0.46 (9:1 cyclohexane:EtOAc) 
IR (neat) max 3032, 1712, 1458, 1371, 1326, 1096, 1019, 977 cm-1 
1H NMR (300 MHz, chloroform-d1)  4.65 and 4.75 (AB, JAB = 11.1 Hz, 4H, H10), 4.89 (d, J = 
3.2 Hz, 4H, H9), 5.01 (d, J = 4.5 Hz, 4H, H11), 5.16 (brs, 4H, H8), 6.83-7.54 (m, 42H, HAr) 
13C NMR (75 MHz, chloroform-d1)  166.2 (C1), 151.5 (C4), 150.7 (C6), 145.5 (C5), 
137.6/137.2/ 136.6/135.5 (C1’I/C1’II/C1’III/C1’IV), 
128.5/128.5/128.4/128.4/128.3/128.3/128.2/128.1/128.0/127.9/ 
127.8/127.7/127.6/127.5/127.4/127.3/127.2 (CHAr/C7), 125.3 (C2), 111.1 (C3), 75.1 (C10), 74.3 
(C9), 70.8 (C8), 66.6 (C11) 
ESIMS m/z (%) 1060 [M+H]+ (57), 1059 (100), 952 (36), 951 (66) 
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(±)-93 
2,2’,3,3’,4,4’-Hexakis(benzyloxy)-1,1’-diphenyl-6,6’-dicarboxylic acid 
 
 
C56H46O10 
MW = 878,96 Da 
CAS : [97152-40-4] 
 
Adapted from the method of Schmidt et al.119 To a solution of 221 (12.3 g, 12 mmol, 1 eq) in 
a 5:5:0.3 mixture of acetone/MeOH/H2O (187 mL) was added KOH (14.6 g, 260 mmol, 22 
eq). The suspension was stirred at 75°C for 4 hours before the volume of solvents was 
reduced of 1/3 in vacuo. The reaction mixture was then diluted with H2O (250 ml), acidified to 
pH 1 with concentrated HCl (3 mL) and extracted with EtOAc (4 x 200 mL). The organic layer 
was washed with brine (200 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
oily residue was dissolved in a small amount of EtOAc and (±)-93 was crystallized as a white 
solid (1.94 g) by adding cyclohexane. The liquid phase obtained was then concentrated in 
vacuo and purified by column chromatography (1:1 cyclohexane/EtOAc to remove apolar 
impurities then 10:10:0.1  0:10:0.1 EtOAc/acetone/AcOH) to afford (±)-93 as a white solid 
(4.70 g) (63%). 
m.p. 185-186°C (cyclohexane) [lit.118 m.p. 187°C (CHCl3)] 
Rf = 0.53 (98:2 EtOAc:acetone) 
IR (neat) max 3032, 1685, 1584, 1454, 1410, 1363, 1322, 1097 cm-1 
1H NMR (300 MHz, chloroform-d1)  4.74 (d, J = 11.1 Hz, 2H, H8/H9/H10), 4.94-5.02 (m, 6H, 
H8/H9/H10), 5.14-5.30 (m, 4H, H8/H9/H10), 6.82 (d, J = 6.1 Hz, 4H, HAr), 7.03-7.51 (m, 26H, 
HAr), 7.63 (s, 2H, H3), 12.58 (brs, 1H, COOH) 
13C NMR (75 MHz, chloroform-d1)  172.1 (C1), 151.6 (C4), 151.0 (C6), 146.3 (C5), 
137.7/137.2/136.6 (C1’I/C1’II/C1’III), 128.9/128.6/128.6/128.2/128.1/127.9/127.8/127.3 (CHAr), 
123.6 (C2), 112.0 (C3), 76.6 (C10), 74.5 (C8), 71.0 (C9) 
ESIMS m/z (%) 901 [M+Na]+ (100) 
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(±)-152 
2,2’,3,3’,4,4’-Hexakis(benzyloxy)biphenyl-6,6’-dicarboxylic acid chloride 
 
 
C56H44Cl2O8 
MW = 915,85 Da 
CAS : [193535-28-3] 
 
According to the procedure described in the literature,95 a suspension of (±)-93 (1.5 g, 1.71 
mmol, 1 eq) in 20 mL of benzene and 2 drops of DMF was stirred at room temperature. 
Oxalyl chloride (1 mL, 11.70 mmol, 6.8 eq) was then added dropwise to the solution and the 
mixture was gradually heated to boiling. After refluxing for 12 hours, solvents were removed 
in vacuo. Product was tritured in PET, filtered and cristallized from a benzene-PET mixture to 
give (±)-152 as a slight rose solid (1.43 g, 91%). 
m.p. 142-143°C [lit.118 m.p. 143.5°C (Benzene-PET)] 
Rf = 0.37 (8:2 cyclohexane:EtOAc) 
1H NMR (300 MHz, chloroform-d1)  4.75 (s, 4H, H8/H9/H10), 5.02 and 5.06 (AB, JAB = 11.0 
Hz, 4H, H8/H9/H10), 5.20 (s, 4H, H8/H9/H10), 6.84 (d, J = 6.6 Hz, 4H, H8/H9/H10), 7.10-7.50 (m, 
26H, HAr), 7.70 (s, 2H, H3) 
13C NMR (75 MHz, chloroform-d1)  172.1 (C1), 151.6 (C4), 151.0 (C6), 146.4 (C5), 
137.8/137.2/136.6 (C1’I/C1’II/C1’III), 129.0/128.6/128.6/128.2/128.1/127.9/127.8/127.3 (CHAr), 
123.7 (C2), 112.2 (C3), 75.3 (C10), 74.5 (C8), 71.1 (C9) 
ESIMS m/z (%) 915 [M]+. (100) 
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Sugar derivatives (D) 
General procedure a1 (Steglich esterification) : 
 
To a solution of the appropriate glucose derivative E (1 eq) and acid F (2.2 eq) in dry CH2Cl2 
(0.025M in glucose derivative, volume V) were added at 0°C DMAP (2.2 eq) and DCC (4.4 
eq). The mixture was stirred under nitrogen at room temperature for 16-48h and then, the 
white precipitate (dicyclohexylurea DCU) was filtered through Celite®. The filter cake was 
washed with CH2Cl2 (2 x V) and the solvent was evaporated in vacuo.108 The residue was 
purified by column chromatography with the indicated eluent to furnish the desired esters D. 
General procedure a2 (modified Steglich esterification) : 
To a solution of the appropriate glucose derivative E (1 eq) and acid F (2.2 eq) in dry CH2Cl2 
(0.025M in glucose derivative, volume V) were added DMAP (0.5 eq), DMAP·HCl (0.5 eq) 
and DCC (2.2 eq). The solution was purged with nitrogen and stirred under reflux for 15-24h. 
The solution was then returned to room temperature and the white precipitate 
(dicyclohexylurea DCU) was filtered through Celite®. The filter cake was washed with CH2Cl2 
(2 x V) and the filtrate was worked-up as indicated (i, ii or iii). The residue was purified by 
column chromatography with the indicated eluent to furnish the desired esters.107 
 
Work-up procedures :  
(i) the filtrate is concentrated in vacuo. 
(ii) the filtrate is washed with H2O (3 x V), brine (V), dried over MgSO4, filtered and 
concentrated in vacuo. 
(iii) the filtrate is poured into ice-cold 1M aqueous solution of H3PO4 (V) and the 
organic layer is separated, washed with brine (V), dried over MgSO4, filtered, and 
concentrated in vacuo. 
General procedure a3 : 
To a solution of the appropriate glucose derivative E (1 eq) and acid F (2.5 eq) in dry CH2Cl2 
(0.025M in glucose derivative) were added at 0°C DMAP (7 eq) and EDCI (5 eq). The 
solution was purged with nitrogen and stirred at room temperature for 8-18h. A 1M aqueous 
solution of H3PO4 was then added to quench the reaction and the mixture was extracted with 
CH2Cl2 (3 x V). The organic layer was then washed with brine (2 x V), dried over MgSO4, 
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filtered and concentrated in vacuo.92 The resulting residue was purified by column 
chromatography with the indicated eluent to furnish the desired esters D. 
General procedure b1 (« two steps » acylation) : 
To a solution of the appropriate glucose derivative E (1 eq) and DMAP (3 eq) in dry CH2Cl2 
(0.025M in glucose derivative) was added slowly at 0°C the appropriate acyl chloride (2.4 
eq). The solution was purged with nitrogen and stirred at room temperature for 16-22h. The 
reaction was quenched with saturated aqueous solution of NaHCO3 (V) and the aqueous 
layer was extracted with CH2Cl2 (3 x V). The combined organic layers were washed with 
brine (2 x V), dried over MgSO4, filtered and concentrated in vacuo. The residue was purified 
by column chromatography with the indicated eluent to furnish the desired esters D.  
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134a 
Methyl-4,6-O-benzylidene-2,3-bis(3,4,5-tribenzyloxy)benzoyl--D-glucopyranoside 
 
 
C70H62O14 
MW = 1127,23 Da 
CAS : [183270-10-2] 
 
By use of general procedure a2, commercially available Methyl-4,6-O-benzylidene--D-
glucopyranoside (129, 1 g, 3.54 mmol, 1 eq) was coupled with acid 32 (3.43 g, 7.79 mmol, 
2.2 eq). After the work-up procedure (i) and purification by column chromatography (7:3  
8:2 CH2Cl2:PET), 134a was obtained as a white solid (3.89 g, 97%). 
By use of general procedure b1, compound 129 (1 g, 3.54 mmol, 1 eq) was coupled with 
crude acyl chloride 32b (3.9 g, 8.50 mmol, 2.4 eq) to afford 134a as a white solid (3.19 g, 
80%) following column chromatography (4:1  1:0 CH2Cl2:PET). 
m.p. 177°C (lit.167 m.p. 180-180.5°C)  
Rf = 0.39 (4:1 CH2Cl2:PET) 
22D = +61.5° (c = 1.04, CHCl3) 
IR (neat) max 1723, 1588, 1431, 1339, 1201, 1102, 755, 741, 697 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.45 (s, 3H, H7), 3.88 (dt, J = 4.4, 9.6 Hz, 2H, H4/H6), 
4.08 (dt, J = 4.9, 10.0 Hz, 1H, H5), 4.38 (dd, J = 4.7 Hz, 10.2 Hz, 1H, H6), 4.87-5.12 (m, 13H, 
H2/H9/H10/H11), 5.25 (d, J = 3.6 Hz, 1H, H1), 5.57 (s, 1H, H8), 6.03 (t, J = 9.8 Hz, 1H, H3), 
7.19-7.43 (m, 39H, HAr) 
13C NMR (75 MHz, chloroform-d1)  165.6/165.4 (CI=O/CII=O), 152.5 (C3’I/C3’II/C5’I/C5’II), 
142.9/142.8 (C4’I/C4’II), 137.4/137.4/136.9/136.5/136.5 (C1’III/C1’IV/C1’V), 129.0 (CHAr), 128.5 
(CHAr), 128.4 (CHAr), 128.3 (CHAr), 128.3 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 128.0 (CHAr), 
127.9 (CHAr), 127.8 (CHAr), 127.6 (CHAr), 127.5 (CHAr), 126.2 (C2’V/C3’V), 124.7/124.0 
(C1’I/C1’II), 109.4/109.3 (C2’I/C2’II/C6’I/C6’II), 101.6 (C8), 97.8 (C1), 79.2 (C4), 75.1/75.0 
(C9/C10/C11), 73.1 (C2), 71.2/71.1 (C9/C10/C11), 69.9 (C3), 68.9 (C6), 62.6 (C5), 55.5 (C7) 
ESIMS m/z (%) 1126 [M+H]+ (100) 
O
O
O
O
O
OO
BnO
O
BnO
BnO
O
O
O
I
II
23
4
5
6
1' 2'
3'
4'
5'
6'
1'
2'
3'
4'
5' 6'
1
7
III
8
V
IV
10
1'
1'
2'
2'
3'
3'
4'
4'
9
11
1'
2' 3'
4'
III
1'2'
3'
4'
Chapter 5 – Experimental Section 
 168
 
134b 
Benzyl 4,6-O-benzylidene-2,3-bis(3,4,5-tribenzyloxy)benzoyl--D-glucopyranoside 
 
 
C76H66O14 
MW = 1203,33 Da 
CAS : [154774-22-8] 
 
By use of general procedure a2, compound 30 (500 mg, 1.40 mmol, 1 eq) was coupled with 
acid 32 (1.36 g, 3.08 mmol, 2.2 eq). After the work-up procedure (i) and purification by 
column chromatography (9:1  1:0 CH2Cl2:PET), 134b was obtained as a slight yellow solid 
(940 mg, 56%). 
m.p. 174.5-175.5°C 
Rf = 0.55 (4:1 CH2Cl2:PET) 
22D = +37.4° (c = 0.97, CHCl3) 
IR (neat) max 1723, 1588, 1427, 1332, 1201, 1099, 1000, 752, 734, 697 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.76 (dt, J = 4.8, 9.5 Hz, 1H, H5), 3.95-4.05 (m, 2H, 
H4/H6), 4.54 (dd, J = 4.6, 10.3 Hz, 1H, H6), 4.74 and 5.00 (AB, JAB = 12.4 Hz, 2H, H7), 4.90 
(d, J = 7.7 Hz, 1H, H1), 5.06-5.17 (m, 12H, H9/H10/H11), 5.63 (s, 1H, H8), 5.63 (t, J = 8.6 Hz, 
1H, H2), 5.80 (t, J = 9.5 Hz, 1H, H3), 7.23-7.52 (m, 44H, HAr) 
13C NMR (75 MHz, chloroform-d1)  165.3/164.8 (CI=O/CII=O), 152.4/152.4 (C3’I/C3’II/C5’I/C5’II), 
142.7 (C4’I/C4’II), 137.4/137.3/136.7/136.5/136.5 (C1’III/C1’IV/C1’V/C1’VI), 129.0 (CHAr), 128.4 
(CHAr), 128.4 (CHAr), 128.3 (CHAr), 128.3 (CHAr), 128.3 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 
128.0 (CHAr), 127.9 (CHAr), 127.9 (CHAr), 127.8 (CHAr), 127.8 (CHAr), 127.7 (CHAr), 127.5 
(CHAr), 127.5 (CHAr), 126.1 (C2’V/C3’V), 124.4/124.2 (C1’I/C1’II), 109.3 (C2’I/C2’II/C6’I/C6’II), 101.4 
(C8), 100.0 (C1), 78.7 (C4), 75.0 (C9/C10/C11), 72.6 (C2), 72.4 (C3), 71.1 (C9/C10/C11), 70.8 (C7), 
68.6 (C6), 66.6 (C5) 
ESIMS m/z (%) 1203 [M+H]+ (100) 
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134c 
2-Nitrobenzyl 4,6-O-benzylidene-2,3-bis(3,4,5-tribenzyloxy)benzoyl--D-
glucopyranoside 
 
 
C76H65NO16 
MW = 1248,33 Da 
CAS : [341035-12-9] 
 
By use of general procedure a2, compound 31 (1 g, 2.48 mmol, 1 eq) was coupled with acid 
32 (2.40 g, 5.45 mmol, 2.2 eq). After the work-up procedure (i) and purification by column 
chromatography (3:2  4:1 CH2Cl2:PET), 134c was obtained as a white solid (3.10 g, 
100%). 
m.p. 165.5°C 
Rf = 0.60 (4:1 CH2Cl2:PET) 
22D = +42.4° (c = 0.99, CHCl3) 
IR (neat) max 1723, 1588, 1526, 1500, 1431, 1336, 1201, 1102, 1026, 1004, 752, 737, 697 
cm-1 
1H NMR (300 MHz, chloroform-d1)  3.67 (dt, J = 4.7, 9.4 Hz, 1H, H5), 3.78-3.92 (m, 2H, 
H4/H6), 4.40 (dd, J = 4.6, 10.3 Hz, 1H, H6), 4.86 (d, J = 7.7 Hz, 1H, H1), 4.93-5.27 (m, 14H, 
H7/H9/H10/H11), 5.48 (s, 1H, H8), 5.51 (t, J = 8.2 Hz, 1H, H2), 5.71 (t, J = 9.5 Hz, 1H, H3), 7.14-
7.37 (m, 41H, HAr), 7.57 (d, J = 6.8 Hz, 1H, H2’V), 7.96 (d, J = 7.2 Hz, 1H, H5’V) 
13C NMR (75 MHz, chloroform-d1)  165.3/165.0 (CI=O/CII=O), 152.5/152.5 (C3’I/C3’II/C5’I/C5’II), 
146.7 (C6’VI), 142.8/142.8 (C4’I/C4’II), 137.4/137.3/136.7/136.5/136.5 (C1’III/C1’IV/C1’V), 
133.8/133.7 (C1’VI/C4’VI), 129.1 (CHAr), 128.4 (CHAr), 128.4 (CHAr), 128.3 (CHAr), 128.2 (CHAr), 
128.1 (CHAr), 128.1 (CHAr), 128.0 (CHAr), 127.9 (Cq), 127.9 (CHAr), 127.8 (CHAr), 127.5 
(CHAr), 126.1 (C2’V/C3’V), 124.6 (C5’VI), 124.3/124.1 (C1’I/C1’II), 109.3/109.3 (C2’I/C2’II/C6’I/C6’II), 
101.5 (C8), 101.3 (C1), 78.7 (C4), 75.1 (C9/C10/C11), 72.7 (C2), 72.3 (C3), 71.2/71.2 
(C9/C10/C11), 68.5 (C6), 68.1 (C7), 66.8 (C5) 
ESIMS m/z (%) 1270 [M+Na]+ (100) 
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135a 
Methyl-4,6-O-benzylidene-2,3-bis(3,4,5-trihydroxy)benzoyl--D-glucopyranoside 
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C28H26O14 
MW = 586,50 Da 
CAS : [732310-87-1] 
 
A solution of 134a (2.75 g, 2.44 mmol) and 10% Pd/C (500 mg) in 120 mL of anhydrous THF 
was purged 3 times with H2. The mixture was stirred at room temperature under H2 for 24 
hours, filtered through Celite®. The filter cake was then washed with acetone (60 mL). 
Concentration in vacuo give 135a as a black solid (1.43 g, 100%). 
m.p. 195-197°C 
Rf = 0.39 (1:4 cyclohexane:EtOAc) 
22D = +18.0° (c = 1.06, acetone) 
IR (neat) max 3397 (st), 1704, 1617, 1540, 1452, 1336, 1226, 1094, 1040, 767 cm-1 
1H NMR (300 MHz, acetone-d6)  3.46 (s, 3H, H7), 3.87-4.07 (m, 3H, H4/H5/H6), 4.33 (dd, J = 
2.9, 8.8 Hz, 1H, H6), 5.11-5.20 (m, 2H, H1/H2), 5.67 (s, 1H, H8), 5.86 (t, J = 9.4 Hz, 1H, H3), 
7.06-7.07 (m, 4H, H2’I/H6’I/H2’II/H6’II), 7.30-7.43 (m, 5H, H2’III/H3’III/H4’III) 
13C NMR (75 MHz, acetone-d6)  166.2/166.2 (CI=O/CII=O), 146.0/145.9 (C4’I/C4’II), 139.0 
(C1’III), 138.5 (C3’I/C3’II/C5’I/C5’II), 129.6 (C4’III), 128.8 (C2’III), 127.0 (C3’III), 121.1/120.4 (C1’I/C1’II), 
110.1/110.0 (C2’I/C2’II/C6’I/C6’II), 102.2 (C8), 98.7 (C1), 79.9 (C4), 72.7 (C2), 69.9 (C3), 69.2 (C6), 
63.6 (C5), 55.6 (C7) 
ESIMS m/z (%) 609 [M+Na]+ (100) 
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135d 
4,6-O-benzylidene-2,3-bis(3,4,5-trihydroxy)benzoyl-D-glucopyranose 
 
 
C27H24O14 
MW = 572,47 Da 
No CAS 
 
A solution of 134b (761 mg, 0.63 mmol) and 10% Pd/C (300 mg) in 40 mL of anhydrous THF 
was purged 3 times with H2. The mixture was stirred at room temperature under H2 for 24 
hours, filtered through Celite®. The filter cake was then washed with THF (100 mL) and 
concentration in vacuo of the filtrate gave a pale green oil. The resultant crude product was 
purified by RP column chromatography Reverse Phase (C18) column chromatography 
(100:0:0.1  30:70:0.1 H2O:MeOH:HCOOH) to give 135d as a pale yellow solid (144 mg, 
40%) and mono-benzylated  product 135c (65 mg, 15%). 
Compound 135c was obtained as a 1:0.8 mixture of  and  anomers. 
m.p. 120-122°C 
Rf = 0.67 (C18-TLC; 30:70:0.1 H2O:MeOH:HCOOH) 
IR (neat) max 3175 (st), 1701, 1609, 1452, 1343, 1211, 1095, 1040, 766 cm-1 
ESIMS m/z (%) 1143 [2M-H]- (53), 684 (100), 571 [M-H]- (99) 
A pure sample of -135d or -135d could not be separated, and only assignable peaks from 
the mixture are listed. 
1H NMR (300 MHz, acetone-d6)  3.77 (dt, J = 4.7 Hz, J = 9.6 Hz, 1H, H5), 3.85-4.04 (m, 4H, 
H4H4/H6H6), 4.19-4.28 (m, 2H, H5H6), 4.33 (dd, J = 4.6, 10.1 Hz, 1H, H6), 5.13 (dd, J 
= 3.7, 9.7 Hz, 1H, H2), 5.15 (d, J = 7.4 Hz, 1H, H1), 5.25 (t, J = 8.7 Hz, 1H, H2), 5.55 (d, J = 
3.4 Hz, 1H, H1), 5.62-5.69 (m, 1H, H3), 5.68 (s, 1H, H7), 5.69 (s, 1H, H7), 5.94 (t, J = 9.8 
Hz, 1H, H3), 7.03 (s, 2H, H2’I/H6’I or H2’II/H6’II), 7.05 (s, 2H, H2’I/H6’I or H2’II/H6’II), 7.06 (s, 
2H, H2’I/H6’I or H2’II/H6’II), 7.07 (s, 2H, H2’I/H6’I or H2’II/H6’II), 7.30-7.43 (m, 10H, 
H2’III/H3’III/H4’III) 
13C NMR (75 MHz, acetone-d6)  166.5 (CII=O), 166.3 (CI=O), 166.1 (CII=O), 166.0 
(CI=O), 146.2/146.2 (C3'I/C3'II/C5'I/C5'II), 140.2/139.8 (C4'I/C4'II), 138.6 (C1'III), 138.5 (C1'III), 
129.7 (CHAr), 129.5 (CHAr), 128.9 (CHAr), 128.7 (CHAr), 127.1 (C2'III/C3'III), 127.0 (C2'III/C3'III), 
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120.6 (C1'II), 120.4 (C1'II), 120.3 (C1'I), 119.9 (C1'I), 110.0/109.9 (C2'I/C2'II/C6'I/C6'II), 109.7 
(C2'I/C2'II/C6'I/C6'II), 102.1 (C7), 101.9 (C7), 96.7 (C1), 91.7 (C1), 80.3 (C4), 79.8 (C4), 
74.5 (C2), 73.3 (C2), 72.6 (C3), 69.7 (C3), 69.4 (C6), 69.1 (C6), 67.2 (C5), 63.3 (C5) 
 
135c 
Benzyl 4,6-O-benzylidene-2,3-bis(3,4,5-trihydroxy)benzoyl-D-glucopyranoside 
 
 
C34H30O14 
MW = 662,59 Da 
No CAS 
Pale yellow solid 
 
 
Rf = 0.27 (C18-TLC; 30:70:0.1 H2O:MeOH:HCOOH) 
1H NMR (300 MHz, acetone-d6)  3.81 (dt, J = 4.7 Hz, J = 9.6 Hz, 1H, H5), 3.94 (t, J = 10.1 
Hz, 1H, H6), 4.04 (t, J = 9.5 Hz, 1H, H4), 4.40 (dd, J = 4.7, 10.0 Hz, 1H, H6), 4.72 and 4.89 
(AB, JAB = 12.7 Hz, 2H, H7), 5.05 (d, J = 7.7 Hz, 1H, H1), 5.38 (t, J = 8.8 Hz, 1H, H2), 5.67 (t, 
J = 9.0 Hz, 1H, H3), 5.70 (s, 1H, H8), 7.04 (s, 2H, H2’I/H6’I or H2’II/H6’II), 7.06 (s, 2H, H2’I/H6’I or 
H2’II/H6’II), 7.21-7.42 (m, 5H, H2’III/H3’III/H4’III/H2’IV/H3’IV/H4’IV) 
13C NMR (75 MHz, acetone-d6)  165.9/165.6 (CI=O/CII=O), 146.0/145.9 (C3’I/C3’II/C5’I/C5’II), 
139.1/139.0/138.6/138.4 (C4’I/C4’II/C1’III/C1’IV), 129.6 (CHAr), 129.0 (CHAr), 128.8 (CHAr), 128.4 
(CHAr), 128.2 (CHAr), 127.1 (CHAr), 121.1/121.1 (C1’I/C1’II), 110.2/110.1 (C2’I/C2’II/C6’I/C6’II), 
102.0 (C8), 101.6 (C1), 79.7 (C4), 73.1 (C2), 72.7 (C3), 71.4 (C7), 69.1 (C6), 67.3 (C5) 
ESIMS m/z (%) 661 [M-H]- (100) 
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Sugar derivatives HHDP bearing (B) 
Bis-esterification of glucose derivative 129 with HHDP unit 
A solution of commercially available Methyl-4,6-O-benzylidene--D-glucopyranoside (129, 
849 mg, 3.01 mmol, 1 eq) and DMAP (1.1 g, 9.00 mmol, 3 eq) in dry CH2Cl2 (60 mL) was 
added slowly at 0°C a solution of racemic bis-acyl chloride (±)-93 (2.75 g, 3.00 mmol, 1 eq) in 
20 mL of dry CH2Cl2. The solution was purged with nitrogen and stirred at room temperature 
for 24 hours. The reaction was quenched by addition of ice. After extraction with CH2Cl2 (2 x 
60 mL), the combined organic layers were dried over MgSO4, filtered off, and concentrated in 
vacuo. The residue was purified by column chromatography (7:3 CH2Cl2:CHCl3) to give 1.6 g 
of a mixture of (S)-153, (R)-153 and dimer 154. The mixture was purified an other time to 
obtain pure fractions of (S)-153 (823 mg, 24%), (R)-153 (143 mg, 4%) and 154 (632 mg, 
17%). 
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(S)-153 
-D-Glucopyranoside, Methyl 4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,5,5´,6,6´-
hexakis(benzyloxy)-1,1´-(S)-biphenyl]-2,2´-dicarboxylate 
 
C70H60O14 
MW = 1125,22 Da 
No CAS 
Yellow crystals 
 
 
m.p. 118-120°C 
Rf = 0.32 (7:3 CH2Cl2:CHCl3) 
22D = -34.0° (c = 0.5, CHCl3) 
IR (neat) max 1755, 1591, 1452, 1364, 1332, 1178, 1095, 1058, 741, 697 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.51 (s, 3H, H7), 3.83-3.94 (m, 2H, H4/H6), 4.00 (dd, J = 
4.4, 9.7 Hz, 1H, H5), 4.36 (dd, J = 4.4, 10.1 Hz, 1H, H6), 4.58-5.27 (m, 14H, H1/H2/H9/H10), 
5.61 (s, 1H, H8), 5.67 (t, J = 9.5 Hz, 1H, H3), 6.94-7.55 (m, 37H, HAr) 
13C NMR (75 MHz, chloroform-d1)  168.0/168.0 (CI=O/CII=O), 152.8/152.7/152.7/152.5 
(C3'I/C3'II/C5'II/C5'II), 144.6/144.3 (C4'I/C4'II), 137.7/137.6/137.5/136.9/136.5/136.5 
(C1'III/C1'IV/C1'V), 129.3 (CHAr), 129.2 (Cq), 128.7 (Cq), 128.6 (CHAr), 128.5 (CHAr), 128.4 
(CHAr), 128.3 (CHAr), 128.2 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 128.0 (CHAr), 128.0 (CHAr), 
127.9 (CHAr), 127.8 (CHAr), 127.7 (CHAr), 127.7 (CHAr), 127.4 (CHAr), 126.4 (CHAr), 
122.2/121.9 (C1'I/C1'II), 107.2/107.1 (C2'I/C6'II), 101.8 (C8), 98.3 (C1), 78.3 (C4), 75.5/75.4/75.3 
(C9/C10), 74.3 (C2), 73.6 (C3), 71.3/71.4 (C9/C10), 68.9 (C6), 62.9 (C5), 55.3 (C7) 
ESIMS m/z (%) 1147 [M+Na]+ (100) 
Anal. calcd for C70H60O14 : C, 74.72; H, 5.37 ; found : C, 74.91; H, 5.56 
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(R)-221 
-D-Glucopyranoside, Methyl 4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,5,5´,6,6´-
hexakis(benzyloxy)-1,1´-(R)-biphenyl]-2,2´-dicarboxylate 
 
 
C70H60O14 
MW = 1125,22 Da 
No CAS 
White crystals 
 
m.p. 76-78°C 
Rf = 0.21 (7:3 CH2Cl2:CHCl3) 
22D = +152.8° (c = 0.53, CHCl3) 
IR (neat) max 1754, 1590, 1449, 1360, 1335, 1178, 1094, 1052, 739, 697 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.32 (s, 3H, H7), 3.80-3.83 (m, 3H, H4/H5/H6), 4.30-4.33 
(m, 1H, H6), 4.51-5.25 (m, 15H, H1/H2/H3/H9/H10), 5.59 (s, 1H, H8), 6.81-7.53 (m, 37H, HAr) 
13C NMR (75 MHz, chloroform-d1)  168.6/166.2 (CI=O/CII=O), 153.1/152.6/152.1/151.8 
(C3'I/C3'II/C5'II/C5'II), 137.5/137.5/137.4/137.3/137.1/136.5/136.2 (C4'I/C4'II/C1'III/C1'IV/C1'V), 129.2 
(CHAr), 128.6 (CHAr), 128.3 (CHAr), 128.3 (CHAr), 128.2 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 
128.0 (CHAr), 127.9 (CHAr), 127.9 (CHAr), 127.6 (CHAr), 127.5 (CHAr), 127.5 (CHAr), 127.2 
(CHAr), 126.2 (CHAr), 125.4 (C1'I/C1'II), 101.6 (C8), 98.1 (C1), 78.3 (C4), 75.5/75.3/75.1 (C9/C10), 
71.1/71.1 (C2/C3), 68.7 (C6), 62.7 (C5), 55.5 (C7) 
ESIMS m/z (%) 1147 [M+Na]+ (100) 
Anal. calcd for C70H60O14 : C, 74.72; H, 5.37 ; found : C, 74.91; H, 5.42 
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(S)-93 
2,2’,3,3’,4,4’-Hexakis(benzyloxy)-(S)-biphenyl-6,6’-dicarboxylic acid 
 
 
C56H46O10 
MW = 878,96 Da 
CAS : [188855-50-7] 
 
According to the procedure described in the literature,95 to a solution of potassium tert-
butoxide (301 mg, 2.64 mmol, 6 eq) and H2O (48 µL, 2.64 mmol, 6 eq) in THF (20 mL), 
stirred at room temperature for 5 minutes, was added (S)-153 (500 mg, 0.44 mmol, 1 eq) and 
the mixture was stirred for 12 hours at room temperature. The reaction mixture was then 
diluted with CH2Cl2 (20 mL) and a 2M aqueous solution of HCl (20 mL) was added. This 
mixture was stirred for 30 minutes before the resulting aqueous portion was extracted with 
CH2Cl2 (2 x 20 mL). The combined organic layers were washed with brine (20 mL), dried on 
MgSO4, filtered and concentrated in vacuo. The crude solid was recrystallized from 
Et2O:hexane (1:1) to give (S)-93 as a white solid (387 mg, 100%). 
m.p. 185-186°C (lit.118 m.p. 187°C) 
Rf = 0.24 (15:1 CH2Cl2:MeOH) 
[]D24 = -9.8° (c = 1.5, CH2Cl2) 
IR (neat) max 3032, 1685, 1584, 1454, 1410, 1363, 1322, 1097 cm-1 
1H NMR (300 MHz, chloroform-d1)  4.72-5.02 (m, 8H, H8/H9/H10), 5.16 and 5.24 (AB, JAB = 
11.4 Hz, 4H, H8/H9/H10), 6.81 (d, J = 7.7 Hz, 4H, HAr), 7.02-7.11 (m, 5H, HAr), 7.22-7.51 (m, 
21H, HAr), 7.63 (s, 2H, HAr) 
13C NMR (75 MHz, chloroform-d1)  172.2 (C1), 151.5 (C4), 151.0 (C6), 146.3 (C5), 
137.7/137.2/136.5 (C1’I/C1’II/C1’III), 129.0 (CHAr), 128.6 (CHAr), 128.5 (CHAr), 128.2 (CHAr), 
128.1 (CHAr), 127.9 (CHAr), 127.8 (CHAr), 127.3 (CHAr), 123.6 (C2), 112.1 (C3), 75.2 (C10), 
74.5 (C8), 71.0 (C9) 
ESIMS m/z (%) 901 [M+Na]+ (100) 
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(R)-93 
2,2’,3,3’,4,4’-Hexakis(benzyloxy)-(R)-biphenyl-6,6’-dicarboxylic acid 
 
 
C56H46O10 
MW = 878,96 Da 
CAS : [219670-14-1] 
 
According to the procedure described in the literature,95 to a solution of potassium tert-
butoxide (152 mg, 1.33 mmol, 6 eq) and H2O (24 µL, 1.33 mmol, 6 eq) in THF (10 mL), 
stirred at room temperature for 5 minutes, was added (R)-153 (250 mg, 0.22 mmol, 1 eq) and 
the mixture was stirred for 12 hours at room temperature. The reaction mixture was then 
diluted with CH2Cl2 and a 2M aqueous solution of HCl (10 mL) was added. This mixture was 
stirred for 30 minutes before the resulting aqueous portion was extracted with CH2Cl2 (2 x 20 
mL). The combined organic layers were washed with brine (20 mL), dried on MgSO4, filtered 
and concentrated in vacuo. The crude solid was recrystallized from Et2O:hexane (1:1) to give 
(R)-93 as a white solid (195 mg, 100%). 
m.p. 185-186°C (lit.118 m.p. 187°C) 
Rf = 0.24 (15:1 CH2Cl2:MeOH) 
[]D24 = +9.4° (c = 1.5, CH2Cl2) 
IR (neat) max 3032, 1685, 1584, 1454, 1410, 1363, 1322, 1097 cm-1 
1H NMR (300 MHz, chloroform-d1)  4.72-5.02 (m, 8H, H8/H9/H10), 5.16 and 5.24 (AB, JAB = 
11.3 Hz, 4H, H8/H9/H10), 6.82 (d, J = 6.0 Hz, 4H, HAr), 7.03-7.09 (m, 5H, HAr), 7.22-7.51 (m, 
21H, HAr), 7.63 (s, 2H, HAr) 
13C NMR (75 MHz, chloroform-d1)  172.2 (C1), 151.6 (C4), 151.0 (C6), 146.3 (C5), 
137.7/137.2/136.5 (C1’I/C1’II/C1’III), 129.0 (CHAr), 128.6 (CHAr), 128.6 (CHAr), 128.2 (CHAr), 
128.1 (CHAr), 127.9 (CHAr), 127.8 (CHAr), 127.3 (CHAr), 123.6 (C2), 112.1 (C3), 75.2 (C10), 
74.5 (C8), 71.0 (C9) 
ESIMS m/z (%) 901 [M+Na]+ (100) 
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Bis-esterification of glucose derivative 30 with HHBP unit 
To a solution of 30 (410 mg, 1.15 mmol, 1 eq), racemic bis-acid (±)-93 (1.11 g, 1.26 mmol, 
1.1 eq) and DMAP (309 mg, 2.53 mmol, 2.2 eq) in dry CH2Cl2 (10 mL) at 0°C was added 
DCC (1.04 g, 5.05 mmol, 4.4 eq). The solution was purged with nitrogen and stirred at room 
temperature for 18 hours. The mixture was then filtered through Celite. The filter cake was 
washed with CH2Cl2 and the combined filtrates were concentrated in vacuo. After addition of 
EtOAc, the excess of DCU was removed by filtration (this manipulation was repeated 5 
times). The resultant crude product was purified by column chromatography (90:10:0  
100:0:0 95:0:5 CH2Cl2:PET:Et2O) to obtain in pure form (S)-156 (485 mg, 35%) and (R)-
156 (535 mg, 39%). 
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(S)-156 
Benzyl 4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,5,5´,6,6´-hexakis(benzyloxy)-1,1´-(S)-
biphenyl-2,2´-dicarboxylate]--D-Glucopyranoside 
 
 
C76H64O14 
MW = 1201,31 Da 
No CAS 
Pale yellow foam 
 
m.p. 91-92°C 
Rf = 0.75 (4:1 CH2Cl2:PET) 
21D = -73.1° (c = 0.52, CHCl3) 
IR (neat) max 3430 (st), 1752, 1590, 1452, 1368, 1332, 1186, 1094, 1007, 748, 697 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.56-3.64 (m, 1H, H5), 3.90-3.99 (m, 2H, H4/H6), 4.46 
(dd, J = 4.6, 10.5 Hz, 1H, H6), 4.63-5.22 (m, 16H, H1/H2/H9/H10), 5.42 (t, J = 9.6 Hz, 1H, H3), 
5.62 (s, 1H, H8), 6.83 (s, 1H, H2'I or H6'II), 6.98-7.54 (m, 41H, HAr) 
13C NMR (75 MHz, chloroform-d1)  168.3/167.4 (CI=O/CII=O), 152.7/152.6/152.6/152.5 
(C3'I/C3'II/C5'II/C5'II), 144.5 (C4'I/C4'II), 137.6/137.5/137.5/136.8/136.8/136.4/136.4 
(C1'III/C1'IV/C1'V), 129.4 (CHAr), 128.9 (Cq), 128.8 (Cq), 128.6 (CHAr), 128.5 (CHAr), 128.3 
(CHAr), 128.2 (CHAr), 128.2 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 128.0 (CHAr), 128.0 (CHAr), 
127.9 (CHAr), 127.8 (CHAr), 127.8 (CHAr), 127.8 (CHAr), 127.7 (CHAr), 127.5 (CHAr), 126.4 
(CHAr), 122.3/122.2 (C1'I/C1'II), 107.2/106.9 (C2'I/C6'II), 101.7 (C8), 99.1 (C1), 77.2 (C4), 
75.9/75.8 (C2/C3), 75.5/75.5/75.3/75.3/71.3/70.8 (C9/C10), 68.6 (C6), 62.2 (C5) 
ESIMS m/z (%) 1223 [M+Na]+ (20), 477 (100) 
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(R)-156 
Benzyl 4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,5,5´,6,6´-hexakis(benzyloxy)-1,1´-(R)-
biphenyl-2,2´-dicarboxylate]--D-Glucopyranoside 
 
 
C76H64O14 
MW = 1201,31 Da 
No CAS 
Yellow foam 
 
m.p. 94-95°C 
Rf = 0.45 (4:1 CH2Cl2:PET) 
21D = +4.9° (c = 1.03, CHCl3) 
IR (neat) max 3436 (st), 1719, 1591, 1456, 1364, 1332, 1197, 1094, 1025, 741, 697 cm-1 
1H NMR (300 MHz, chloroform-d1)  3.44-3.53 (m, 1H, H5), 3.61-3.67 (m, 1H, H4), 3.86 (t, J = 
10.1 Hz, 1H, H6), 4.38-4.45 (m, 1H, H6), 4.60-5.15 (m, 17H, H1/H2/H3/H9/H10), 5.52 (s, 1H, 
H8), 6.81-7.53 (m, 42H, HAr) 
13C NMR (75 MHz, chloroform-d1) 167.5/167.0 (CI=O/CII=O), 152.6/152.6/152.1/152.0 
(C3'I/C3'II/C5'II/C5'II), 145.5/144.8 (C4'I/C4'II), 137.4/137.2/136.7/136.6/136.2/136.1 
(C1'III/C1'IV/C1'V), 129.2 (CHAr), 128.6 (CHAr), 128.5 (CHAr), 128.5 (CHAr), 128.3 (CHAr), 128.2 
(CHAr), 128.2 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 128.1 (CHAr), 128.0 (CHAr), 128.0 (CHAr), 
127.8 (CHAr), 127.9 (CHAr), 127.7 (CHAr), 127.6 (CHAr), 127.6 (CHAr), 127.5 (CHAr), 127.3 
(CHAr), 127.2 (CHAr), 126.4 (CHAr), 126.2 (CHAr), 124.7/124.9 (C1'I/C1'II), 101.4 (C8), 99.6 (C1), 
77.6 (C4), 77.2/75.3/75.2/75.2/75.1/71.4/ 70.9/70.8 (C2/C3/C9/C10), 68.3 (C6), 66.7 (C5)  
ESIMS m/z (%) 1223 [M+Na]+ (6), 477 (100)  
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(S)-158 
4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,5,5´,6,6´-hexakis(hydroxy)-1,1´-(S)-biphenyl-
2,2´-dicarboxylate]--D-Glucopyranose 
 
C27H22O14 
MW = 570,46 Da 
No CAS 
 
A solution of (S)-156 (1.99 g, 1.66 mmol) and 10% Pd/C (800 mg) in anhydrous THF (100 
mL) was purged 3 times with H2. The mixture was stirred at room temperature under H2 for 
48 hours, filtered through Celite®. The filter cake was then washed with THF (100 mL). 
Concentration in vacuo give (S)-158 (1:1 mixture of  and  anomers) as a beige foam (947 
mg, 100%). 
m.p. 210.5°C (decomposition) 
Rf = 0.38 (RP-C18; 30:70:0.1 H2O:MeOH:HCOOH) 
IR (neat) 3751, 3496, 3281, 2930, 1743, 1620, 1452, 1361, 1324, 1190 cm-1 
A pure sample of -(S)-158 or -(S)-158 could not be separated, and only assignable peaks 
from the mixture are listed. 
1H NMR (300 MHz, acetone-d6)  3.71-4.34 (m, 8H, H4/H4/H5/H5/H6/H6Q), 4.84 (t, J = 8.7 
Hz, 1H, H2), 5.06 (dd, J = 3.6, 9.3 Hz, 1H, H2), 5.15 (d, J = 8.1 Hz, 1H, H1), 5.28 (t, J = 9.6 
Hz, 1H, H3), 5.47 (d, J = 3.6 Hz, 1H, H1), 5.53 (t, J = 9.6 Hz, 1H, H3), 5.73 (s, 2H, H8/H8), 
6.55/6.56/6.58/6.59 (4 s, 4H, H2’IH2’IH6’IIH6’II), 7.37-7.52 (m, 10H, HAr) 
13C NMR (75 MHz, acetone-d6)  169.3/169.2/169.0/168.8 (CI=O/CII=O), 
145.2/145.1/144.4/144.4/144.4/144.3/138.7/138.6/136.4/136.3/136.3/136.2 
(C3'I/C3'II/C4'II/C4'II/C5'I/ C5'II/C1'III), 129.7 (CHAr), 128.9 (CHAr), 127.3 (CHAr), 127.2 (CHAr), 127.0 
(Cq), 126.8 (Cq), 126.8 (Cq), 126.7 (Cq), 126.0 (CHAr), 114.6/114.5/114.4 
(C2’IIC2’IIC6’IC6’I), 107.7/107.4/107.4/107.3 (C2’IC2’IC6’IIC6’II), 102.4/102.2 (C8/C8), 
95.6 (C1), 92.4 (C1), 79.1 (C4), 78.5/78.4 (C2C4), 76.6 (C3), 75.7 (C2), 74.3 (C3), 
69.5/69.2 (C6/C6), 67.7 (C5), 63.7 (C5) 
ESIMS m/z (%) 1139 [2M-H]- (16), 569 [M-H]- (100) 
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(S)-160 
Benzyl 4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,5,5´,6,6´-hexakis(hydroxy)-1,1´-(S)-
biphenyl-2,2´-dicarboxylate]--D-Glucopyranoside 
 
C34H28O14 
MW = 660,58 Da 
CAS : [176330-22-6] 
Brown oil 
 
Partially deprotected product obtained during hydrogenation of (S)-156 
Rf = 0.11 (RP-C18; 30:70:0.1 H2O:MeOH:HCOOH) 
1H NMR (300 MHz, acetone-d6)  3.76 (dt, J = 4.8, 9.5 Hz, 1H, H5), 3.94 (t, J = 10.3 Hz, 1H, 
H6), 4.01 (t, J = 9.6 Hz, 1H, H4), 4.39 (dd, J = 4.7, 10.2 Hz, 1H, H6), 4.79 and 4.94 (AB, JAB = 
12.4 Hz, 2H, H7), 4.95 (t, J = 9.1 Hz, 1H, H2), 5.07 (d, J = 8.1 Hz, 1H, H1), 5.30 (t, J = 9.5 Hz, 
1H, H3), 5.75 (s, 1H, H8), 6.56 (s, 1H, H2'I or H6'II), 6.58 (s, 1H, H2'I or H6'II), 7.33-7.51 (m, 10H, 
HAr) 
13C NMR (75 MHz, acetone-d6)  169.4/168.8 (CI=O/CII=O), 
145.3/145.2/144.6/138.6/138.5/136.5/ 136.4 (C3'I/C3'II/C4'II/C4'II/C5'I/C5'II/C1'III/C1'IV), 129.8 (CHAr), 
129.3 (CHAr), 128.9 (CHAr), 128.6 (CHAr), 128.5 (CHAr), 127.3 (CHAr), 126.7/126.6 (C1'I/C1'II), 
114.8/114.6 (C2'II/C6'I), 107.4/107.4 (C2'I/C6'II), 102.3 (C8), 100.3 (C1), 78.3 (C4), 77.0 (C2), 76.6 
(C3), 71.5 (C7), 69.1 (C6), 67.8 (C5) 
ESIMS m/z (%) 1319 [2M-H]- (12), 659 [M-H]- (100) 
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(S)-161 
2,3-[4,4´,5,5´,6,6´-hexakis(hydroxy)-1,1´-(S)-biphenyl-2,2´-dicarboxylate]--D-
glucopyranose 
 
 C20H18O14 
MW = 482,35 Da 
CAS : [7243-72-3] 
( : [83541-37-1];  : [83541-38-2]; open 
form : [121153-24-0; 81571-73-5; 36378-47-
9]) 
Pale yellow foam 
 
Rf = 0.73 (RP-C18; 30:70:0.1 H2O:MeOH:HCOOH) 
IR (neat) max 3387, 2963, 2927, 2857, 1744, 1620, 1445, 1365, 1314, 1230, 1182, 1084, 
1037 cm-1;  
1H-NMR (300 MHz, acetone-d6/D2O 8:1)  6.68-6.58 (2 s, 4H, H2’IH2’IH6’IIH6’II), 
5.42-5.35 (m, 2H, H1 and H3, 5.05-4.96 (m, 2H, H1and H3), 4.91 (dd, J = 3.6, 9.6 Hz, 
1H, H2), 4.70 (dd, J = 8.1, 9.4 Hz, 1H, H2), 4.03-3.47 (m, 8H, 
H4/H4/H5/H5/H6/H6) 3.47-3.98 (m, 8H); 
13C-NMR (75 MHz, acetone-d6/D2O 8:1)  169.6/169.5/169.1/168.9 (CI=O/CII=O), 
145.1/145.0/145.0/144.9/144.3/144.2/144.1/136.1/136.0/130.3/129.5/129.3/129.2/ 
128.7/127.6/127.4/127.1/125.4/114.5/114.5/114.4/107.3 
(C2’IIC2’IIC3’IC3’IC3’IIC3’IIC4’IC4’IC4’IIC4’IIC5’IC5’IC5’IIC5’IIC6’IC6’I), 107.7/107.6 
(CHar), 94.8 (C1), 91.5 (C1), 80.7 (C3), 78.3 (C3), 77.8 (C2), 77.7 (C2), 
73.0/69.0/68.7/68.4 (C4/C4C5C5), 62.3/62.2 (C6/C6); 
ESIMS m/z (%): 481 (100) [M-H]-;  
HRMS (ESI-TOF) calcd for C20H17O14 [M-H]- 481.0618, found 481.0630. 
 
 
OHO
HO
O
O
O
O
OH
HO
HO
HO
HO
HO
I
II
2
3
4
5
6
1'
2'
3'
4'
5'
6'
1'
2'
3'
4'
5' 6' 1
OH (/)
S
Chapter 5 – Experimental Section 
 184
 
(S)-173 
4,6-[(R)-phenylmethylene]cyclic 2,3-[4,4´,6,6´-tetrakis(hydroxy)-5,5´-dibenzyloxy-1,1´-
(S)-biphenyl-2,2´-dicarboxylate]--D-Glucopyranose 
 
C41H34O14 
MW = 750,70 Da 
No CAS 
 
To a stirred solution of CuCl2 (179 mg, 1.33 mmol, 5 eq) in dry MeOH (3 mL), n-butylamine 
(525 µL, 5.30 mmol, 20 eq) was added at room temperature, and the mixture was stirred for 
30 minutes. To this blue solution, a solution of 159b (200 mg, 0.265 mmol, 1 eq) in dry 
MeOH (3 mL) was added and the mixture was stirred for 45 minutes. Addition of 0.5M 
aqueous solution of HCl (5 mL) quenched the reaction. The mixture was extracted with 
EtOAc (2 x 20 mL). The organic layer was successively washed with H2O (15 mL) and brine 
(15 mL), dried over MgSO4 and concentrated in vacuo. The resulting residue was purified by 
column chromatography (1:1 PET:EtOAc) to give (S)-173 (1:1 mixture of  and  anomers) 
as a brown powder (107 mg, 54%). 
m.p. 165-166°C 
Rf = 0.38 (2:3 PET:EtOAc) only one product is seen by TLC 
IR (neat) max 3480, 2954, 2863, 1750, 1455, 1369, 1184, 1096 cm-1 
ESIMS m/z (%) 1499 [2M-H]- (46), 749 [M-H]- (100) 
HRMS calcd for C41H33O14 [M-H]- 749.1870, found 749.1873 
A pure sample of -(S)-256 or -(S)-256 could not be separated, and only assignable peaks 
from the mixture are listed. 
1H NMR (300 MHz, acetone-d6)  3.73 (dt, J = 4.7, 9.5 Hz, 1H, H5), 3.88 (t, J = 9.6 Hz, 1H, 
H6 or H6), 3.89 (t, J = 10.1 Hz, 1H, H6 or H6), 3.98 (t, J = 9.4 Hz, 1H, H44.00 (t, J = 9.4 
Hz, 1H, H4), 4.16 (dd, J = 4.7, 9.6 Hz, 1H, H5), 4.22-4.27 (m, 1H, H6), 4.33 (dd, J = 4.8, 
10.1 Hz, 1H, H6), 4.85 (dd, J = 8.2, 9.2 Hz, 1H, H2), 5.07 (dd, J = 3.6, 9.3 Hz, 1H, H2), 
5.12-5.21 (m, 1H, H1), 5.15 (s, 4H, H8H8), 5.17 (s, 4H, H8H8), 5.30 (t, J = 9.6 Hz, 1H, 
H3), 5.50 (d, J = 3.2 Hz, 1H, H1), 5.55 (t, J = 9.6 Hz, 1H, H3), 5.74 (s, 2H, H9H9), 6.55 (s, 
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1H, H2'I or H6'II), 6.56 (s, 1H, H2'I or H6'II), 6.58 (s, 1H, H2'I or H6'II), 6.58 (s, 1H, H2'I or 
H6'II), 7.29-7.56 (m, 30H, H2'III/H3'III/H4'III/H2'IV/H3'IV/H4'IV) 
13C NMR (75 MHz, acetone-d6)  169.0/168.9 (CI=O/CII=O), 168.7/168.5 (CI=O/CII=O), 
150.4/150.3/150.2/150.1/150.1 (C3'I/C3'II/C5'I/C5'II), 138.7 (C4'I/C4'II), 131.3/131.1/131.1/131.0 
(C1'III), 138.6 (C1'IV), 129.8 (CHAr), 129.2 (CHAr), 129.2 (CHAr), 129.0 (CHAr), 128.9 (CHAr), 
128.7 (CHAr), 127.3/127.3 (C2'IV/C3'IV), 136.8/136.8/136.7 (C1'I/C1'II), 114.0/114.0/113.9/113.8 
(C2'II/C6'I), 107.1/107.1/106.9/106.8 (C2'I/C6'II), 102.4 (C9), 102.2 (C9), 95.6 (C1), 92.4 (C1), 
79.1 (C4), 78.4 (C4), 78.4 (C2), 76.6 (C3), 75.6 (C2), 74.8 (C8C8), 74.2 (C3), 69.5 (C6), 
69.2 (C6), 67.7 (C5), 63.7 (C5) 
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Intermediates A 
175  
7-methanodibenzo[f, h][1,4]dioxecin-5,10-dione, 7, 8- O-benzylidene, 2, 3, 12, 13, 14, 15-
heptahydroxy-8-(1, 2, 3-trihydroxypropyl)-stereoisomer 
 
 
C41H34O14 
MW = 570,46 Da 
No CAS 
 
Compound (S)-158 (60 mg, 0.10 mmol) was dissolved in 9 mL of phosphate buffer solution 
(0.2 M, pH 5.3) and stirred at 65°C for 4 days. The reaction mixture was then lyophylized and 
purified by preparative HPLC (microsorb C-18; solvent A: H2O + 0.1% HCOOH, solvent B: 
MeCN + 0.1% HCOOH; method: gradient 0-100% B in 25 min; flow: 20 mL/min) to give 161 
as a pale yellow solid (9 mg, 16%) and -157 (11 mg, 23%). Epimer -157 was only obtained 
as an impure fraction (4 mg, brown solid) 
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175 
 
 
C27H22O14 
MW = 750,70 Da 
No CAS 
 
 
m.p. 179.3-180.5°C; 
Rf = 0.37 (RP-TLC, 30:20:0.1 H2O/MeCN/HCOOH);  
Rt = 6.8 min (Pursuit 3 C-18, 150 x 4.6 mm, solvent A: H2O + 0.1% HCOOH, solvent B: 
MeCN + 0.1% HCOOH; method: gradient 0-100% of B in 10 min; flow: 1 mL/min);  
21D = -56.5° (c = 0.23, MeOH);  
IR (neat) max 3385, 1721, 1599, 1463, 1374, 1320, 1190, 1072 cm-1; 
1H NMR (300 MHz, acetone-d6)  7.31-7.52 (m, 5H, H2'III/H3'III/H4'III), 6.43 (s, 1H, H6’II), 5.65 (s, 
1H, H7), 5.10 (t, J = 2.5 Hz, 1H, H2), 4.87 (d, J = 2.1 Hz, 1H, H1), 4.76 (t, 1H, J = 2.8 Hz, H3), 
4.12 (dd, 1H, J = 4.4, 9.6 Hz, H6), 3.95 (dd, J = 3.0, 8.9 Hz, 1H, H4), 3.59-3.75 (m, 2H, H5/H6);
13C NMR (75 MHz, acetone-d6)  171.0 (CII=O), 164.6 (CI=O), 146.5 (C5’I), 145.9 (C5’II), 143.9 
(C3’I), 144.4 (C3’II), 139.2 (C1’III), 137.3 (C4’I/C4’II), 134.9 (C4’I/C4’II), 129.3 (C4’III), 128.7 (C3’III), 
128.3 (C1’II), 127.1 (C2’III), 124.0 (C1’I), 118.8 (C2’I), 116.2/115.4 (C2’II/C6’I), 105.5 (C6’II), 101.7 
(C8), 83.3 (C4), 80.0 (C2), 72.6 (C3), 71.5 (C6), 65.7 (C1), 62.5 (C5); 
ESIMS m/z (%)1139 (10) [2M-H]-, 569 (100) [M-H]-;  
HRMS (ESI-TOF) calcd for C27H21O14 [M-H]- 569.0931, found 569.0947 
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-175  
position H (mult., J in Hz) C (mult.) HMQCa HMBCb 
glucose 
1 4.86 (d, 1.7) 65.6 C1 H2, H3, C2, C1’I, C2’I, C3’I 
2 5.10 (br) 80.0 C2 H1, C1, C4, C2’I, CI=O 
3 4.78 (t, 2.6) 72.5 C3 H4, C1, CII=O 
4 3.94 (dd, 2.6, 8.7) 83.3 C4 H2, H6, H7, C3, C7 
5 3.59-3.73 (m) 62.4 C5 H4, H6, H7 
6 3.59-3.73 (m) 4.21 (dd, 4.0, 9.4) 71.5 C6 H7, C4, C5 
aromatics I and II 
1’I  124.0  H1 
1’II  128.7   
2’I  118.8  H1, H2 
2’II  115.4 or 116.2  H6’II 
3’I  144.3  H1 
3’II  143.8  H6’II 
4’I  139.1   
4’II  139.1   
5’I  146.5   
5’II  145.7  H6’II 
6’I  115.4 or 116.2   
6’II 6.41 (s) 105.4 C6’II C2’II, C3’II, C5’II 
benzylidene group 
7 5.64 (s) 101.7 C7 
H2’III, H3’III, H4’III, H4, 
C4, C5, C6, C1’III, C2’III, 
CII=O 
1’III  134.8  H7 
2’III 7.32-7.52 (m) 128.2 C2’III H7 
3’III 7.32-7.52 (m) 129.3 C3’III H2’III, H3’III, H4’III 
4’III 7.32-7.52 (m) 129.4 C4’III H2’III, H3’III, H4’III 
carbonyls 
CI=O  164.6  H2 
CII=O  171.0  H3, H7 
a Carbons correlate with the protons resonating at the ppm value indicated in the H column. 
b Indicated carbons and protons correlated with the protons or carbons at the position indicated in the left 
column. 
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175 
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C27H22O14 
MW = 750,70 Da 
No CAS 
 
Rf = 0.52 (RP-C18; 3:2 H2O:ACN 0.1% HCOOH double elution);  
Rt = 13.15 min (Pursuit 3 C-18, 150 x 4.6 mm, solvent A: H2O + 0.1% HCOOH, solvent B: 
MeCN + 0.1% HCOOH; method: gradient 0-100% of B in 10 min; flow: 1 mL/min);  
IR (neat) max 3385, 1721, 1599, 1463, 1374, 1190, 1072 cm-1;  
1H NMR (300 MHz, acetone-d6)  5.63 (s, 1H, H), 5.60 (d, J = 4.6, 1H, H), 5.35 (t, 1H, J = 
2.6 Hz, H3), 4.97 (dd, J = 2.81, 4.53, Hz, 1H, H2), 4.21 (dd, 1H, J = 4.8, 10.2 Hz, H6), 3.78-
3.60 (m, 3H, H4/H5/H6); 
13C NMR (75 MHz, acetone-d6)  138.8 (C1’III), 129.3 (C4’III), 128.6 (C3’III/ C5’III), 126.9 (C2’III / 
C6’III), 104.9 (C6’II), 101.6 (C7), 84.4 (C4), 76.1 (C2), 71.2 (C6), 70.0 (C3), 68.0 (C1), 61.7 (C5) 
ESIMS m/z (%) 569 (100) [M-H]-;  
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176 
 
C41H34O14 
MW = 570,46 Da 
No CAS 
 
A solution of (S)-159 (12 mg, 0.016 mmol) in phosphate buffer 0.2 M at pH = 7.5 (800 μL) 
and MeOH (800 μL) was stirred at 50°C for 2 hours and 30 minutes. The reaction was 
followed by analytic HPLC (reverse phase, H2O:MeCN). The mixture was then acidified to pH 
= 3 with aqueous solution of HCl (2M) and the excess of MeOH was evaporated. The 
reaction mixture was then purified by preparative HPLC (microsorb C18 250 x 41.4 mm; 
solvent A: H2O+0.1% HCOOH, solvent B: MeCN+0.1%HCOOH; method: 40-100% of B in 20 
min, 20 mL/min) to give 176 as a white solid (3 mg, 25%).  
m.p. 203°C (decomposition) 
Rt = 5.9 min [HPLC, Column : Pursuit 3 C18 (150 x 4,6 mm), Solvents : A : H2O + 0.1% 
HCOOH, B : MeCN + 0.1% HCOOH, Méthod : gradient 40 to 100% B in 10 min, Flow : 
1mL/min, UV : 280nm] 
21D = +16.7° (c = 0.54, acetone) 
IR (neat) max 1719, 1628, 1456, 1376, 1215, 1179, 1161, 1110, 1073, 750, 701 cm-1 
1H NMR (300 MHz, acetone- d6)  3.60-3.69 (m, 1H, H6), 3.73 (dt, J = 4.8, 9.4 Hz, 1H, H5), 
3.95 (dd, J = 3.0, 8.9 Hz, 1H, H4), 4.22 (dd, J = 4.7, 10.0 Hz, 1H, H6), 4.79 (t, J = 2.9 Hz, 1H, 
H34.87 (d, J = 2.1 Hz, 1H, H1), 5.07-5.23 (m, 5H, H2H8), 5.65 (s, 1H, H7), 6.47 (s, 1H, H6'II), 
7.31-7.58 (m, 15H, H2'III/H3'III/H4'III/H2'IV/H3'IV/H4'IV) 
13C NMR (75 MHz, acetone- d6)  170.4 (CII=O), 164.4 (CI=O), 151.9 (C5’I), 151.0 (C5’II), 
149.6/149.5 (C3’I/C3’II), 139.1/138.8/138.4 (C1’III/C1’IV), 138.0 (C4’I), 135.8 (C4’II), 132.6 
(C1’I/C1’II), 129.4/129.3/129.1/129.0/128.8/128.8/128.6 (C4’III/C2’IV/C3’IV/C4’IV), 127.1 (C2’III/C3’III), 
118.3 (C2’I), 116.0/115.6 (C2’II/C6’I), 105.3 (C6’II), 101.7 (C7), 83.2 (C4), 80.2 (C2), 75.2(C8), 
74.8 (C8), 72.4 (C3), 71.6 (C6), 65.5 (C1), 62.4 (C5) 
ESIMS m/z (%) 1499 [2M-H]- (5), 749 [M-H]- (100) 
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179 
5-O-Desgalloyl epipunicacortein A 
 
C20H18O14 
MW = 482,35 Da 
No CAS 
 
In a dry 10 mL schlenk, compound -175 (17,7 mg, 0.031 mmol) was dissolved in dry THF 
(3.5 ml) under argon atmosphere and Pd(OH)2/C (12 mg) was added. The reaction mixture 
was repeatedly saturated with H2 and the reaction was followed by C18-TLC (3:2 H2O/MeCN, 
0.1% HCOOH). Additional amount of Pd(OH)2/C was added during the reaction in order to 
consume all the starting material until a total amount of 51.5 mg. After 96 hours, the starting 
material was completely consumed and the reaction mixture was filtered through a filter 
(Acrodisc 13 mm syringe filter, with 0.2 µm nylon membrane) and the palladium was washed 
with THF (3 x 3 mL) then with acetone (3 x 3 mL). The solvent was removed under vacuum 
to give 13,8 mg (93%) of a yellow amorphous solid. The crude was purified for analysis on 
Sephadex LH-20 (H2O) to give 1.1 mg of pure compound 179 
Rf = 0.90 (RP-TLC, 30:20:0.1 H2O/MeCN/HCOOH) 
Rt = 3.2 min (Pursuit 3 C-18, 150 x 4.6 mm, solvent A: H2O + 0.1% HCOOH, solvent B: 
MeCN + 0.1% HCOOH; method: isocratic 0% of B in 5 min then gradient 0-100% of B in 13 
min; flow: 1 mL/min) 
21D = +16.7° (c = 0.54, acetone) 
IR (neat) max 1719, 1628, 1456, 1376, 1215, 1179, 1161, 1110, 1073, 750, 701 cm-1 
1H NMR (400 MHz, acetone-d6/D2O 8:1)  3.47-3.76 (m, 4H), 4.66 (t, J = 2.8 Hz, 1H), 4.82 (d, 
J = 1.8 Hz, 1H), 4.91 (t, J = 2.3 Hz, 1H), 6.40 (s, 1H) 
13C NMR (100 MHz, acetone-d6/D2O 8:1)  170.8, 166.5, 146.6, 145.5, 143.9, 143.5, 138.2, 
134.8, 127.7, 122.4, 118.4, 116.2, 105.2, 81.3, 74.0, 73.7, 64.9, 63.6, 61.9 
ESIMS m/z (%): 481 (100) [M-H]- 
HRMS (ESI-TOF) calcd for C20H19O14 [M+H]+ 483.0775, found 483.0786. 
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I
II
23
4
5
6
1'
2'
3'
4'
5'
6'
1'
2'
3'4'
5'
6'
1
OH OH
OH O O
O
O
HO
HO
OH
OH
OH
HO
OH
 
position H (mult., J in Hz) C (mult.) HMQCa HMBCb 
glucose 
1 4.86 (d, 1.8) 64.9 C1 C1’I, C2’I, C3’I 
2 4.91 (t, 2.3) 81.3 C2 C3, C2’I, CI=O 
3 4.66 (t, 2.8) 74.0 C3 H2 
4 3.47-3.76 (m) 73.7 C4  
5 3.47-3.76 (m) 71.9 C5 H6 
6 3.47-3.76 (m) 63.6 C6 C5 
aromatics I and II 
1’I  122.4  H1 
1’II  127.7   
2’I  118.4  H1, H2 
2’II  116.2  H6’II 
3’I   H1 
3’II  
143.5 / 143.9 
  
4’I  138.2   
4’II  134.5  H6’II 
5’I  146.6   
5’II  145.5  H6’II 
6’I  116.2   
6’II 6.40 (s) 105.2 C6’II C2’II, C4’II, C5’II, CII=O 
carbonyls 
CI=O  166.5  H2 
CII=O  170.8  H6’II 
a Carbons correlate with the protons resonating at the ppm value indicated in the H column. 
b Indicated carbons and protons correlated with the protons or carbons at the position indicated in the left 
column. 
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Annex 1 
Steglich Esterification 
The Steglich Esterification is a mild reaction, which allows the esters and amide formation by 
reaction with carboxylic acids from sterically demanding and acid labile substrates. It consists 
in the introduction of dicycloehylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) as 
catalyst.168 
Mechanism of the Steglich Esterification 
The first step is the activation of the carboxylic acid. 
DCC (dicyclohexylcarbodiimide) and the carboxylic acid are able to form an O-acylisourea (I) 
intermediate, which offers reactivity similar to the corresponding carboxylic acid anhydride. 
The alcohol may then add to the activated carboxylic acid to form the stable dicyclohexylurea 
(DHU) and the ester: 
 
R O
H
O N
N R O
O N
N
H
N
N
H
R O
O
I
N
N
H
RO
O
I
N
N
H
RO
O
II
H
H+
H
O
R
HN
HN
O R O
R
O
H
DHU
DCC
O-acyl isourea
O-acyl isourea  
Scheme 73. DCC catalyzed esterification 
 
In practice, the reaction with carboxylic acids, DCC and amines leads to amides without 
problems, while the addition of approximately 5 mol-% 4-dimethylaminopyridine (DMAP) is 
crucial for the efficient formation of esters. 
N-Acylureas (Scheme 74), which may be quantitatively isolated in the absence of any 
nucleophile, are the side products of an acyl migration that takes place slowly. Strong 
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nucleophiles such as amines react readily with the O-acylisourea and therefore need no 
additives: 
N
N
H
RO
O
O-acyl isourea
N
H
N R
O O
DHU
DHU
R'NHCOR
R'OCOR
N-acyl isourea
fast
slow
slow
R'NH2
R'OH
 
Scheme 74. 
 
A common explanation of the DMAP (Figure 44) acceleration suggests that DMAP, as a 
stronger nucleophile than the alcohol, reacts with the protoned O-acylisourea (II) leading to a 
reactive amide ("active ester").  
 
N
N
N
N
 
Figure 44. The dimethylamino group acts as an electron-donor substituent, increasing both the 
nucleophilicity and the basicity of the pyridine nitrogen. 
 
This intermediate cannot form intramolecular side products but reacts rapidly with alcohols. 
DMAP acts as an acyl transfer reagent in this way, and subsequent reaction with the alcohol 
gives the ester. 
 
N N
N
H
N
RO
O
H
- DHU
N
N
R
O
N
N
R
O
H
O
R'
-DMAP/H+
R O
R'
O
 
Scheme 75. DCC-DMAP catalyzed esterification 
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In any case the proton transfer step (from I to II, Scheme 73) is essential to the success of 
the reaction. It has been observed that the failure might conceivably arise from low effective 
concentrations of alcohol and acid (both proton sources). Therefore this approach to 
esterification was reexamined in the presence of additives (specifically various amine 
hydrochlorides) to mediate such proton-transfer steps. Best results were obtained in media 
where such salts were totally soluble, and the use of DMAP-HCl as the amine hydrochloride 
proved most efficient and convenient.107 
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Annex 2 
Palladium catalyzed hydrogenolysis 
In the manufacture of pharmaceuticals and fine chemicals there is often a requirement for a 
protection strategy to minimize possible side reactions during a synthesis. 
Small, easily removed protection, available for a range of functional groups, is highly desired. 
One such easily removed protection is derived from the facile catalytic hydrogenolysis of 
benzylic groups. An analysis of the published medicinal chemical routes shows that over 
1000 drug syntheses currently use this type of protection. 
The classic functional groups requiring protection are alcohols, acids and amines. 
Simple cleavage of these protecting groups is critical. 
Cleavage by catalytic hydrogenation can be performed with good selectivity under mild 
conditions using a heterogeneous Palladium on Carbon (Pd/C) catalyst in the presence of 
hydrogen gas or a hydrogen transfer agent, e.g. ammonium formate or isopropanol. Efficient 
removal depends on selection of the most active and selective catalyst, and an optimized set 
of reaction conditions as:  
- nature and amount of catalyst 
- solvent 
Nature of catalyst - Pd/C and Pd(OH)2/C 
Pd/C is formed from the PdCl2 precursor in acidic media through two consecutive processes:  
a) absorption of palladium chloride to form surface complexes 
b) redox interaction between PdCl2 and carbon with the formation of palladium media 
particles.  
Effect of such stages of catalyst synthesis as drying, calcination, and reduction of the 
supported precursors to metal has important effects on the activity of the catalysts.  
It is for these reasons that commercial Pd/C catalysts exhibit remarkable supplier-dependent 
disparity in the property and quality. Even different lots of the same brand can often show 
different catalytic activity. 169,170  
Since the unexpected reactivity would cause serious damage to a synthetic process, 
especially in multi-step synthesis of complex natural products, therefore, when a Pd/C 
catalyst is used in an article, the name of the supplier and the product number of the catalyst 
must be clarified. 
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Moreover acid sensitive substrates are often degraded by the residual acids. 
 
Pd(OH)2 doesn’t presents these disadvantages. It is often preferred to Pd/C. 
 
In certain cases a combination of Pd/C and Pd(OH)2/C serves as better catalysts than either 
catalysts alone.171 
 
Amount of catalyst 
The amount of catalyst can be increased in order to increase the reaction rate. 
As during the reaction the catalyst is deactivated (impurities on the surface of the catalyst) 
the best is to remove the old catalyst before make a new addition. Frequently in the literature 
it is reported for difficult reactions “repeated hydrogenation” (filter off the old catalyst and add 
a new one).172 
 
Solvent 
Solvent choice is critical for any debenzylation reaction.  
The most used solvent for hydrogenolysis Pd/C catalyzed is methanol. According to the 
Hughes and Ingold theory of solvent effect, reactions involving dipolar activated complexes 
are accelerated by polar solvents. 
Obviously the solvent is chosen on the basis of the solubility of the starting compound and of 
the product.  
It is for this that sometimes mixtures of solvents are used.173  
The reaction can be forced by using AcOH as solvent.172 
Interestingly the reaction can be performed in water.174 
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 Annex 3 
NMR spectra of most significant intermediates of the 
synthesis 
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Peak Nr. Data Point Frequency PPM Intensity %Int. 
1 7526 2260.12 7.5305 83540024 19.3 
2 7549 2255.78 7.5160 174586320 40.3 
3 7568 2252.19 7.5040 206544160 47.7 
4 7577 2250.49 7.4984 169035968 39 
5 7590 2248.03 7.4902 149004816 34.4 
6 7601 2245.96 7.4833 140621104 32.4 
7 7745 2218.76 7.3927 64975944 15 
8 7754 2217.06 7.3870 92581696 21.4 
9 7765 2214.98 7.3801 187511984 43.3 
10 7774 2213.28 7.3744 286476928 66.1 
11 7791 2210.07 7.3637 301896864 69.6 
12 7798 2208.75 7.3593 337196800 77.8 
13 7801 2208.19 7.3574 339064768 78.2 
14 7809 2206.68 7.3524 274379840 63.3 
15 7820 2204.60 7.3455 85839488 19.8 
16 9013 1979.30 6.5948 391964832 90.4 
17 9024 1977.23 6.5879 429482784 99.1 
18 9063 1969.86 6.5634 414873344 95.7 
19 9075 1967.60 6.5558 433454944 100 
20 10398 1717.75 5.7234 238724000 55.1 
21 10407 1716.05 5.7177 251462272 58 
22 10669 1666.57 5.5528 58110480 13.4 
23 10720 1656.94 5.5208 106006800 24.5 
24 10771 1647.31 5.4887 74111752 17.1 
25 10806 1640.70 5.4666 112370280 25.9 
26 10825 1637.11 5.4547 121519016 28 
27 11062 1592.36 5.3056 64956432 15 
28 11111 1583.10 5.2747 95896608 22.1 
29 11114 1582.54 5.2728 95387600 22 
30 11163 1573.28 5.2420 77726944 17.9 
31 11307 1546.09 5.1514 110389072 25.5 
32 11350 1537.97 5.1243 131730632 30.4 
33 11434 1522.11 5.0715 90394880 20.9 
34 11453 1518.52 5.0595 82931408 19.1 
35 11483 1512.85 5.0407 78949968 18.2 
36 11502 1509.27 5.0287 75197984 17.3 
37 11766 1459.41 4.8626 91120160 21 
38 11809 1451.29 4.8355 87556800 20.2 
39 11815 1450.16 4.8318 96364184 22.2 
40 11858 1442.04 4.8047 68997144 15.9 
41 12603 1301.35 4.3359 47022532 10.8 
42 12629 1296.44 4.3196 57374968 13.2 
43 12657 1291.15 4.3020 61819312 14.3 
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44 12683 1286.24 4.2856 62158920 14.3 
45 12723 1278.68 4.2604 49697956 11.5 
46 12748 1273.96 4.2447 65708400 15.2 
47 12774 1269.05 4.2283 46595772 10.7 
48 12799 1264.33 4.2126 82899472 19.1 
49 12819 1260.55 4.2000 46670560 10.8 
50 12868 1251.30 4.1692 62023180 14.3 
51 12893 1246.58 4.1535 44708632 10.3 
52 12919 1241.67 4.1371 46337532 10.7 
53 12945 1236.76 4.1207 38405772 8.9 
54 13138 1200.31 3.9993 75575752 17.4 
55 13169 1194.46 3.9798 68966728 15.9 
56 13189 1190.68 3.9672 105766432 24.4 
57 13218 1185.20 3.9490 106096160 24.5 
58 13239 1181.24 3.9358 74312200 17.1 
59 13270 1175.38 3.9163 85552160 19.7 
60 13284 1172.74 3.9074 69478928 16 
61 13303 1169.15 3.8955 74052568 17.1 
62 13338 1162.54 3.8735 121343976 28 
63 13355 1159.33 3.8628 133959624 30.9 
64 13392 1152.35 3.8395 89071200 20.5 
65 13406 1149.70 3.8307 69360600 16 
66 13539 1124.59 3.7470 45988976 10.6 
67 13565 1119.68 3.7306 48270704 11.1 
68 13592 1114.58 3.7136 52431392 12.1 
69 13614 1110.42 3.6998 53117776 12.3 
70 13641 1105.32 3.6828 38039640 8.8 
71 13667 1100.41 3.6665 39170560 9 
72 13689 1096.26 3.6526 42276380 9.8 
73 13693 1095.50 3.6501 37213844 8.6 
74 13702 1093.80 3.6444 36595984 8.4 
75 13724 1089.65 3.6306 84005200 19.4 
76 13736 1087.38 3.6230 54743232 12.6 
77 13746 1085.49 3.6167 51439084 11.9 
78 13759 1083.04 3.6086 52940884 12.2 
79 16198 622.44 2.0739 73114152 16.9 
80 16213 619.61 2.0645 119483664 27.6 
81 16225 617.34 2.0569 178613616 41.2 
82 16236 615.27 2.0500 217127584 50.1 
83 16248 613.00 2.0424 140082720 32.3 
84 16260 610.73 2.0349 64653696 14.9 
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Peak Nr. Data Point Frequency PPM Intensity %Int. 
1 15550 2006.69 6.6861 279459936 61.2 
2 15561 2004.61 6.6791 252330240 55.3 
3 15716 1975.34 6.5816 456465440 100 
4 17565 1626.16 5.4182 51362940 11.3 
5 17613 1617.10 5.3880 147604976 32.3 
6 17626 1614.64 5.3798 115376216 25.3 
7 17664 1607.47 5.3559 64191152 14.1 
8 18141 1517.39 5.0558 45616348 10 
9 18192 1507.75 5.0237 100948552 22.1 
10 18241 1498.50 4.9928 144097792 31.6 
11 18284 1490.38 4.9658 115671168 25.3 
12 18343 1479.24 4.9287 72438264 15.9 
13 18362 1475.65 4.9167 68811464 15.1 
14 18394 1469.61 4.8966 62368660 13.7 
15 18413 1466.02 4.8846 63635248 13.9 
16 18659 1419.56 4.7298 62225960 13.6 
17 18702 1411.44 4.7028 61699752 13.5 
18 18710 1409.93 4.6977 59720888 13.1 
19 18753 1401.81 4.6707 42138240 9.2 
20 19858 1193.14 3.9754 29158396 6.4 
21 19874 1190.11 3.9653 25065348 5.5 
22 19887 1187.66 3.9572 30927706 6.8 
23 19910 1183.32 3.9427 48879336 10.7 
24 19925 1180.48 3.9332 40120480 8.8 
25 19950 1175.76 3.9175 35408164 7.8 
26 19963 1173.31 3.9093 38805584 8.5 
27 20008 1164.81 3.8810 105108928 23 
28 20026 1161.41 3.8697 64711076 14.2 
29 20057 1155.56 3.8502 114569416 25.1 
30 20085 1150.27 3.8326 66980280 14.7 
31 20101 1147.25 3.8225 111336448 24.4 
32 20114 1144.79 3.8143 114539872 25.1 
33 20127 1142.34 3.8061 119413872 26.2 
34 20135 1140.83 3.8011 134122096 29.4 
35 20149 1138.18 3.7923 83508336 18.3 
36 20171 1134.03 3.7785 65394692 14.3 
37 20186 1131.19 3.7690 81843072 17.9 
38 20198 1128.93 3.7615 67006344 14.7 
39 20233 1122.32 3.7394 34472640 7.6 
40 20260 1117.22 3.7225 35517668 7.8 
41 20550 1062.45 3.5400 30443886 6.7 
42 20563 1060.00 3.5318 32279918 7.1 
43 20576 1057.54 3.5236 33061712 7.2 
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44 20599 1053.20 3.5091 28330512 6.2 
45 20613 1050.56 3.5003 27167082 6 
46 20627 1047.91 3.4915 25284098 5.5 
47 20640 1045.46 3.4834 19067768 4.2 
48 20659 1041.87 3.4714 17118906 3.8 
49 22895 619.61 2.0645 160898816 35.2 
50 22907 617.34 2.0569 220025312 48.2 
51 22918 615.27 2.0500 271195904 59.4 
52 22930 613.00 2.0424 187959200 41.2 
53 22942 610.73 2.0349 93564776 20.5 
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Peak Nr. Data Point Frequency PPM Intensity %Int. 
1 9842 2255.59 7.5154 83780016 14.7 
2 9855 2253.13 7.5072 88762080 15.5 
3 9884 2247.65 7.4889 126962656 22.2 
4 9891 2246.33 7.4845 116567704 20.4 
5 10085 2209.70 7.3625 46358536 8.1 
6 10111 2204.79 7.3461 135128160 23.7 
7 10142 2198.93 7.3266 189180032 33.1 
8 10149 2197.61 7.3222 181031024 31.7 
9 11594 1924.73 6.4130 203252112 35.6 
10 12825 1692.26 5.6384 173118112 30.3 
11 13686 1529.66 5.0967 93945376 16.5 
12 14061 1458.84 4.8607 104625480 18.3 
13 14070 1457.14 4.8550 102711144 18 
14 14170 1438.26 4.7921 53510536 9.4 
15 14184 1435.62 4.7833 93811312 16.4 
16 14198 1432.97 4.7745 55814192 9.8 
17 15060 1270.19 4.2321 38857048 6.8 
18 15081 1266.22 4.2189 48893200 8.6 
19 15110 1260.74 4.2007 50507156 8.8 
20 15131 1256.78 4.1874 37358292 6.5 
21 15487 1189.55 3.9634 35888828 6.3 
22 15501 1186.90 3.9546 37642384 6.6 
23 15533 1180.86 3.9345 43406800 7.6 
24 15547 1178.22 3.9257 40813856 7.1 
25 15853 1120.43 3.7332 12089353 2.1 
26 15877 1115.90 3.7180 11817798 2.1 
27 15906 1110.42 3.6998 23249874 4.1 
28 15931 1105.70 3.6841 22490648 3.9 
29 15955 1101.17 3.6690 21114428 3.7 
30 15978 1096.82 3.6545 41492704 7.3 
31 16030 1087.00 3.6218 29009736 5.1 
32 16082 1077.18 3.5891 11316653 2 
33 18505 619.61 2.0645 229480384 40.2 
34 18517 617.34 2.0569 418512128 73.3 
35 18528 615.27 2.0500 571044416 100 
36 18540 613.00 2.0424 421937472 73.9 
37 18551 610.92 2.0355 238229760 41.7 
 
 
Annex 3 – NMR spectra 
 208
10
.2
60
0.
84
68
1.
99
89
1.
07
81
1.
00
00
1.
34
97
6.
86
83
In
te
gr
al
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
ANA184-C / acetone / 300 MHz 
 
 
20
8.
39
88
17
1.
68
38
17
0.
13
10
14
5.
64
95
14
3.
69
56
13
8.
81
10
12
9.
33
34
12
8.
67
72
12
7.
55
45
12
7.
14
62
12
6.
94
94
11
6.
67
71
11
0.
02
81
10
4.
99
04
10
1.
61
49
84
.4
67
7
76
.1
27
4
71
.2
20
8
70
.0
32
5
68
.0
34
9
61
.7
57
8
30
.6
12
8
30
.3
57
6
30
.0
95
2
29
.8
40
0
29
.5
84
8
29
.3
29
7
29
.0
67
2
(ppm)
020406080100120140160180200
ANB129-D / acetone / 300 MHz
 
O O
OH O O
O
O
HO
HO
OH
OH
OH
HO
OH
S
Ph
-175
O O
OH O O
O
O
HO
HO
OH
OH
OH
HO
OH
S
Ph
-175
Annex 3 – NMR spectra 
 209
O O
OH O O
O
O
HO
HO
OH
OH
OH
HO
OH
S
Ph
-175
 
 
Peak Nr. Data Point Frequency PPM Intensity %Int. 
1 17111 3016.90 7.5398 3596144 0.9 
2 17143 3009.07 7.5202 12237014 2.9 
3 17153 3006.63 7.5141 11713036 2.8 
4 17176 3001.00 7.5001 15038347 3.6 
5 17182 2999.53 7.4964 12964499 3.1 
6 17195 2996.36 7.4885 5326320 1.3 
7 17412 2943.29 7.3558 11310963 2.7 
8 17420 2941.34 7.3510 11084601 2.7 
9 17434 2937.91 7.3424 19861324 4.8 
10 17463 2930.82 7.3247 26064110 6.3 
11 17480 2926.66 7.3143 10438850 2.5 
12 17487 2924.95 7.3100 9489064 2.3 
13 18920 2574.54 6.4343 20277984 4.9 
14 20241 2251.51 5.6270 17216606 4.1 
15 20271 2244.18 5.6086 9134295 2.2 
16 20290 2239.53 5.5970 8909749 2.1 
17 20681 2143.92 5.3581 6376718 1.5 
18 20692 2141.23 5.3513 10607604 2.5 
19 20702 2138.78 5.3452 5839642 1.4 
20 21295 1993.78 4.9828 5547512 1.3 
21 21306 1991.09 4.9761 6388929 1.5 
22 21313 1989.37 4.9718 6552925 1.6 
23 21324 1986.68 4.9651 5855504 1.4 
24 22527 1692.51 4.2299 4471856 1.1 
25 22547 1687.62 4.2177 5451362 1.3 
26 22569 1682.24 4.2042 5585897 1.3 
27 22588 1677.60 4.1926 5120827 1.2 
28 23221 1522.81 3.8058 3077296 0.7 
29 23257 1514.00 3.7838 5100854 1.2 
30 23294 1504.96 3.7612 8316235 2 
31 23304 1502.51 3.7551 7995297 1.9 
32 23326 1497.13 3.7416 4639209 1.1 
33 23345 1492.48 3.7300 4230922 1 
34 23365 1487.59 3.7178 6085204 1.5 
35 23385 1482.70 3.7056 5734215 1.4 
36 23403 1478.30 3.6946 4745713 1.1 
37 23422 1473.66 3.6829 5832350 1.4 
38 23476 1460.45 3.6499 8703358 2.1 
39 23518 1450.18 3.6243 9085879 2.2 
40 23557 1440.64 3.6004 4438933 1.1 
Annex 3 – NMR spectra 
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41 26075 824.91 2.0616 155258672 37.2 
42 26084 822.71 2.0561 234060080 56.1 
43 26094 820.27 2.0500 416900224 100 
44 26102 818.31 2.0451 226217600 54.3 
45 26111 816.11 2.0396 106353888 25.5 
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Peak Nr. Data Point Frequency PPM Intensity %Int. 
1 16002 2560.63 6.3995 22883876 7 
2 18360 1964.93 4.9107 10237276 3.1 
3 18369 1962.65 4.9050 15560459 4.7 
4 18378 1960.38 4.8994 11419893 3.5 
5 18499 1929.81 4.8230 17527060 5.3 
6 18506 1928.04 4.8185 16507023 5 
7 18745 1867.67 4.6676 9755505 3 
8 18756 1864.89 4.6607 14021730 4.3 
9 18767 1862.11 4.6538 8864376 2.7 
10 19601 1651.42 4.1272 222677824 67.8 
11 20180 1505.14 3.7616 13581372 4.1 
12 20193 1501.86 3.7534 14200167 4.3 
13 20214 1496.55 3.7402 16280302 5 
14 20226 1493.52 3.7326 23618884 7.2 
15 20239 1490.24 3.7244 18645908 5.7 
16 20248 1487.96 3.7187 17111658 5.2 
17 20260 1484.93 3.7111 15595108 4.7 
18 20369 1457.40 3.6423 13916445 4.2 
19 20391 1451.84 3.6284 15279323 4.6 
20 20414 1446.03 3.6139 11579298 3.5 
21 20437 1440.22 3.5994 12751497 3.9 
22 20452 1436.43 3.5899 9024115 2.7 
23 20478 1429.86 3.5735 8695014 2.6 
24 20535 1415.46 3.5375 10052471 3.1 
25 20548 1412.18 3.5293 10712378 3.3 
26 20557 1409.90 3.5236 11441523 3.5 
27 20571 1406.37 3.5148 13021095 4 
28 20582 1403.59 3.5078 12278170 3.7 
29 20592 1401.06 3.5015 14380900 4.4 
30 20604 1398.03 3.4939 13495195 4.1 
31 20618 1394.49 3.4851 17598772 5.4 
32 20642 1388.43 3.4699 9592655 2.9 
33 22874 824.56 2.0607 145909104 44.4 
34 22882 822.54 2.0557 235314080 71.6 
35 22891 820.27 2.0500 328625248 100 
36 22900 817.99 2.0443 237550464 72.3 
37 22909 815.72 2.0386 130078344 39.6 
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COSY 1H-1H of compound 179 
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HSQC 1H-13C of compound 179 
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HMBC 1H-13C of compound 179 
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Selective ROESY of compound 179 
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Résumé 
Le sujet de cette thèse concerne le développement d’une méthodologie de synthèse d’ 
ellagitannins C-arylglucosidiques, possibles agents chimiothérapeutiques contre le cancer. 
Les ellagitannins C-arylglucosidiques sont des polyphénols bioactifs d’origine végétale, 
dérivés du métabolisme secondaire de l’acide gallique, et qui appartiennent à une sous-
famille des tannins hydrolysables. La structure chimique de ces molécules est caractérisée 
par trois éléments structuraux clés :  
un glucose sous forme ouverte,  
une liaison C-arylglucosidique,   
un motif de type 2,3- hexahydroxydiphenoyl (HHDP). 
  
OH OH
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Les unités HHBP et NHTP de type pyrogallol forment des cycles de dix et onze chaînons qui 
apportent à la structure un caractère rigide, stéréochimiquement très bien defini. La structure 
globulaire de ces molécules leur confère une aptitude certaine à interagir de manière 
spécifique avec des protéines d’intérêt pharmaceutique. Des études préliminaires ont montré 
que certains ellagitannins sont de puissant inhibiteurs de la topoisomérase II humaine, une 
enzyme ciblée par les chimiothérapies actuelles contre le cancer. La topoisomérase II 
intervient lors de la réplication de l’ADN, en éliminant les contraintes de torsion. Si la 
topoisomérase II est inhibée, la réplication ne peut plus se faire, bloquant ainsi la 
prolifération des cellules tumorales. 
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Forts de ces résultats préliminaires, nous avons concentré nos efforts sur le développement 
d’une stratégie de synthèse chimique de ces molécules afin de mieux comprendre leurs 
propriétés et réactivités chimiques, ainsi que leur mode d’action. Cela permettra in fine 
d’améliorer l’accès à des têtes de séries identifiées et de développer de nouvelles 
méthodologies pour la production d’analogues présentant des propriétés pharmacologiques 
améliorées. Dans le schéma suivant sont reportés les principaux résultats obtenus.  
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La construction stéréosélective de l’unité HHBP constitue l’étape décisive de toutes les 
synthèses d’ellagitannins décrites jusqu’à présent. Dans notre cas, l’intermédiaire 5 a été 
obtenu par une double estérification, en utilisant de la DMAP, du sucre 4 par l’acide 
racémique 2 (obtenu en 3 étapes en partant de l’acide ellagique naturel et commercial). Les 
diastéréoisomères S et R ont pu être isolés après chromatographie sur colonne. Le composé 
S-5 a ensuite été engagé dans une hydrogénation afin d’obtenir avec un rendement 
quantitatif le composé S-6. En ce qui concerne l’étape clé de C-arylglucosidation de notre 
synthèse, les seuls travaux rapportés à ce jour dans la littérature sont ceux de Tanaka, qui a 
réalisé l’hémisynthèse de la casuariine et de son épimère en C-1 à partir de la 
pédunculagine en chauffant à 70°C pendant 2h30 dans une solution de tampon phosphate à 
pH 7.6. 
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Tanaka avait proposé un mécanisme en deux étapes. Tout d’abord, une mutarotation du 
glucose provoquant l’ouverture du cycle pyranosique et la formation d’un intermédiaire 
aldéhydique. La deuxième étape du mécanisme est une aldolisation induite par un équilibre 
céto-énolique au niveau de l’unité HHBP, formant ainsi la liaison C-arylglucosidique 
attendue. Nous avons exploré des conditions similaires pour la C-arylglucosidation du 
composé couplé 6. Les mêmes conditions que celles décrites par Tanaka ont été utilisées et 
conduisent à un mélange complexe de produits non analysables. 
D’autres conditions opératoires ont été testées, impliquant des variations de la température, 
du temps de réaction, de la nature des solvants et du choix de bases organiques ou 
inorganiques. Malgré les nombreuses conditions testées, nous n’avons pas pu réaliser la C-
arylglucosidation dans des conditions basiques. Il s’avère que les conditions basiques 
utilisées ne sont pas adaptées a nos composés, conduisant inéluctablement à leur 
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dégradation. Cependant, la mutarotation du sucre peut être aussi induite sous des conditions 
acides. Nous avons donc essayé la réaction dans un tampon phosphate à des pH acides. A 
l’aide de ces nouvelles conditions, le produit 7 a pu être isolé et des expériences RMN 
mono- et bidimensionnelle ont permi de confirmer la formation de la liaison C-
arylglucosidique. Un seule étape de déprotection de l’épimère majoritaire a ensuite permis 
d’obtenir un premier membre de la classe des ellagitannins C-arylglucosidiques, à savoir 
l’épipunicacortéine A 5-O-desgalloylée (1).  
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